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ABSTRACT
A MULTI-METHOD EXPLORATION OF THE GENETIC AND ENVIRONMENTAL RISKS
CONTRIBUTING TO TOBACCO USE BEHAVIORS IN YOUNG ADULTHOOD
By Elizabeth Kieuvan Do, B.A., M.P.H.
A dissertation submitted in partial fulfillment of the requirements for the degree Doctor of
Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2017.
Major Director: Hermine H. Maes, Ph.D.
Associate Professor, Departments of Psychiatry and Human and Molecular Genetics
and Massey Cancer Center
Tobacco use remains the leading preventable cause of morbidity and mortality in both the
United States and worldwide. Twin and family studies have demonstrated that both
genetic and environmental factors are important contributors to tobacco use behaviors.
Understanding how genes, the environment, and their interactions is critical to the
development of public health interventions that focus on the reduction of tobacco-related
morbidity and mortality. However, few studies have examined the transition from
adolescent to young adulthood – the time when many individuals are experimenting with
and developing patterns of tobacco use. This thesis seeks to provide a comprehensive
set of studies looking at risk for tobacco use behaviors and nicotine dependence using
samples of young adults. The first aim is to examine the joint contributions of genetic
liability and environmental contexts on tobacco use in adolescence and young adulthood
xii

using classical twin study methodologies. The second goal is to identify genetic variants
and quantifying genetic risk for tobacco use in young adulthood and examining their
interaction with environmental context across development. Accordingly, the thesis is
divided up into the following sections: i) reviews of existing literature on genes,
environment, and tobacco use; ii) twin studies of genetic and environmental influences
on tobacco use behavior phenotypes; iii) prevalence, correlates, and predictors of
tobacco use behaviors; iv) genetic analyses of tobacco use behaviors; v) a commentary
on the emergence of alternative nicotine delivery systems and its public health impacts;
and vi) plans for an internet-based educational intervention seeking to reduce tobacco
use (and nicotine dependence) by providing students attending university with information
on genetic and environmental risk factors for nicotine dependence.
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CHAPTER ONE: GLOBAL INTRODUCTION
Elizabeth K. Do
Introduction
Tobacco use remains the leading preventable cause of morbidity and mortality in the
United States (US), as well as worldwide. In 2015, an estimated 36.5 million adults in the
US currently smoked cigarettes. Cigarette smoking accounts for an estimated $96 billion
in direct medical costs and $97 billion in lost productivity annually3. Although there has
been a slight overall decline in current smoking prevalence between 2005-2011,
especially among adults aged 18 to 24 years (from 24.4% to 18.9%), and a decline in the
prevalence of cigarette smoking4, there has been an increase in the use of emerging
tobacco products in recent years2. The National Adult Tobacco Survey, the Food and
Drug Administration (FDA) analyzed data between 2013 and 2014 and found that young
adults aged 18-24 reported the highest prevalence of use of emerging tobacco products,
such as water pipes/hookah and e-cigarettes5.
Specifically, within the United States, between 13.6% and 32.1% of adults report trying
one or more other tobacco products6,7. A more recent study indicates that nearly half of
current adolescent and young adult tobacco users engage in dual and multiple tobacco
product use, many of which fall outside of current FDA regulatory authority8. Given the
increased morbidity and mortality associated with tobacco use, disrupting the transition
to regular use of tobacco products among young adults is likely to result in a number of
lives saved and disease prevented at the population level9.
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There exists a widespread assumption within the public health community that tobacco
use is largely fixed by age 18, since most cigarette smokers report either having first tried
or experimented with smoking by age 182. However, for many young adults, tobacco use
patterns continue to change following age 18. For some, the period of young adulthood
is marked by the transition from occasional adolescent smoking to regular or established
smoking10. Many users who first try smoking at younger ages do not become “regular” or
daily users until much later, typically between the ages of 20-21 11. Furthermore, studies
suggest that both the proportion and intensity of smoking rise substantially after the age
of 1712. The possible escalation and continuation of tobacco use may make it more
difficult for users to stop using13. Thus, young adulthood is a critical period in the
development of tobacco use behavior that needs to be studied.
Given the high prevalence of tobacco use, the addictive nature of nicotine, and high
healthcare costs attributed to tobacco-related morbidity and mortality, developing
effective methods to aid individuals reduce tobacco use is critical. However, before this
is possible, a better understanding of the etiology of tobacco use and addiction, which
involves the complex interplay of genetic and environmental factors across development,
is needed – especially among those at elevated risk of developing patterns of regular
tobacco use.
To date, only a handful of studies have focused on the transition from adolescent to young
adulthood – the time at which many individuals are experimenting with and developing
patterns of tobacco use. As a means to contribute to the literature, this dissertation seeks
to provide a comprehensive set of studies looking at risk for tobacco use behaviors and
nicotine dependence using samples of young adults, keeping in mind two aims: (1)
2

examining the joint contributions of genetic liability and environmental contexts on
tobacco use in adolescence and young adulthood using twin methodologies and (2)
identifying genetic variants and quantifying genetic risk for tobacco use in young
adulthood and examining its interaction with environmental context across development.
In efforts to address these aims, the proposal is divided up into a few different sections:
reviews of existing literature on genes, environment, and tobacco use; twin studies of
genetic and environmental influences on tobacco use behavior phenotypes; prevalence,
correlates, and predictors of tobacco use behaviors; molecular genetic analyses of
tobacco use behaviors; a commentary on the emergence of alternative nicotine delivery
systems and its public health impacts; and, plans for an internet-based educational
intervention seeking to reduce tobacco use (and nicotine dependence) by providing
students attending university with information on genetic and environmental risk factors
for nicotine dependence.
Reviews of Existing Literature on Genes, Environment, and Tobacco Use
Chapter 2 (Narrative Review of Genes, Environment, and Tobacco Use) and chapter 3
(Genotype x Environment Interaction in Smoking Behaviors: A Systematic Review) are
reflective of efforts to understand the state of the science on the influences of genes,
environments, and their interactions on tobacco use behaviors, and provide a
comprehensive foundation for the specific aims of this dissertation. Whereas the narrative
review provides a description of gene variants and environmental factors associated with
cigarette use, and a broad overview of studies examining gene-environment interaction,
the systematic review takes a more technical approach by looking at variability in tobacco
use behavior phenotype definitions and methodological approaches across existing
3

studies of gene by environment interactions. Together, this set of studies suggest the
need for more studies of gene by environment interaction, with the caveat that variations
in methodological approaches within the existing literature make it difficult to interpret and
summarize findings across studies, and that future studies need better strategies for the
harmonization and standardization of tobacco use behavior phenotypes.
Twin Studies of Genetic and Environmental Influences on Tobacco Use Behavior
Phenotypes
Chapter 4 (Genetic and Environmental Influences on Smoking Behavior across
Adolescence and Young Adulthood in the Virginia Twin Study of Adolescent Behavioral
Development and the Transitions to Substance Abuse Follow-Up) and chapter 5 (A Twin
Study of the Genetic and Environmental Relationship of Stressful Life Events and
Smoking Initiation Using the Virginia Twin Studies of Adolescent Behavioral
Development) were conducted to investigate the role of genetic and environmental factors
contributing to two tobacco use behaviors: smoking initiation and current quantity smoked
within the Virginia Twin Studies of Adolescent and Behavioral Development (VTSABD).
The study described in chapter 4 was conducted to address the existing gap in the
literature regarding the underlying relationship between smoking initiation and current
quantity smoked by applying a common causal contingency model. The aims of this study
were to determine whether: (1) the genetic and environmental factors contributing to
smoking initiation and current quantity smoked are the same, (2) the magnitude of genetic
and environmental factor contributions is the same across adolescence and young
adulthood, and (3) if qualitative and quantitative differences in the sources of variance
between males and females exist. Meanwhile, chapter 5 takes a different approach by
4

focusing on smoking initiation and its relation to stressful life events. Given that no
genetically informed studies of the association between stressful life events and smoking
initiation have been conducted, it is unclear whether shared genetic or environmental
factors contribute to the covariation between stressful life events and smoking initiation,
and whether the covariation structure between these two traits differ from early
adolescence to young adulthood and across sex. To address this gap in the literature, the
study described in chapter 5 utilizes twin modeling analyses applied to VTSABD data.
Prevalence, Correlates, and Predictors of Tobacco Use Behaviors
Chapter 6 (Prevalence and Correlates of Tobacco Use and Nicotine Delivery Systems
among Young Adults in a University Setting), chapter 7 (Initial Experiences with Nicotine
and its Association with Recent Use of Tobacco and Nicotine Dependence), and chapter
8 (An Exploration of Sex Differences in Responses to Items of the Fagerström Test for
Nicotine Dependence) investigate the prevalence, correlates, and predictors of tobacco
use behaviors, with a focus on the following tobacco use behavior phenotypes: ever
tobacco use, age of initiation/onset, current use, regular use, the Fagerström Test for
Nicotine Dependence (FTND), in addition to two items of the FTND – cigarettes per day
and time to first tobacco use after waking. The main objectives of chapter 6 are to:
determine how prevalent tobacco use and nicotine delivery systems are among students
currently attending university and whether this differs by sex or race/ethnicity, and
examine whether tobacco use phenotypes are correlated with other environmental
factors, such as parental autonomy granting, parental involvement, and the experience
of stressful life events prior to university enrollment.
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Examining differences in tobacco use and the negative health outcomes resulting from
tobacco use by race/ethnicity is an important understudied area of research. Although
previous studies have identified biological predispositions and social determinants
associated with traditional cigarette use among adult Black/African Americans not found
for White/Caucasian Americans, there are few twin and family studies with a sizeable
number of non-White participants to determine whether heterogeneity exists in the
heritability of tobacco use behaviors14.
Chapter 6 provides a background chapter on Spit for Science: The VCU Student Survey
(S4S) – the sample that was used for all the molecular genetic analyses of tobacco use
behaviors in this dissertation. Chapter 7 leverages data from S4S and the VTSABD to
determine whether initial experiences with tobacco use differs by tobacco product used
and are associated with recent tobacco use and meeting criteria for nicotine dependence,
as well as determine whether any of these associations differ by sex. The study described
in chapter 8 was conducted to test sex differences in the response to FTND items within
African and White/Caucasian Americans, and to investigate the psychometric properties
of FTND items across these groups. Taken together, these chapters are meant to
describe phenotypic definitions for subsequent genetic analyses and to identify correlates
and predictors of multiple tobacco use behaviors, while also providing information on the
prevalence of emerging alternative tobacco products and nicotine delivery systems within
an active and on-going study of university students.

6

Molecular Genetic Analyses of Tobacco Use Behaviors
Chapter 9 (Genetic Analyses of Tobacco Use Behaviors Among an Ethnically Diverse
University Sample) and chapter 10 (Polygenic Risk Scores for Tobacco use Behaviors: A
Comparison of Methodologies, Applied to a University Sample) utilizes genotypic data
from the Spit for Science sample to address the second aim of this dissertation: to identify
genetic variants and quantify genetic risk for tobacco use in young adulthood and to
examine its interaction with environmental context across development. More specifically,
chapter 9 examines several tobacco use behaviors (e.g. initiation, age of onset, current
use, regular use, cigarettes per day, time to first tobacco use, and the FTND) among a
diverse sample of young adults attending university in efforts to calculate the heritability
of tobacco use behaviors within this sample, and to identify genetic variants contributing
to tobacco use behaviors in young adulthood by means of conducting genome wide
association analyses on each of these phenotypes. Chapter 10 expands on the work
conducted in chapter 9 by describing the development polygenic risk scores using two
methodological approaches, determining whether these polygenic risk scores are
predictive of tobacco use behaviors, and to assess gene-by-environment interactions
between these polygenic risk scores and environmental variables (parental autonomy
granting, parental involvement, and stressful life events).
Commentary on the Emergence of Alternative Nicotine Delivery Systems and its
Public Health Impacts
Chapter 11 (A Moving Target: The Emergence of Alternative Nicotine Delivery Systems
and Public Health Impact) is a commentary regarding the growing prevalence of
7

alternative tobacco products and nicotine delivery systems, policy implications of tobacco
product regulation, and what this might mean for future directions of research. It remains
unclear whether these alternative tobacco products and nicotine delivery systems will be
replacing traditional tobacco products without expanding patterns of nicotine use among
adolescents and young adults – the main target of tobacco company advertising and
public health harm reduction and prevention efforts. And, as information is collected
regarding how much and how these products are being used, the availability and
marketing of these products will continue to grow and change with user preferences. It is
for this reason that it is important that more attention is given to the relationship between
alternative tobacco products, nicotine delivery systems, and traditional cigarette use.
More work needs to be done to better understand the increasing complexity of tobacco
use among adolescents and young adults to promote effective public health planning and
to ensure that the regulation of alternative tobacco products (or lack thereof) does not
undermine current anti-tobacco regulatory efforts
Plans for an Internet-Based Educational Intervention Seeking to Reduce Tobacco
Use (and Nicotine Dependence)
Chapter 12 (Plans for a Pilot Randomized Control Trial of Internet-Based Educational
Intervention for Reduction of Tobacco Use and Nicotine Dependence) contains
information on the planning of a feasibility study involving an Internet-based educational
intervention examining how providing college students with information on the influence
of genes and the environment on tobacco use behaviors and nicotine dependence
impacts subsequent patterns of tobacco use behavior. To date, few interventions are
specifically aimed at young adult smokers, even though tobacco use is common among
8

college students, and college is a critical time for experimentation with and development
of patterns of tobacco use. The study described in this chapter applies principles of the
Health Belief Model (HBM), which assumes health behavior is determined by perceptions
of perceived threat, perceived susceptibility and severity, perceived benefits, perceived
barriers and the strategies available to decrease its occurrence. By applying the HBM
concept and constructs to our intervention, which seeks to reduce tobacco use (and risk
for nicotine dependence) in young adult tobacco users, we seek to increase their
perceived threat, susceptibility, and severity of nicotine dependence while decreasing
their perceived barriers to reducing tobacco use among college student participants by
providing knowledge of genetic and environmental risks for nicotine dependence and
means to decrease barriers to reducing tobacco use.
Altogether, this set of studies contributes to the literature by providing a better
comprehensive understanding of how genes, the environment, and their potential
interactions influence many tobacco use behavior phenotypes by keeping in mind two
aims: (1) examining the joint contributions of genetic liability and environmental contexts
on tobacco use in adolescence and young adulthood using twin methodologies and (2)
identifying genetic variants and quantifying genetic risk for tobacco use in young
adulthood and examining its interaction with environmental context across development.
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CHAPTER 2:
NARRATIVE REVIEW OF GENES, ENVIRONMENT, AND TOBACCO USE 1

Elizabeth K. Do and Hermine H. Maes

INTRODUCTION
Tobacco use remains the leading cause of preventable death in the United States and
results in nearly $170 billion in direct medical care for adults and greater than $156 billion
in lost productivity due to premature death and exposure to secondhand smoke 1. These
costs emphasize the need to understand what genes and environments are involved in
the establishment of cigarette use behavior2. Knowing what genes and environmental risk
factors impact cigarette use can help to reduce its prevalence by shaping prevention and
intervention efforts. However, to date, many studies on cigarette use have focused solely
on genes and environments contributing independently to risk for cigarette use and its
health consequences. Fewer studies have investigated the effects of gene-environment
interaction (GxE), which can be conceptualized as the difference in the contribution of
genetic factors, conditional on environmental exposure 3. Since cigarette use involves
both motivational and reward systems that develop through interactions between genes
and the environment, studies of the joint effects of multiple genetic mutations across
different environments could be useful in understanding the range of genetic susceptibility
to environmental risk factors influencing cigarette use and its health consequences 4. GxE
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studies have been useful in determining whether genetic effects are more or less
important under particular environmental conditions5. For example, restricting the
availability of tobacco has been found to reduce the effect of genes influencing whether
individuals initiate and maintain smoking behaviors. Alternatively, under environments
where there are fewer restrictions, the importance of the role of genes is expected to
increase since individuals are able to express the full range of phenotypes 6, inclusive of
nicotine dependence and tobacco-related health conditions such as heart disease and
cancer. Quitting cigarette use can effectively reduce the risk of these tobacco-related
outcomes for each individual smoker, while also substantially reducing excess healthcare utilization and improved labor supply on a larger scale 4. However, to improve
strategies for disease prevention and intervention efforts focused on smoking cessation,
a better understanding of genetic, social environment, and individual determinants of risk
contributing to cigarette use are needed. In other words, we need to be able to disentangle
the etiology of cigarette use and identify the conditions under which genes, the
environment, and their interaction impact cigarette use behaviors. Through this narrative
review, we seek to integrate twin and molecular genetic studies of GxE in cigarette use.
Specifically, this narrative review provides a brief overview of studies investigating genetic
and environmental factors influencing cigarette use separately, and then summarizes
gene-environment interactions in cigarette use behaviors.
Phenotypic Measures of Cigarette Use
It is important to understand how cigarette use has been measured before getting into
details about how we can determine how much of cigarette use is attributed to genes, the
environment, and their interactions. The most common phenotypic measures of cigarette
11

use include: initiation; adolescent smoking; cigarettes per day; regular smoking; nicotine
dependence; and smoking cessation. Initiation is usually a self-report measure that is
assessed using a yes or no question, such as “Have you ever smoked an entire
cigarette?”7. Although adolescent smoking is often treated as binary (yes/no) variable, the
way in which it is assessed differs across studies. One study may measure adolescent
smoking by asking the question, “Have you ever smoked (or tried smoking)?” to which
adolescents can respond either yes or no8. While another study may ask adolescents to
choose from a nine-point scale with multiple response categories, ranging from “I have
never smoked, not even one puff” to “I smoke at least once a day” and recode responses
to either no (non-smoker) to yes (smoker)9,10. There is also some variation in how to
assess cigarettes per day: some studies collect the average number of cigarettes smoked
per day, while others collect the maximum number of cigarettes per day11. Nicotine
dependence is most often assessed using the Fagerström Test for Nicotine
Dependence12. Smoking cessation is assessed in a variety of ways, though the most
common seems to be through self-reports of abstinence (e.g. 7-day point prevalence
abstinence, 30-day prolonged abstinence, 6-month prolonged abstinence) or by asking
about quit attempts. These different stages of cigarette use vary in their heritability,
suggesting that different points along smoking trajectories may be influenced by different
etiological factors13. Distinguishing between these phenotypes helps to provide insight
into the nature of cigarette use, which may provide guidance for potential interventions
and treatments14.
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Quantitative Studies of Inferred Genetic Susceptibility for Cigarette Use
Classic twin methodologies have been useful in quantifying genetic and environmental
factors associated with cigarette use phenotypes. Generally, twin study methods have
been used to compare the agreement in the behavior of monozygotic or identical twins
that share the same genetic make-up and dizygotic or fraternal twins who share, on
average, 50% of their genetic make-up. Statistical models estimate the percentage of
variance in the trait explained by genes (i.e. heritability) and by common environment (i.e.
experiences that render family members more alike) and unique environment (i.e.
experiences that cause dissimilarity between family members)15. Heritability estimates
differ according to phenotype and age. For the initiation of cigarette use, shared
environmental factors account for a small proportion of the liability 16, relative to additive
genetic factors, which account for ~60% of the variance 17. Data from one meta-analysis
showed differences in the heritability of initiation by sex, suggesting that genetic and
environmental factors may contribute differently to individual differences in initiation in
male and female smokers. Whereas the weighed mean heritability for females reached
~50%, the weighted mean heritability for males was ~40%18. Meanwhile, heritability
estimates for smoking persistence range from 50% to 70%, for smoking quantity from
40% to 60%, for nicotine dependence from 60% to 80%, and for smoking cessation
~50%19–21. It has also been suggested that the liability to smoking initiation, regular
tobacco use, and nicotine dependence are correlated. Specifically, more than 80% of the
variance in liability to initiation and regular use is shared, while a smaller proportion is
shared between regular use and nicotine dependence 17. Added to this, age-dependent
genetic effects have been identified, whereby the genetic liability influencing later
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cigarette use behaviors is more influential when cigarette use is initiated during
adolescence22, implying a gene-environment interaction with the environment being
operationalized as age.
Gene-Finding Efforts for Cigarette Use
While twin and family studies were able to establish that cigarette use phenotypes were
heritable, technological advances made it possible to sequence the human genome and
look for the genes underlying these twin and family heritability estimates. Gene finding
methods are used to determine the locations of gene variants that differentially impact the
liability to traits. In general, these gene-finding methods are statistical in nature, such that
researchers infer the probability that a locus in the genomic region under investigation
contributes to liability for the trait (e.g. cigarette use phenotypes) from an examination of
the distribution of genetic markers within either families, as in linkage studies, or
populations, as in genome-wide association studies (GWAS) 23. Genome-wide linkage
studies were first used to identify chromosomal regions that could have contained loci
contributing to cigarette use phenotypes, involved with either the neurotransmission of
neuromodulators or the rewarding efforts of nicotine on the mesolimbic system 24.
Candidate gene studies investigated associations between measures of cigarette use
initiation, intensity, and dependence and genes involved with nicotine receptors,
dopaminergic transmission, and serotonin transporters. Despite some regions showing
suggestive linkage in multiple studies, results have been heterogeneous. Added to this,
genes implicated in candidate gene studies have not been reliably associated with
cigarette use phenotypes in larger GWAS, the effects of most candidate genes for
cigarette use remain largely ambiguous. Replication of candidate gene studies remains
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a problem because of small sample sizes in each individual study, differences in
measures of cigarette use, and differences in genetic and environmental backgrounds 25.
GWAS simultaneously analyzes common genetic variants across the entire genome and
has have been used since the early 2000s to identify genetic variants contributing to
cigarette use phenotypes26. Gene-finding efforts have identified associations between a
variety of cigarette use phenotypes and single nucleotide polymorphisms (SNPs) within
neuronal nicotinic acetylcholine receptor genes (nAChRs), the initial physiological targets
of nicotine in the central and peripheral nervous system 27–29, and variable-number-oftandem-repeats (VNTR) polymorphisms located in dopaminergic genes and serotonin
transporter genes30.
Nicotinic receptor genes
Although nAChRs in CHRNA7, CHRNA9, CHRNA5, CHRNB3, and CHRNA4 were found
to be significantly associated with nicotine addiction in early candidate gene studies,
GWAS failed to provide support for these findings31. Instead, independent GWAS have
provided evidence for association between common variants within the CHRNA5CHRNA3-CHRNB4 gene cluster located on chromosome 15 and nicotine dependence.
The studies identified in this review investigated the following SNPs within this cluster:
rs1696996832,33, rs68024433, rs374307832, and rs105173034,35 which is in near-perfect
linkage disequilibrium with rs16969968 in Caucasian samples. Numerous studies have
demonstrated the association between functional variant rs16969968 and cigarettes per
day (CPD) and nicotine dependence27,29,36, heavy smoking28,37 and decreased response
to nicotine antagonists in vitro34. The same locus was associated with the risk of lung
cancer and chronic obstructive pulmonary disease in several GWAS 22. SNP rs680244
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has been associated with variability in CHRNA5 mRNA levels 33. SNP rs3743078 is a
proxy for variant rs578776, which has also been associated with nicotine dependence 32.
Gene variant rs1051730 has been previously associated with smoking quantity and
increased susceptibility for lung cancer and vascular disease among smokers.
Dopaminergic genes
The dopaminergic system is also believed to play an important role in nicotine
dependence, since nicotine increases dopaminergic activity in the brain to induce feelings
of pleasure or reward. Candidate genes include: dopamine receptors (D2 and D4),
dopamine transporter gene (DAT1), ankyrin repeat and kinase domain containing 1
(ANKK1), tetratricopeptide repeat domain 12 (TTC12), and the serotonin transporter gene
(5-HTTLPR). ANKK1 contains a TaqIA1 C>T polymorphism (rs1800497) that has
previously been associated with reduced dopamine D2 receptor availability and binding
capacities in the brain, which is believed to cause carriers of the allele to compensate for
the reduced state of reward following nicotine use. It is also weakly associated with
adolescent smoking initiation9. Dopamine receptor D4 is a G protein-coupled receptor
encoded by the DRD4 gene that is activated by the neurotransmitter dopamine. The 48base pair variable-number-of-tandem-repeats polymorphism in exon III of the DRD4 gene
ranges from 2 to 11 repeats. Previous studies have indicated that the longer the repeat,
the more dampened the response to dopamine. The DAT1 transporter gene regulates reuptake
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neurotransmission, and maintaining dopamine homeostasis. DAT1 contains a
polymorphic 40-base pair VNTR which has been previously associated with lower risk of
early smoking onset and current smoking. The gene cluster TTC12-ANKK1-DRD2 plays
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a central role in modulating dopamine reward system, by mediating the reinforcing effect
of all known addictive substances34.
Serotonin transporter gene
It has been demonstrated that 5-HTTLPR plays a role in nicotine dependence via
mediating rewarding effects in the dopaminergic reward system; two common variants (a
14-repeat short (S) variant having less transcriptional activity and lower serotonin uptake
and a 16-repeat long (L) variant) seem to have differential effects. While the S allele has
a significant effect on smoking behavior, the L allele contributes more to smoking rate 38.
It has been suggested that the differential effects are due to interactions with other
polymorphisms, though results are inconclusive 39.
Meta-Analyses, Missing Heritability, and Why Studying GxE is Important
Although independent genome wide association studies have identified variants
associated with cigarette use, these variants currently explain very little of the phenotypic
variation because genetic effects due to common alleles are quite small and the detection
of signals requires very large sample sizes. GWAS are underpowered to detect these
effects. To overcome the issue of power and false-positive findings, meta-analysis
statistically synthesizes information from multiple studies 40. The largest genetic metaanalysis of cigarette use conducted by the Tobacco and Genetics Consortium included
sixteen GWAS and found five significant loci. Each of the five loci was associated with
only one specific smoking phenotype: nonsynonymous rs6265 on BDNF and smoking
initiation (OR = 1.06, 95%CI: 1.04, 1.08, p-value = 1.8 x 10 -8); nonsynonymous rs1051730
in 15q25 on nicotinic receptor gene CHRNA3 (β = 1.03, SE = 0.053, p-value = 2.8 x 10 -
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73),

rs1329650 on 10q25 (β = 0.367, SE = 0.059, p-value = 5.7 x 10 -10), and rs3733829 in

9p13 of EGLN2 (β = 0.333, SE = 0.058, p-value = 1.0 x 10 -8) and number of cigarettes
per day, and rs3025343 near DBH on chromosome 9 and smoking cessation (OR = 1.12,
95%CI: 1.08-1.18, p-value = 3.6 x 10-8)11. Still, the variance attributed to these genetic
variants only explains a small proportion of phenotypic variation in cigarette use, which
does not correspond to estimates of heritability calculated from twin and family studies. A
portion of this “missing heritability” might be explained by gene-environment interaction 41,
emphasizing the importance of studying GxE. Although reliable demonstration of GxE
requires very large sample sizes, studies of GxE can be helpful in determining why
heritability estimates for cigarette use phenotypes vary, and could explain why the search
for susceptibility genes from GWAS have not been especially successful. Identified
genetic loci from the current literature contribute only modestly to the variability in
cigarette use phenotypes. Once we can identify more genes contributing to cigarette use,
studies of GxE could be used to shape smoking cessation therapies and tobacco control
efforts, through interventions tailored to genotypes or environmental factors contributing
to tobacco use.
Social and Environmental Risk Factors for Cigarette Use
Although it is clear from the literature that genes influence cigarette use, the motivation
to begin smoking is also strongly impacted by the social environment, especially during
adolescence42. As twin and family studies have demonstrated, shared environmental
factors also account for a replicable proportion of the variation in initiation specifically 16,
and smoking behaviors more generally43. Thus, research on genetics and cigarette use
should consider social and environmental factors that may modify genetic risk, especially
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when we consider cigarette use as a dynamic process in which individuals can move from
initiation, to intermittent use, to regular use, and/or dependence. Understanding the
genetic and environmental factors that interrupt progress along this trajectory or
potentiate continued use could be useful for intervening with cigarette use and promoting
either prevention of initiation or cessation after continued cigarette use 44. Below, we
review epidemiological findings of key environmental covariates that may influence
cigarette use and should be considered for genetic research on cigarette use.
Sociodemographic Characteristics. Sociodemographic characteristics should be
considered potential environmental covariates in genetic research on cigarette use
because the prevalence of smoking tends to be higher among disadvantaged groups.
Additionally, disadvantaged users of cigarettes may be more likely to initiate use, less
likely to be successful in quit attempts and face higher exposure to the harms of tobacco 45.
Groups that are at higher risk for smoking include the poor, semi-skilled manual
occupation groups, the unemployed, poor educational achievers, and single mothers 12,46.
Smoking prevalence among these groups may be due to reduced support for quitting, low
motivation to quit, stronger addiction to tobacco, targeted marketing by tobacco
companies, and psychological differences regarding self-efficacy in the ability to quit 45,
which could be intensified by high feelings of anxiety47, hopelessness, lack of social,
communication, and refusal skills, and low self-esteem 48, or experiencing highly stressful
events in childhood49. These are all potential points of intervention for cessation efforts
and have the potential to reduce health costs associated with cigarette use. Cigarette use
also varies by sex between countries, making it difficult to determine whether males or
females are more likely to smoke50. However, according to a review paper of 12 studies
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published between 1980 and 2010 assessing smoking initiation, boys had a lower age of
smoking initiation relative to girls51. Meanwhile, according to longitudinal studies, girls and
boys have similar levels of overall substance use during early adolescence, but boys have
greater increases in substance use during middle and late adolescence after initiation 52.
Studies of adult smokers have also demonstrated that women tend to smoke fewer
cigarettes per day, use cigarettes with lower nicotine content, and do not inhale as deeply
as men. However, it remains uncertain whether this may be due to differences in
sensitivity to nicotine or differences in other social factors associated with the experience
of cigarette use53.
Family Cigarette Use.

Although family influences play an important role on the

development of cigarette use, most of the research done has focused the role of parents
and siblings on experimentation with and the onset of cigarette use 54–56. As evidenced by
previous studies, negative family environments characterized by low connectedness or
cohesion57 high levels of parent-child conflict, inadequate parental monitoring, and family
violence contribute to tobacco use58. Individuals with negative family environments may
be less likely to comply with parental requests to abstain from smoking and their initial
use may go undetected or unpunished59. Alternatively, an authoritative, positive parental
style60, and parental anti-smoking socialization (i.e. messages about smoking, reactions
to smoking, household smoking rules), parental expectations and opinions about the
choice to smoke61–63 may help prevent early adolescents from smoking. Added to this,
there is consistent evidence demonstrating that parental smoking is a risk factor for
adolescent smoking58,64. However, one study found that the effect of parental disapproval
both in smoking and nonsmoking parents was stronger and more robust than that of
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parental smoking and even attenuated the effect of peer smoking, suggesting that
parental disapproval makes adolescents more resistant to peer smoking 65. However, it
remains unclear to what extent this is pure environment and passive gene-environment
correlation. The presence of gene-environment correlation would imply that non-smoking
parents pass on their “non-smoking” genes but also create a non-smoking environment.
Siblings also influence the initiation and escalation of cigarette use, such that having older
siblings who smoke increases a child’s risk of smoking even after adjusting for parents’
smoking66. Risk of initiation increases substantially as the number of smokers in an
adolescent's environment increases, with adolescent females more likely to smoke than
adolescent males56,67. Besides their smoking behavior, social connectedness between
siblings appears to moderate shared environmental influences on smoking frequency and
any subsequent changes on smoking frequency68. Given that few longitudinal studies
have
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experimentation and initiation, information that could inform the development of effective
cigarette use prevention programs addressing family influences remains limited 54.
Peer Cigarette Use. Peer relationships, especially those during adolescence, contribute
to an individual’s initiation, progression, and trajectories of cigarette use 69. In fact,
adolescent smoking is more strongly associated with peer smoking, relative to parents’
smoking56,70–73. It has also been suggested that parental smoking does not moderate the
association between friends smoking and adolescent smoking; although, parental
behaviors may effect smoking progression through their impact on the selection of
friends72 and limiting increases in the number of friends who smoke 61. It has been
previously suggested that adolescents who frequently smoke in the presence of others,
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use smoking as a way to achieve social belonging74 and are more likely to smoke when
their best friends smoke. However, there is debate about whether peer influence leads to
smoking (e.g. socialization) or whether individuals who smoke tend to seek out other
smokers (e.g. selection)75. Added to this, cigarette use initiation is more likely to occur in
schools with higher smoking rates76, since smoking may seem more normative and
acceptable77 and more social sources of cigarettes may exist78. This might explain why,
despite legislation that prohibits tobacco sales to minors, adolescents are still able to
acquire cigarettes through direct purchase from others or from older friends 79. It is also
unclear to what extent this is pure environment, rather than active gene-environment
correlation whereby individuals are acting on their propensity to use cigarettes by seeking
out friend groups that permit cigarette use. Longitudinal study designs of adolescents and
their peer groups may help to determine whether gene-environment correlation is present,
while disentangling whether socialization or selection has a stronger impact on
trajectories of cigarette use. Findings from these longitudinal studies may be helpful in
the design of interventions. For example, interventions may want to focus on cognitive
factors as a means to mitigate effects of peer group influences on cigarette use through
social skills or altering social norms69.
Age of onset. Approximately 90% of adult smokers first tried cigarettes before the age
of 18, and practically all began using cigarettes before the age of 26 80. In addition to being
at higher risk for nicotine dependence81, individuals who have an earlier onset of cigarette
use are at increased risk for heavy smoking22 and worse tobacco-related health outcomes
in adulthood82. Added to this, one study conducted on students in grades 9-12 in Canada
found that a delay of one year in the age of smoking onset was associated with lower
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odds of being a current smoker (adjusted OR = 0.76, 95% CI= 0.73-0.79). Increasing the
age of onset also seems to increase the likelihood of successful smoking cessation, as
results from another study found that the likelihood of smoking cessation was greater in
smokers who had begun cigarette smoking after age 13, relative to individuals who had
begun earlier83. These findings suggest that early prevention and intervention are needed
to avoid early-onset cigarette use to reduce negative consequences associated with
cigarette use, such as nicotine dependence and tobacco-related health outcomes in
adulthood82.
Public policy. Given the toll taken by cigarette use, several public policies have been
implemented to control tobacco use. The choice of public policy varies considerably
between and within countries, allowing for a natural experiment in the study of the effects
of tobacco control on the demand for and use of cigarettes. Examples of tobacco control
policies include prohibition of paid-for advertising for tobacco products, promotion of
smoke-free policies, and excise taxes on tobacco products 84. Since countries do differ
greatly in the prevalence of cigarette use, potentially due to differences in cultural norms
and attitudes towards cigarette use, results might not replicate across countries. In
general, studies have found that smoking restrictions in public places have a negative
effect on average cigarette consumption by smokers, such as smoking restrictions in
restaurants, limited cigarette sale through vending machines, and smoking restrictions in
shopping areas85 and workplaces86. And, as summarized from one systematic review,
increasing taxes on tobacco products independently reduces smoking prevalence among
youth and adults, while banning smoking in public places reduces the prevalence of
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smoking among the general population, and mass media campaigns reduce the initiation
of smoking in youths and prevalence in adults87.
Religion. Although religion seems to be inversely related to all measures of tobacco use
(i.e. lifetime, occasional, and regular use), findings suggest that religion’s primary
influence on cigarette use is the negative effect it has on ever use88. Importance of religion
and attendance in worship services are negatively associated with smoking, such that the
more religious a teenager perceives him or herself to be, the less likely it is that he or she
would smoke89. Furthermore, private religiosity is protective against initiation of regular
smoking among nonsmokers as well as the initiation of experimental smoking, but only
when the young person attends religious services or a religious youth group frequently.
Meanwhile, public religiosity predicts the reduction and cessation of cigarette use among
regular smokers90. It has been suggested that religiosity may discourage the use of
substances through adolescents’ exposure to religious doctrines discouraging the use of
substances, which implies that religious individuals may be more likely to hold
conservative attitudes towards substance use, such as cigarette use, and will affiliate with
peers that are similar to them91.
Evidence of Gene-Environment Interaction in Cigarette Use
From the previous sections of this manuscript, it is clear that genes and environments
contribute to risk for cigarette use. However, it is important to remember that cigarette
use phenotypes are complex traits arising from interactions among social-environmental,
psychological, and genetic factors92 and these interactions need to be taken into
consideration when developing downstream public health interventions. Despite progress
made in the prevention of and treatment for cigarette use, available treatments are
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effective for only a portion of smokers. Whereas the identification of specific genetic
variants is necessary in determining the underlying biological mechanism of risks for
cigarette-related health outcomes, understanding how these variants interact with
aspects of the environment to influence cigarette use has the potential to more effectively
tailor interventions to smokers’ individual risks and needs 93. In studies of geneenvironment interaction, genetic effects can be modeled either as latent variables in twin
and family studies or as genuine measured genes in molecular genetic studies. When
genetic effects are modeled latently, the contribution of gene effects is inferred based on
observed correlations between people with different degrees of sharing across genes or
the environment5. These correlations are used to study whether the heritability is the
same in different groups. Meanwhile, molecular genetic studies focus mostly on one
specific gene of interest, rather than the aggregate effect of genes influencing a trait.
Despite awareness of the importance of gene-environment interactions in tobacco use,
studies available on the subject are currently limited. Evidence from twin studies have
predominantly focused on the importance of genetic factors influencing cigarette initiation,
as it relates to family environment, school environment, neighborhood characteristics, and
religion, while molecular genetic studies of social policy and the environment have
investigated whether genetic influences on initiation, daily smoking, and cessation are
moderated by social policy and the environment. All studies discussed in this section still
await replication.
Family environment. One Finnish twin study demonstrated that at age 14, the effect of
genes on cigarette use increased and common environmental effects decreased as
adolescents reported less parental monitoring. Specifically, genetic factors accounted for
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more than 60% of the variance at the extreme low end, but less than 15% at the extremely
high end of parental monitoring. Meanwhile, common environmental effects accounted
for 20% and 80% of the variance at extremely low and high ends of parental monitoring,
respectively8. Parental monitoring seems to have an effect on genes contributing to
nicotine dependence as well, as demonstrated by a significant interaction found between
rs169169968 and parental monitoring (p =0.009) in the Collaborative Genetic Study of
Nicotine Dependence, whereby nicotine dependence increased with the risk genotype
when combined with the lowest quartile of parental monitoring32. This suggests that
parents moderate the likelihood of an individual at genetic risk for adolescent smoking
and nicotine dependence in later life, through the restrictiveness of the social environment
provided by parents. Variation in rs3743078 did not contribute to this association, as no
significant interaction was found between parental monitoring and rs3743078 (p=0.80).
Meanwhile, whether parents smoke may have less of an effect on adolescent smoking,
as interactions between measures of environmental smoking, conceptualized as paternal
smoking, maternal smoking, or sibling smoking, and genetic variants of DRD2, DRD4, or
DAT1 of the dopaminergic system did not significantly contribute to variation in adolescent
smoking9. Furthermore, only one significant interaction found between maternal smoking
and rs1051730 influenced occasional smoking at 14 years34. One study investigated the
effect of smoking-specific parenting messages across: how often parents talked with their
child about smoking- related issues in the past 12 months (e.g. “frequency”), how
respectful parents were to children about communicating about smoking-related issues
(e.g. “quality), and whether there were smoking-specific rules at home (e.g. “house
rules”). The effect of these smoking-specific parenting messages seems limited, as the
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Dutch study found no evidence for interaction between smoking-specific parenting in
terms of frequency, quality, or house rules, and dopaminergic genes on adolescent
smoking behavior10. Dopaminergic genetic variants DRD2, DRD4, and DAT1 were
chosen for their associations with smoking from previous studies.
School environment. Two twin studies investigated the moderating effect of school-level
variables on heritability of adolescent smoking behavior94,95. Findings from Daw et al.
(2013) suggest that an individual’s susceptibility to school-level patterns of smoking is
conditional on the number of short alleles in 5-HTTLPR. The greater the number of short
alleles, the stronger the individual’s response to the school health behavioral
environment38. No interaction effects were found between dopaminergic genes and peer
smoking9. Institutional control, which incorporated measures of school smoking policies
implemented by adults and whether teachers could smoke on school grounds, was not
found to significantly interact with genetic influences on daily smoking among youth 94.
There was also no evidence for interaction between state-level smoking by adults,
measured by the percentage of adults reporting regular use in the Behavioral Risk Factor
Surveillance System (1992-1993), and genetic influences on regular use during
adolescence. This was not the case for state-level smoking by youth, measured by the
percentage of 9th to 12th graders reporting frequent smoking, which was found to be
negatively associated with genetic influences on regular smoking. Within schools, the
effect of genes on daily smoking decreased as the prevalence of smoking among popular
students increased, suggesting that social pressures within schools moderate the
heritability of daily smoking. These interactions were not found for smoking onset 94. One
study also tested whether the response to a substance use prevention/intervention
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program varied based upon a set of five markers (rs16969968, rs1948, rs578776,
rs588765, and rs684513) and found that there was a main effect of both the intervention
(b=-0.24, p-value<0.05) and genotype at rs16969968 (b = 0.14, p-value <0.05) on high
school smoking. The genotype x intervention interaction effect was also found, where
those with the A/A and G/A genotypes reduced their levels of smoking to levels similar to
those with G/G genotypes following the intervention phenotype (G/G vs. A/A: b = -0.67, p
< 0.05; A/G vs. A/A: b = -0.61, p < 0.05; G/G vs. A/G n.s.) 96.
Neighborhood environment. Neighborhood-level factors have previously been
associated with the risk of smoking initiation. To test whether genetic factors and social
context influence cigarette use, one molecular study investigated the interaction between
an aggregated genotypic risk score (GRS) combining the top genetic variants (i.e. all
SNPs reaching a p-value threshold of <5 x 10-7) from a meta-analysis previously
conducted on African Americans, and neighborhood-level effects on smoking behavior.
Among individuals who had ever smoked cigarettes, the GRS significantly predicted the
number of cigarettes smoked per day (measured by “In the past 30 days, on those days
when you smoked, on average, how many cigarettes did you smoke per day?”) and
accounted for ~3% of the variance. Significant interactions were observed between the
GRS and number of traumatic events experienced and average neighborhood social
cohesion, but not neighborhood physical disorder. The association between the GRS and
cigarettes per day increased with increasing number of traumatic events and decreased
with increasing levels of neighborhood social cohesion 97.
Religion. Most studies investigating the effect of religion on cigarette use have focused
on the association between measures of religiosity and smoking initiation. Only one twin
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study investigating the moderating effect of religion on cigarette use was identified, which
investigated the interaction between self-rated religiousness, religious affiliation, and
organizational religious activity and smoking initiation heritability. This study provided no
evidence for interaction between religious affiliation or organizational religious activity and
genetic influences of smoking initiation. It did, however, find that high levels of self-rated
religiousness attenuated the additive genetic component for smoking initiation 7.
Public Policy. Given that smoking ranks highly among public health problems in the
world, public policy initiatives have been implemented to decrease smoking prevalence,
while also emphasizing the negative health consequences of cigarette use. Examples of
legal and regulatory policies related to tobacco include prohibition of smoking in public
places and workplaces, restrictions on sale and marketing of tobacco products (especially
to children), and federal legislation giving government agencies the authority to regulate
tobacco98. One study conducted in the Netherlands explored whether a change in
environmental conditions – that is, smoking policies such as cigarette pack warnings
about health consequences and bans on smoking advertisements – led to a change in
the relative contribution of genetic factors to smoking initiation by comparing data on two
cohorts of young adult twins. This study found that although the changes in policies and
attitudes towards smoking led to a decrease in the prevalence of smoking, it did not
change the heritability of smoking. These findings did not provide support for GxE
between initiation and public policy initiatives 99. Meanwhile, a few studies demonstrate
interactions between policy initiatives and the heritability of daily and regular smoking
have found evidence for GxE95,100,101, suggesting that historical time periods can be
characterized as distinct social environments that moderate the contribution of genes to
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cigarette use102. One study using twin pairs from the National Survey of Midlife
Development in the United States found that the timing of the first Surgeon General’s
Report coincides with an increase in the genetic influences on regular smoking, but
subsequent legislation prohibiting smoking in public places reduced these influences 100.
Another study conducted using data from the National Longitudinal Study of Adolescent
Health, investigated interactions between state-level measures characterizing social and
institutional effects on smoking and daily smoking and smoking onset of adolescents. At
the state level, the effect of genes on daily smoking were lower in states with relatively
high taxes on cigarettes and greater controls on vending machine and cigarette
advertising, while there was no variation in heritability estimates for smoking onset among
adolescents95. Fletcher (2012) also found that variation in the SNP rs2304297 of nicotinic
acetylcholine receptor CHRNA6 moderated the influence of tobacco taxation on multiple
measures of tobacco use, such that individuals with the protective G/G polymorphism
responded to taxation while others had no response. Only one study investigated GxE
between policy and cessation, as a study by Boardman et al. (2011) demonstrated that
the genetic influences on smoking desistance (measured using a pair-wise measure
indicating the length of time in years for a twin to quit smoking after his/her sibling had
quit) increased in importance following restrictive legislation on smoking behaviors during
the early and mid-1970s102.
Pharmacological treatment. Studies provide support for the role of genetic variation in
response to bupropion and nicotine replacement therapy for smoking cessation.
Generally, variations in genes within the dopamine and opioid pathways and in nicotinemetabolizing enzymes appear to play a role in the efficacy of nicotine-replacement
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therapy, while variation in dopamine pathway genes are important for response to
bupropion93. In the one study investigating pharmacological treatment on genetic risk for
smoking cessation, genetic variants rs16969968 and rs680244 were used to categorize
patients into three haplotypes: (1) low smoking risk allele at rs16969968 and low mRNA
expression allele at rs680244, (2) low smoking risk and high mRNA expression, and (3)
high smoking risk and high mRNA expression. These haplotypes are located CHRNA5CHRNA3-CHRNB4 on chromosome 15 and were chosen for their consistent association
with measures of smoking heaviness and nicotine dependence in other studies, and
potential relation with cessation likelihood. In the smoking cessation trial, haplotype
interacted with treatment in affecting success of cessation, in that active treatment was
strongly associated with a lower risk of relapse in individuals with haplotype 3 (relative
hazard = 0.48, p-value = 9.7x10-7) and haplotype 2 (relative hazard = 0.48, p-value =
2.7x10-8), but not haplotype 1 (relative hazard ratios = 0.83, p-value = 0.36). No significant
differences were found in the effect of haplotype on abstinence/relapse between
bupropion only, nicotine replacement therapy only, and combined therapies treatment
groups33. Exposure to environmental smoking-related cues may also play an important
role in promoting relapse, as individual differences in response to the sight or smell of a
lit cigarette may be mediated by the DRD4 VNTR polymorphism. Participants who were
homozygous or heterozygous for the seven repeat or longer allele demonstrated
significantly higher craving, more arousal, less positive affect, and more attention to the
smoking cues than participants for whom this polymorphism was absent 103. The
integration of genetic testing into standard clinical practice would be premature now, but
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pharmacologic studies of treatments for nicotine dependence eventually may guide
individualized smoking-cessation treatments.
DISCUSSION AND CONCLUSION
Both twin/family and molecular genetic studies provide preliminary evidence that geneenvironment interactions have differential effects on cigarette use over the course of
development. Twin and family studies demonstrate that the relative contributions of
genetic and environmental factors to cigarette use changes across time from
adolescence, when most smokers initiate cigarette use, through adulthood, when many
smokers have established patterns of cigarette use. Familial and environmental factors
contribute to whether individuals initiate cigarette use. However, as individuals move from
initiation to more established patterns of use, the importance of common environmental
factors decreases while the influence of genes increases. As the contribution of genes to
cigarette use increases, the influence of environmental factors does not go away, but
rather, environmental factors begin playing a different, but still important role – that is, as
a moderator of the influence of genetic susceptibilities104. This implies the presence of a
gene-environment interaction, such that certain environments allow for greater
expression of genetic effects, possibly due to the availability of opportunities for
individuals to show their genetic predispositions6. While twin studies of gene-environment
interaction have been useful in explaining how the effect of genes may change as a
function of the environment, molecular genetic studies of gene-environment interaction
have been useful in parsing out the role of specific genes influencing cigarette use
behaviors through the testing of the main effect of a specific gene of interest from
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candidate and genome wide association studies on a given cigarette use phenotype and
the testing of interactions between the specific genes of interest and the environment.
From this review of the literature on the influence of genes, environments, and their
interaction on cigarette use, we find that significant GxE interactions vary across cigarette
use phenotypes. Let us first consider gene-environment interactions contributing to
cigarette initiation. Religion was the only environmental variable found to moderate
genetic influences on initiation during adolescence7. More specifically, of the studies
investigating gene-environment interaction contributing to initiation 7,94,95,105, only one twin
study yielded a significant interaction between aggregated genetic risk and self-rated
religiousness. The Timberlake et al. (2006) study was the only twin study that included
this very specific environmental factor on smoking initiation, even though previous
associations have been found between religion and decreased risk for smoking initiation
in epidemiological studies7. To our knowledge, the interaction between specific genetic
variants and self-rated religiousness has not been tested in molecular genetic studies and
none of the genetic association studies investigating gene-environment interaction
contributing to initiation yielded positive GxE results9,10. These findings suggest a few
different things: either the contribution of genes on initiation remains consistent across
different environmental contexts, the effect of GxE in twin studies is quite small, and/or
current genetic association studies investigating GxE in cigarette initiation are
underpowered to detect effects. Under the first scenario, the environment would have no
effect on genetic influences contributing to initiation and encouraging a change in the
environment (e.g. increasing self-rated religiousness) would not necessarily reduce
cigarette prevalence. The second scenario suggests that the effect of gene-environment
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interaction is small and certain environments provide only a minimally greater expression
of genetic effects. In the context of religiousness, this might be explained by the fact that
genetic influences on smoking have been found to be low or nonexistent among
individuals raised with a strong religious upbringing 7. The third scenario implies a problem
with power, so investigators will need to look towards increasing their sample sizes in
future studies of gene-environment interaction in cigarette initiation to detect an effect if it
is there.
Gene-environment interactions contributing to other cigarette use behaviors, such as
adolescent smoking, cigarettes smoked per day, nicotine dependence, and cessation
have yielded significant findings as well. A couple of measures of the parental
environment moderated genetic influences on adolescent smoking8,34. Specifically,
significant interactions were found between parental monitoring and rs16969968 of
CHRNA532 and maternal smoking during pregnancy and rs1051730 of CHRNA3 34 for
smoking at age 14. Meanwhile, social pressures to smoke, prevalence of smoking among
popular students, marketing and vending restrictions on the sale of cigarettes, and schoollevel smoking moderated the heritability of daily smoking among adolescents 38,94,95. Only
one molecular genetic study investigated and found a significant interaction between 5HTTLPR and school tobacco use in influencing tobacco use frequency, such that the
greater the number of short alleles, the stronger the individual’s response to the school
health behavioral environment38. In adulthood, the experience of traumatic events and
neighborhood social cohesion interacted with aggregated genetic risk to influence the
number of cigarettes smoked per day. The interaction between the experience of
traumatic events and neighborhood social cohesion and aggregated genetic risk seemed
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to be largely driven by a single variant (rs203652) located on the CHRNA5-CHRNA3CHRNB4 gene cluster97. Parental monitoring also interacted with genetic variant,
rs16919968, to determine nicotine dependence in adulthood 32, while treatment status
interacted with genetic risk for smoking cessation 33.
From these studies, we can see that the environment moderates the effect of genes
across different cigarette use phenotypes. However, the extent to which the environment
moderates the genetic influences across different cigarette use phenotypes varies. There
are a couple of reasons why it is the case that GxE is found for some cigarette use
phenotypes and not others. It could be that the genes influencing initiation may be
different from the genes influencing other cigarette use behaviors95,106,107, such as
adolescent smoking, daily smoking, number of cigarettes smoked per day, nicotine
dependence, and smoking cessation. It is also possible that, the effect of certain
environmental measures of smoking that are potentially influenced by both genes and
environment [e.g. smoking status of father, sibling, friend, or best friend 34] seems to vary
among carriers of nicotinic receptor genes, but not among carriers of dopaminergic gene
variants - possibly, suggesting that either: the effect of nicotinic receptor genes is larger
than that of dopaminergic genes or that the effect of dopaminergic genes does not vary
as a function of environmental context. Under these assumptions, we might hypothesize
that cigarette use initiation may be more heavily influenced by genes predisposing
individuals to addictive behaviors via effects on neurotransmitter pathways, such as
genetic variants that contribute to novelty seeking108, while daily smoking, the number of
cigarettes smoked per day, and nicotine dependence may have more to do with genes
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that contribute to nicotine response, such as genes influencing nicotine metabolism 109–
111.

However, we are unable to conclude from some small GxE studies that the phenotypes
are not genetically the same, if GWAS on the same phenotypes do not come up with the
same list of associated genes. As such, we remain unable to make definitive claims
regarding the nature of changing gene-environment interaction contributing to cigarette
use due to the limited availability of studies investigating this phenomenon. Each study
reviewed here examined the association between specific cigarette use phenotypes and
a given environmental measure within either adolescents or adults. This made it difficult
to determine how environmental contexts differentially influence genetic factors that
contribute to cigarette use phenotypes such as initiation, daily use, nicotine dependence,
and cessation and demonstrates how the use of various cigarette use phenotypes may
complicate the literature and comparability of findings across studies. Added layers of
complexity are found in the fact that there is a great deal of variability in heritability across
each cigarette use phenotype95 and heritability estimates may be contingent on social
and institutional characteristics of the environment, such as temporal changes in genetic
epidemiology of smoking, changes in smoking norms, changes in the cost of smoking,
and legal limits placed upon smokers102. Using longitudinal data with repeated measures
of different cigarette use phenotypes and environmental contexts would allow researchers
to evaluate genetic contributions to the inter-individual variability of each cigarette use
phenotype and assess the stability or change of individual differences in each cigarette
use phenotype over time. The same longitudinal data could be used to predict cigarette
use behaviors over time112. Future studies might also want to include a range of nicotinic
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receptor, dopaminergic, and serotoninergic gene variants to parse out the effect sizes of
main effects on cigarette use phenotypes and interaction effects with different
environmental contexts.
In this review of the literature, only a handful of significant gene-environment interactions
influencing cigarette use were identified and none were replication studies. To ensure
that these findings are not false positives, replication studies using alternative samples
are needed. It has been suggested elsewhere that gene-environment interaction studies
will be underpowered to detect effects under the following conditions: when the estimated
main effects of genes are weak, when the genetic effect is found only among individuals
exposed to a particular environmental risk, and when environmental influences are not
detected because risk is only conferred among individuals with genetic liability 6.
Replications of findings from studies that have identified significant gene-environment
interactions influencing cigarette use would imply that the under-examined role of genetic
factors in response to particular environments would be an important step in efforts to
further reduce smoking rates101.
Currently, efforts to reduce smoking rates have focused on the implementation of policies
that restrict availability or use of cigarettes in public places. Anti-smoking policies directed
at adolescents address onset of cigarette use, while emphasizing the role of immediate
social influences and refusal skills, which have been shown to reduce initiation by 30% 113.
However, it is possible that these policies may only be effective for those who are not
genetically susceptible to smoking. Furthermore, although restrictions on smoking in
public places, anti-tobacco ads, and increased costs of purchasing cigarettes through
excise taxes have also aided smokers in quitting, there remain concerns that policies
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have focused too heavily on implementing social restrictions on cigarette use, while doing
less to help genetically vulnerable smokers quit 95. To address this gap in the literature
and further reduce smoking rates, greater focus needs to be placed on determining the
extent to which individual differences are due to genes, environmental factors, or their
interaction. Gene-environment interaction studies may help us to better understand how
prevention and intervention efforts can be tailored to genotypes under different
environmental contexts at the level of family, school, neighborhood, and public policy.’
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CHAPTER 3:
GENOTYPE X ENVIRONMENT INTERACTION IN SMOKING BEHAVIORS: A
SYSTEMATIC REVIEW2
Elizabeth K. Do and Hermine H. Maes
BACKGROUND
This article presents a systematic review of the evidence for gene-environment
interaction (GxE) in smoking behaviors, inclusive of smoking initiation, smoking
frequency, smoking quantity, nicotine dependence, and smoking cessation. Smoking
remains the most preventable cause of morbidity and mortality, yet approximately six
million people die from tobacco consumption annually1. Twin and family studies have
demonstrated that, like other complex traits, smoking behavior is influenced by both
genetic and environmental risk factors2. Added to this, heritability estimates seem to differ
according to the smoking behavior being studied. For smoking initiation, heritability
estimates account for approximately 60% of the variance3, while heritability estimates for
smoking persistence ranges from 55 to 69%, smoking quantity ranges from 40 to 56%,
nicotine dependence ranges from 60 to 76%, and smoking cessation is approximately
50%4–6. Although this suggests that smoking behavior is moderately to highly heritable,
few genetic association studies have identified robust associations between specific
genes and smoking behavior, aside from studies investigating genes in the CHRNA5CHRNA3-CHRNB4

gene

cluster

and

nicotine

dependence7–11.

Alternatively,

environmental risk factors for smoking behavior have been well documented and include:
socioeconomic status12,13, parental smoking14,15, lack of parent-child involvement as

This paper was previously published as: Genotype x Environment Interaction in Smoking
Behaviors: A Systematic Review. Elizabeth K. Do; Hermine H. Maes, Nicotine & Tobacco
Research (2016): doi: 10.1093/ntr/ntw153.
2
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evidenced by low connectedness or cohesion16, having siblings who smoke17, and having
friends who smoke18,19.
Exposure to these environments does not necessarily guarantee the development of
smoking behaviors, which brings up the question of what role individual differences in
genetic vulnerability to adverse environments plays in shaping smoking behaviors. The
study of gene-environment interactions, in part, addresses this question by examining
whether individuals with specific genotypes are sensitive to the effects of their
environment. Given that genetic factors and one’s social context may jointly shape one’s
risk for smoking behaviors20–23, the study of gene by environment interactions (GxE) is
essential to fully understand the etiology of smoking behaviors and has become an active
area of research.
To our knowledge, no systematic review of GxE studies of smoking behavior has been
previously published. Thus, the aim of the current article is to identify and summarize
studies that test for GxE in relation to smoking behavior among adolescents and adults
systematically. We focused specifically on study characteristics related to methods and
findings.
METHODS
Systematic review search strategy. A systematic review of the English language
literature exploring GxE in smoking behaviors was undertaken. Studies were identified
using the electronic databases of Google Scholar, PubMed, ScienceDirect, and Elsevier
and included articles on twin-based and molecular genetic studies through May 2014.
Search terms included combinations of “smoking”, “smoking behavior”, “smoking
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cessation “, “genetic factors”, “environmental factors”, “twin”, “gene by environment”,
“gene-environment”, “interaction”, and “moderation.” To be included in this review, the
article had to measure smoking behavior as an outcome of interest and investigate the
effect of some environmental factor on the heritability of a given smoking behavior. We
allowed for the inclusion of both twin and molecular genetic studies. Initial searches were
supplemented by reviewing the reference sections of identified studies. Through these
searches, we located sixteen studies.
Extraction of references. Titles and abstracts of all references were initially assessed
for relevance. For completeness, bibliographies of extracted references were manually
searched for further relevant references. Where relevant references were found, their
bibliographies were also manually searched.
Data extraction. All data were extracted for the following variables: (1) study name, (2)
study population, (3) study design, (4) definition of environmental risk factor, (5) definition
of genetic risk factor, (6) definition of smoking behavior (i.e. outcome of interest), (6)
statistical parameters utilized, and (7) primary results presented. Focus was placed on
measures of association (i.e. odds ratios, hazards ratios). Data were extracted into a
prepared, structured Microsoft Excel database (Microsoft; Redmond, WA, USA).
RESULTS
For the purposes of describing the current state of smoking-related GxE research, we
summarize the research design and study samples, measurements of outcome,
environment, and genotype, and main study findings of these sixteen studies below.
Research Design and Study Samples
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Research Design. The research design varied across studies. Samples were obtained
from an assortment of sources including: national registries 24–26, population-based casecontrol27, longitudinal studies with school based-study designs 21,23,28, longitudinal
community samples20,29–31, hospital samples32, epidemiological studies22,33, and
randomized smoking cessation trials34. Of the identified studies, six utilized twin
samples21,22,24,25,35, while the remainder were molecular genetic studies20,23,26,27,29–34.
Although many of these studies collected longitudinal data, associations between
environmental exposures and outcome were not always determined prospectively. Three
studies utilized cross-sectional data27,32,34, while four studies assessed the environmental
exposures repeatedly25,26,29,30 and seven studies accounted for gene-environment
correlation20,24,28–31,35.
Sample. All sixteen studies differed in their sample size, both within and between
molecular and family studies of smoking behavior. The sample size of family studies
ranged from 1,31022 to 4,12021 individuals, while molecular genetics study samples
ranged from 36529 to 14,56023 individuals. The identified twin and molecular genetic
studies included eight unique samples from the United States [i.e. The National Health
and Nutrition Health Examination III (NHANES) Phase 2 study (1991-1994) 33, the
National Longitudinal Study of Adolescent Health 21,23,28,35, 1995 National Survey of Midlife
Development in the United States22, Collaborative Genetic Study of Nicotine
Dependence27, Detroit Neighborhood Health Study20, 1987 Atherosclerosis Risk in
Communities Study34, the Smoking Cessation Trial of the University of Wisconsin
Transdisciplinary Tobacco Research Center34, and a combined sample from the
University of Connecticut Health Center, Yale University School of Medicine, Medical
42

University of South Carolina, Mclean Hospital of Harvard Medical School, and the
University of Pennsylvania School of Medicine 32. A handful were European studies
conducted in the Netherlands [i.e. Family and Health Study29,30 and Netherlands Twin
Register25], and Finland [i.e. Finntwin1224 and the 1966 Northern Finland Birth Cohort26].
One study used data obtained from the Dunedin Multidisciplinary Health and
Development Study of New Zealand31.
Race/ethnicity. Studies also varied with respect to the amount of racial/ethnic diversity
in the samples. Most studies exclusively focused on participants that were Caucasian,
except for one study that investigated a sample residing in Detroit that was predominantly
African American20.
Sex. Studies seemed to be balanced with respect to sex and none of the identified
studies limited their sample to only males or females.
Age. Some studies focused on adolescent samples, followed longitudinally21,24,28–30,
while others focused on adult samples, aged 18 and older20,22,25,27,34,35. Two studies
included individuals in early adolescence to young adulthood, ranging from age 11 to 31
years23,26. More specific details for each of the studies identified in this systematic review
can be found in the online supplementary material, under Supplementary Table 3.5: Twin
Studies of Gene by Environment Interaction of Smoking Behavior and Supplementary
Table 3.6: Genetic Association Studies of Gene by Environment Interaction on Smoking
Behavior.
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Measurement of Smoking Behavior
Outcome measures. The studies assessed smoking behavior by smoking initiation or
onset25,28,35, adolescent smoking24,26,29,30, smoking frequency, including: number of
cigarettes smoked in the past month23,28, regular smoking22, and cigarettes smoked per
day20; nicotine dependence27,31,32, and age at smoking cessation and relapse34, as
described in Table 3.1: Measures of Smoking Behavior.
Table 3.1: Measures of Smoking Behavior
Phenotype

Smoking initiation

How was it measured?
Did you ever smoke?
(1) Yes
(2) No/A Few Times to Try
Have you ever smoked an entire cigarette?
(1) Yes
(2) No
Lifetime measure of adolescent smoking, measured by adolescents reporting on smoking level based on a ninepoint scale:
(1) I have never smoked, not even one puff
(2) I smoke at least once a day

Adolescent
Smoking

Daily Smoking
Smoking
Frequency

Adolescent smoking at age 14, measured by “Have you ever smoked (or tried smoking)?
(1) Yes
(2) No
If indicated “yes” then asked, “How many cigarettes have you smoked altogether up to now?”
(1) Only one
(2) About 2-10
(3) About 11-50
(4) Over 50
These variables were recoded into one variable with five categories:
(1) No
(2) Yes, only one
(3) Yes, about 2-10
(4) Yes, about 11-50
(5) Yes, over 50
Measure of whether adolescents smoked at age 14 and how much, which was categorized into:
(1) Nonsmokers: adolescents who had never smoked or had smoked once/twice in their lives
(2) Occasional smokers: adolescents smoking occasionally or about twice per week
(3) Regular smokers: everyone else
Ever smoking at least once cigarette every day for 30 days
Total number of cigarettes smoked by the respondent in the past month derived by multiplying responses to the
following two questions:
(1) “During the past 30 days, on how many days did you smoke cigarettes”
(2) “During the past 30 days, on days you smoked, how many cigarettes did you smoke each day?”
Regular smoking was measured using two questions:
(1) “Have you ever smoked cigarette regularly – that is, at least a few cigarettes every day?” and
(2) If yes, “On average, about how many cigarettes did you smoke per day during the one year in your life
when you smoked most heavily?”

Regular Smoking
These two questions were dichotomized into:
(1) Never been regular smokers: smoked less than three cigarettes per day during the time of heaviest
smoking
(2) Regular smokers
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Cigarettes Per
Day
Nicotine
Dependence
Smoking
cessation
Smoking relapse

Respondents provide a quantitative measure to the following question: “In the past 30 days, on those days when
you smoked, on average, how many cigarettes did you smoke per day?”
Fagerström Test for Nicotine Dependence scores, dichotomized by:
(1) Nicotine dependent: FTND scores ≥ 4
(2) Not nicotine dependent: FTND scores < 4
Self-reported age of smoking cessation measured by asking, “How old were you when you stopped smoking?”
Any smoking on seven consecutive days after the target quit date

Data collection methods. Data on the outcomes of interest were collected by six studies
exclusively through self-reported survey response24–26,33–35, while other studies collected
data through in-home face-to-face interviews21,30, semi-structured interviewing (i.e. SemiStructured Assessment for Drug Dependence and Alcoholism (SSADDA)) 32, family
reports31, and school reports28. Two studies used a combination of these methods23,29.
Three studies indicated that data were collected through telephone interviews, though
information regarding the background of the interviewer is not clear 20,22,27. Only two of
these studies investigated a biochemical indicator of smoking behavior 33,34. However, of
these two studies, only one indicated that the biochemical indicator was laboratory-based
serum cotinine levels (mg/ml)33.
Measurement of genes
Heritability estimates. In contrast to estimates of genetic variance based on measured
genotypic data, biometrical genetic methods rely on the expected variance and
covariance estimates of MZ and DZ twins. The expected variance and covariance
estimates of MZ and DZ twins were used to estimate the latent genetic influences for the
liability of smoking behaviors in different ways across twin and family studies. While two
studies calculated heritability estimates from comparisons of correlations of identical and
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fraternal twins24,25, three studies estimated heritability based on extended twin pair
designs that included full and half siblings28,28,35.
Polymorphisms examined. Eight single nucleotide polymorphisms (SNPs) were
investigated across two studies23,33. These SNPs included variants in neuronal nicotinic
acetylcholine receptor genes (nAChRs; including rs16969968, rs680244, rs3743078,
rs1051730, and rs2304297), variable-number-of-tandem-repeats (VNTR) polymorphisms
in dopaminergic genes (rs1800497) and serotonin transporter genes (5-HTTLPR). One
study focused on the polymorphic region of the promoter region of the serotonin
transporter gene (SLC6A4), 5-HTTLPR23. Another study divided individuals based upon
their CHRNA6 genotype (C/C, C/G/, G/G in the rs2304297 SNP), noting that the G/G
genotype has previously been related to lower likelihood of tobacco use 33. These
polymorphisms were chosen because of their potential role in the development of nicotine
addiction. Specifically, nAChRs are the initial physiological targets of nicotine in the
central and peripheral nervous system, while the dopamine and serotonin mediates
feelings of pleasure or reward within the dopaminergic reward system 36, such that
dopaminergic activity in the brain is increased by exposure to nicotine.
Data Collection Methods and Genotyping. Three studies used blood or saliva samples
for genetic analysis. Limited information was provided by these studies on which specific
cell lines were used and it seems to be the case that none of the studies utilized the same
processing facilities, with more specific details described in Table 3.2: Genotyping Data
Collection Methods.
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Table 3.2: Genotyping Data Collection Methods
Study

Genotyping Data Collection Methods

Xie (2012)

Extracted DNA from immortalized cell lines directly from blood or saliva and implementing the Taqman
method to genotype SNP rs16969968 at the Yale University School of Medicine

Hiemstra et al.
(2013)

Taqman analyses performed on the 7500 Fast Real-Time PCR system and scored genotypes using the
algorithm and software supplied by Applied Biosystems

Ducci et al.
(2011)
Meyers et al.
(2013)
Chen et al.
(2009)
Chen et al.
(2012)
Daw et al.
(2013)

Did not disclose the type of samples used but explained that genome-wide genotyping was performed on
DNA available at the Broad Institution Biological Sample Repository using Illumina Infinium 370cnvduo array
Isolated DNA from whole blood, or saliva if unavailable, which was then sent to the Applied Genomics
Technology Facility (Wayne State University, Detroit, MI, USA) for genotyping using the humanomniexpress
Beadchips (Illumina, San Diego, CA, USA)
Collected blood samples for genotypic analyses with initial genotyping performed by Perlegen Sciences
using custom arrays, and follow up genotyping done by Center for Inherited Disease Research (CIDR) using
Illumina Golden Gate technology with focus on two SNPs
Genotyping performed by the Center for Inherited Disease Research at Johns Hopkins University using
Illumina Omni2.5 microarray, with data cleaning led by the GENEVA coordinating center at the University of
Washington
Did not indicate how samples were collected

Measurement of the environment
Types of environmental exposures assessed. The types of environmental risk factors
assessed were diverse. Five studies investigated the role of family level factors, such as
parental monitoring24,27, maternal smoking during pregnancy26, smoking-specific
parenting including frequency, quality of communication, and house rules regarding
smoking30, and environmental smoking by father, mother, and siblings29. Three studies
examined the role of school and peer level factors, including social pressure to smoke
within schools28, institutional control over smoking in schools28, prevalence of youth
smoking23,28and youth drinking23, and smoking by friends and best friends29. Two studies
investigated childhood adversity32 and childhood maltreatment31. Two studies observed
the role of neighborhood level factors, inclusive of social cohesion, physical disorder,
lifetime trauma20, and socioeconomic status as measured by marital status of mothers
during pregnancy, socioeconomic status of cohort collected at age 31 years, and family
socioeconomic status based upon occupation of father during pregnancy and at age 14
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years26. One study investigated the role of treatment status 34 and another focused on the
role of religion, as measured by religious affiliation, organizational religious activity, and
self-rated religiousness35. Four studies assessed the role of public policy initiatives,
examining the effect that cigarette restrictions, tobacco control, prevention budgets,
excise tax per pack of cigarettes21, cohort effects25, and tobacco taxation policies33 have
on heritability estimates of smoking behavior. More detail about the measures of
environmental exposures is provided in Table 3.3: Measures of Environmental Exposure.
Table 3.3: Measures of Environmental Exposure

What is the
environmental
exposure of
interest?
FAMILY LEVEL

Parental
Monitoring

Paternal
Smoking

Maternal
Smoking

How was it measured?

Adolescent report on the degree to which the parent:
(1) Discuss with them their daily plans,
(2) Know of their interests and activities, and
(3) Know their whereabouts and the identity of their
associates when they are not at home
Measure was standardized and treated as a semicontinuous measure
Adolescent report on the degree to which the parent:
(1) Expected a specific time for them to come home
(2) Noticed them coming home later than expected
(3) Arrived home soon after they arrived home from
school
and the degree to which the adolescent:
(4) Told parent when they would be back
(5) Left a note about where they were going
(6) Checked in with parent before going out again
(7) Knew how to get in touch with parent
(8) Talked with parent about their plans for the coming
day
Low parental monitoring defined by the lowest quartile in
the parent monitoring sum of scores (treated as ordinal
Adolescent report indicating stage of smoking, ranked on
an 8-point scale (“My father/mother have never smoked” to
“My father/mother smokes more than 31 cigarettes a day”)
Self-report indicating which stage of smoking applied to
them (“I have never smoked, not even one puff” to “I
smoke at least once a day”)
Recoded into three categories: “Never smoked”, “former
smoker”, and “current smoker”
Adolescent report indicating stage of smoking, ranked on
an 8-point scale (“My father/mother have never smoked” to
“My father/mother smokes more than 31 cigarettes a day”)
Self-report indicating which stage of smoking applied to
them (“I have never smoked, not even one puff” to “I
smoke at least once a day”)
Recoded into three categories: “Never smoked”, “former
smoker”, and “current smoker”
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# of
Items

First
Author
(Year)
Population

Was GxE present? If so, with what
genotype & for what smoking
outcome?

3

Dick et al.
(2007)
Finland

Yes, heritability of adolescent smoking
changed with varying levels of
parental monitoring for smoking at age
14.

9

Chen et al.
(2009)
USA
(Detroit, MI
and St.
Louis, MO)

Yes, interaction found between SNP
(rs16969968) and parental monitoring
influencing nicotine dependence.
Nicotine dependence increased with
the risk genotype when combined with
lowest quartile of parental monitoring.
No evidence of interaction between
SNP (rs3743078) and parental
monitoring.

2

Hiemstra et
al. (2014)
Netherlands

No evidence for interaction between
paternal smoking and DRD2, DRD4,
or DAT1.

2

Hiemstra et
al. (2014)
Netherlands

No evidence for interaction between
maternal smoking and DRD2, DRD4,
or DAT1.

SmokingSpecific
Parenting

Sibling
Smoking

Maternal smoking during (2nd month of) pregnancy,
classified as nonsmokers, light smokers (1-10 cigarettes
per day), and heavy smokers (>10 cigarettes per day)

1

Ducci et al.
(2011)
Finland

Frequency: average of adolescent reported scores
assessing how often parents talked with child about
smoking related issues in the past 12 months

8

Hiemstra et
al. (2013)
Netherlands

Quality: average of adolescent reported scores on quality
of communication about smoking issues

6

Hiemstra et
al. (2013)
Netherlands

House Rules: average of adolescent reported scores
assessing the existence of smoking-specific rules at home

5

Hiemstra et
al. (2013)
Netherlands

Yes, significant interaction detected
between maternal smoking during
pregnancy and TTC12 (rs10502172)
influencing adolescent smoking.
No moderating effects of the
dopaminergic genes by the frequency
of smoking-specific parenting were
found.
No moderating effects of the
dopaminergic genes by quality of
smoking-specific parenting were
found.
No moderating effects of the
dopaminergic genes by house rules
were found.

How many of your siblings smoke, on a scale from 0 to 4
(None of my brothers/sisters smokes to four of my
brothers/sisters smokes)
Answers were dichotomized into “having no smoking
siblings” and “having one or more smoking siblings”

2

Hiemstra et
al. (2014)
Netherlands

No evidence for interaction between
sibling smoking status and DRD2,
DRD4, or DAT1.

2

Boardman
et al. (2008)
USA

Yes, attending a school where more
popular students are more likely to
smoke increases heritability of
smoking daily.

1

Daw et al.
(2013)
USA

SCHOOL LEVEL

School-Level
Smoking
Pattern

Institutional
Control

Prevalence of
Smoking

Racial
Composition

Pressure to smoke within a school: characterizes the
popularity status of smokers and nonsmokers and
indicates the extent to which the most popular students
smoke by asking all students to write down the names of
their five closest female friends and five closest male
friends and linking these names to self-reports on smoking
during the past year
Each student was asked: “During the past twelve months,
how often did you smoke cigarettes?” Responses ranged
from 0 to 6 (never to nearly every day)
School-specific mean response used for analysis
School smoking policy: measured by summing
administrator responses regarding disciplinary action of the
school upon first and second incidences of smoking on
school grounds, inclusive of verbal warming, minor action,
in-school suspension or expulsion
Assessment of whether or not teachers can smoke on
school grounds
Adult Smoker Prevalence: State-level measure of the
percentage of adults who reported regular smoking (i.e.
those who have smoked at least 100 cigarettes and smoke
currently), obtained from the Behavioral Risk Factor
Surveillance System (1992-1993)
Adolescent Smoker Prevalence: percentage of 9th to 12th
graders who reported frequent smoking (i.e. those who
have smoked a cigarette on at last 20 of the past 30 days),
obtained from the Youth Risk Behavior Surveillance study

2

2

Boardman
et al. (2008)
USA

Boardman
(2009)
USA

Yes, adolescents smoke more
cigarettes when attending schools with
higher rates of tobacco use.
No evidence for interaction, though
the heritability estimate is reduced
within schools where normative
pressures to avoid smoking are
present (this finding is not significant,
however).
No evidence for interaction between
state-level smoking by adults and
genetic influence on regular smoking.
State-level smoking by youths
negatively associated with genetic
influences on regular smoking.

Adolescent Smoker Prevalence: Proportion of students
reporting that they have ever smoked a cigarette by the
date of the in-school survey

1

Boardman
et al. (2008)
USA

Proportion of students who are non-Hispanic and white

1

Boardman
et al. (2008)
USA

Yes, attending a school where more
popular students are likely to smoke
increases the heritability of daily
smoking.
Yes, heritability of daily smoking is
reduced within school where most
students are non-Hispanic and white.

2

Hiemstra et
al. (2014)
Netherlands

No evidence for interaction between
friend’s smoking and DRD2, DRD4, or
DAT1.

2

Hiemstra et
al. (2014)
Netherlands

No evidence for interaction between
best friend’s smoking and DRD2,
DRD4, or DAT1.

How many of your friends smoke, ranging from 1 to 5 (no
one to all of them)
Answers were dichotomized into “having no smoking
friends” and “having smoking friends”
Adolescent report indicating stage of smoking, ranked on
an 8-point scale (“My best friend has never smoked” to
“best friend smokes more than 31 cigarettes a day”)
Best Friend’s
Self-report indicating which stage of smoking applied to
Smoking
them (“I have never smoked, not even one puff” to “I
smoke at least once a day”)
Recoded into three categories:
“Never smoked”, “former smoker”, and “current smoker”
NEIGHBORHOOD LEVEL
Friend’s
smoking

49

Social
Cohesion

Physical
Disorder

Socioeconomic
Status

Asks respondents whether they agree or disagree on a 4point scale (strongly agree to strongly disagree) with the
following statements:
(1) This is a close-knit or unified community
(2) People around here are willing to help their
neighbors
(3) People in this neighborhood generally do not get
along with each other (reverse coded)
(4) People in this neighborhood do not share the
same values (reverse coded)
(5) People in this neighborhood can be trusted
Items were summed and then averaged by neighborhood
(via census tracks), to create neighborhood-wide measure.
Items were adapted from the New York City IMPACT
neighborhood evaluation scale and then factor analyses
were conducted, yielding 3 factors:
(1) Presence of buildings with broken windows;
boarded-up windows, or boarded-up doors
(2) Presence of buildings with outside damage that
can only be corrected by major repairs
(3) Presence of entirely vacant buildings
Principal component values for each block group were
calculated and averaged by neighborhood.
Family SES: Based on occupation of father, collected
during pregnancy and at age 14 years. Classified as
professionals; skilled-workers; unskilled workers and
farmers.
SES of Cohort: collected at age 31 years and classified as
professionals skilled workers; unskilled workers farmers;
and others
Marital status of mothers during pregnancy dichotomized
as married or unmarried (including divorced and widowed).
Maternal SES: Proportion of student’s mothers who have
complete college

Traumatic Events: Checklist of 19 items occurring in the
individual’s entire lifetime. Number of items endorsed was
summed to create score from 0 to 19. Higher scores reflect
greater number of traumatic events.
Semi-Structured Assessment for Drug Dependence and
Alcoholism (SSADDA) Environmental section, which asked
Childhood
whether either of their parents died before they were 6
Adversity
years old and whether before the age of 13 they had
witnessed or experienced a violent crime, had been
sexually abused, or had been physically abused.
PHARMACOLOGICAL TREATMENT
Lifetime
Trauma

Treatment
Status

These were randomly assigned, as it was part of a clinical
trial. Groups included: placebo, nicotine patch, nicotine
lozenge, sustained-release bupropion, nicotine patch and
nicotine lozenge, or bupropion and nicotine lozenge.

Yes, significant interactions were
found between genetic risk score and
average neighborhood social cohesion
influencing cigarettes smoked per day.

5

Meyers et
al. (2013)
USA
(Detroit, MI)

19

Meyers et
al. (2013)
USA
(Detroit, MI)

No evidence for interaction between
physical disorder and genetic risk
score.

3

Ducci et al.
(2011)
Finland

No evidence for interaction between
socioeconomic status and
TTC12(rs10502172).

Boardman
et al. (2008)
USA
Meyers et
al. (2013)
USA
(Detroit, MI)

No, maternal smoking was not found
to moderate genetic risk of smoking
behavior.
Yes, significant interactions were
found between genetic risk score and
the number of traumatic events
experienced.

4

Xie et al.
(2012)
USA

Yes, childhood adversity significantly
increased ND risk in both women and
men, and the effect in women was
twice that than in men.

1

Chen et al.
(2012)
USA

Yes, smokers with high-risk haplotype
were three times as likely to respond
to pharmacologic cessation treatment
compared to smokers with the low-risk
haplotype

1

Timberlake
et al. (2006)

No evidence for interaction.

2

Timberlake
et al. (2006)

No evidence for interaction.

2

Timberlake
et al. (2006)

Yes, high levels of self-rated
religiousness attenuated the additive
genetic determinant of smoking
initiation.

2

Boardman
(2009)
USA

1
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RELIGION
Religious
Affiliation
Organizational
Religious
Activity
Self-rated
religiousness

Individuals were characterized as those who had any
affiliation and those who did not (inclusive of atheists,
agnostics, and those without any affiliation).
Frequency of religious attendance and participation in
special activities in the past 12 months, with responses
coded from 0 to 6 (never to more than once a week). Items
were summed.
Indicates the importance of religious faith and extent of
being a religious person, with responses ranging from 0 to
3 (not important/not religious at all to more important than
anything else/very religious).

PUBLIC POLICY
Cigarette
Restrictions

Sum of two characteristics: restrictions on the location of
vending machines selling cigarettes and prohibition of
billboard advertising for tobacco products within 500 feet of
schools
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Yes, marketing and vending machine
restrictions slightly reduce genetic
influences on regular smoking

Full-time staff
equivalent for
tobacco control

Boardman
(2009)
USA
Boardman
(2009)
USA

Number of staff that are dedicated to tobacco control, not
including nonprofit organizations in 1994

1

Prevention
budget

Total amount spent in logged dollars on tobacco control
within each state (drawn from multiple sources)

1

Excise Tax per
pack of
Cigarettes

Derived from data from the Centers for Disease Control
and Prevention State Tobacco Activities Tracking and
Evaluation System (reflecting legislation active as of
December 1, 1995)

1

Boardman
(2009)
USA

State-level per
pack of
tobacco tax
rate

Rates were matched to data at the state and year-levels
and are not adjusted for inflation for the four years of data.

1

Fletcher
(2012)

Four birth cohorts (1920-1939, 1940-1949, 1950-1959, and
1960-1970)

1

Boardman
et al. (2010)
USA

Two birth cohorts (1993-1995 and 2009-2010)

1

Vink et al.
(2011)
Netherlands

Birth Cohort

No evidence for interaction.
No evidence for interaction.
Yes, state-level excise tax on
cigarettes reduce genetic influences
on regular smoking
Yes, G/G polymorphism of CHRNA6
responded to state-level taxation while
others did not.
For those born in the 1940s and
1950s, genetic factors do not
significantly contribute to the risk of
regular smoking. While for those born
in the early 1930s and mid-1950s,
genetic influences are the most
pronounced.
No, the heritability of smoking initiation
did not change as a function of
environmental exposure.

Classification of exposures. There was considerable variation in how studies treated
exposure status in the analysis. In one study, the environment was treated as a binary
variable (i.e. Exposed versus unexposed to childhood adversity)32. In another study, the
environmental variables, which measured sociodemographic factors such as father’s
occupation and mother’s marital status during pregnancy, were treated as categorical 26.
Most studies (62.5% or n=10) used continuous measures or scales, derived using sum
scores of different sets of items20,21,23,24,27–31,33,35, while two studies utilized proportions of
smokers in contact with respondents as a measure of environmental smoking
exposure28,31. One randomized control trial randomly assigned participants to one of six
environmental exposures or treatments (i.e. Placebo, nicotine patch, nicotine lozenge,
bupropion SR, nicotine patch and nicotine lozenge, or bupropion and nicotine lozenge) 34.
Classification of exposure was unclear in two studies investigating genetic influences on
smoking by birth cohort22,37.
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Data collection methods. The most commonly employed method for obtaining
information about environmental exposures were questionnaires. The remaining studies
relied on interviews, review of epidemiological data, or a combination of approaches. Like
data obtained on smoking behavior outcomes, data on environmental exposures were
collected by: self-reported survey response 24–26,33–35; in-home face-to-face interviews21,30;
semi-structured interviewing (i.e. Semi-Structured Assessment for Drug Dependence and
Alcoholism (SSADDA)32; Semi-Structured Assessment for Nicotine Dependence
(SSAND), Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA);
Composite International Diagnostic Interview (CIDI)27); telephone interviews20,22,27; family
reports31; school reports28; or a combination of these methods23,29.
Main study findings
There was considerable heterogeneity in the methods and analyses used across
studies to test for GxE, making it difficult to summarize this research and provide a
synthesis of main findings. Thus, statistical significance is emphasized over the
magnitude of effects.
Main effect of genotype. Thirteen (87.5%) of the sixteen identified studies found
significant main effects for either specific genes or genetic factors associated with
smoking behaviors20–24,26–31,33–35; three did not30,32,37. More specifically, SNPs
rs16969968 of CHRNA5 and rs3743078 of CHRNA3 were associated with nicotine
dependence27, while 5HTTLPR23, CHRNA5-CHRNA3-CHRNB434, and a genetic risk
score20 were associated with smoking heaviness or number of cigarettes smoked, and
DRD4 was associated with smoking onset29. Interestingly these main effects were not
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necessarily consistent across studies, as no main effect of rs16969968 on nicotine
dependence was reported in one study32. No significant main effect for DRD2 or DAT1
on smoking onset was reported29,30.
Main effect of environment. Eight studies found significant main effects for at least one
of the environmental variables20,21,23,24,26–29,32 and all but two of these studies21,28 reported
the effect sizes of these main effects. Two studies found the main effects to be
nonsignificant30,38. The remaining three studies did not provide sufficient information to
make this determination22,35,37.
Gene by environment interaction effects. Of the sixteen studies identified, thirteen
studies found at least one significant GxE effect (p≤0.05). Significant interactions were
detected between environmental factors and SNPs within the CHRNA5-CHRNA3CHRNB4 gene cluster [i.e. Parental monitoring and rs16969968 of CHRNA5 for nicotine
dependence27 and maternal smoking during pregnancy and rs1051730 of CHRNA3 for
smoking at age 1426]. Another significant interaction was detected between schooltobacco use and the serotonin promoter polymorphism, 5-HTTLPR for tobacco use
frequency23. However, no significant interactions between environmental factors and
dopaminergic genes were identified29,30.
Effect Size. It was not clear from some studies whether the effect for genotype or
environment was larger, due in part to studies not reporting the main effect of genotype
and environment21,22,28,31. Studies that did report this information tended to find that the
effects of the environment were larger relative to genetic effects and GxE effects.
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Effects by developmental period. Of the studies focused on adolescent samples, only
two did not find at least some evidence for GxE29,30. Only one study investigating adult
samples did not find at least some evidence for GxE 25.
Results demonstrate heterogeneity in both conceptual and methodological
approaches to conducting tests for gene by environment interactions related to smoking
behavior. This heterogeneity could be an artifact of the cross-disciplinary nature of GxE
research and may reflect differences in conceptual understanding and methodological
conventions adopted across academic disciplines. Given these differences in approach,
it was difficult to synthesize findings, which remains a major limitation to the current
literature on smoking-related GxE. This is emphasized further in a meta-analysis of 103
gene by environment interaction studies conducted in the first decade of this millennium
by Duncan and Keller (2011). Results from the meta-analyses are “consistent with the
existence of publication bias, low statistical power, and a high false discovery rate 39. What
this means is that thus far, gene by environment research might not have produced many
reliable results40.
Despite the differences in approach and difficulty to synthesize findings, we can come
away with a few general conclusions/themes regarding the role of GxE interaction in
smoking behavior. Specifically, the influence of parents and peers seem to moderate the
genetic and environmental influences contributing to the initiation and maintenance of
smoking behaviors, such that greater influence from parents or peers attenuates the
relative importance of genetic versus environmental factors. The magnitude of this
moderation is dependent upon the outcome of interest (e.g. initiation, frequency, nicotine
dependence, cessation, or relapse). Thus, more attention needs to be paid to the
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outcomes of interest and how results are being reported, particularly since the heritability
estimates vary by the smoking behavior being measured and the age at which these
outcomes are collected.
Studies of GxE interaction demonstrate that the influence of genes may change as a
function of the environment and the phenotype being measured, but also suggests that
restricting the availability of tobacco (whether through parental monitoring, prevalence of
smoking among peers, or public policy initiatives to reduce tobacco use through restriction
of use in public spaces or taxation) generally decreases the influence of genes that
influence the initiation and maintenance of smoking behaviors.
Although we can come away with these conclusions, it is still the case that differences
in methodological approaches are likely contributors to potential discrepancies of GxE
effects across studies, and prevents the field from a deeper understanding of GxE
interactions regarding smoking behavior. In efforts to guide future research and address
the current challenges that exist in synthesizing findings of GxE in smoking behavior, we
offer the following suggestions focused on: (1) choice of measurement for environmental
variables, (2) testing and reporting of main and interaction effects, (3) testing for artifactual
interaction via conducting sensitivity analyses and checking for scaling artifacts, (4)
treatment of covariates, and (5) reporting gene-environment correlation (rge). Table 3.4.
Assessing Validity of Gene by Environment Interaction demonstrates how each study
addresses these concerns.
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Table 3.4. Assessing Validity of Gene by Environment Interaction
First Author
(Year)

Account for
rGE

Substitute
genotype

Sensitivity
Analyses

Variable
Transformation

Effect
Estimate CI

# of tests with
p-values or
MTC?

Reports NonSignificant
Findings

Dick et al.
(2007)

Yes, Analyses
are adjusted
for rGE.

No

No

No

Yes

No

No

Chen et al.
(2009)

No

No

No

No

Yes

No

Yes

No

No

No

Yes

No

Yes

No

No

No

Yes

Yes

Yes

Hiemstra et al.
(2013)

Hiemstra et al.
(2014)

Yes,
Pearson’s
correlations
among the
study variables
were provided.
Yes, rGE
found between
maternal and
paternal
smoking at
time 1 and
DAT1.

Ducci et al.
(2011)

No

No

No

No

No (gives SE)

Yes

Yes

Boardman et
al. (2008)

Yes, Controls
for passive
and active rGE
via maternal
and peer
smoking.

No

No

No

No

No

Yes

Daw et al.
(2013)

No

No

Yes

No

No

No

Yes

Yes

No

Yes

No

Yes

No

Yes

No

No

No

No

Yes

No

Yes

No

No

No

No

Yes

No

Yes

Timberlake et
al. (2006)

Yes, cross-trait
Spearman
correlations
between
siblings within
a pair by
zygosity were
assessed in
the initial
testing for
presence or
absence of
rGE.

No

No

No

No

No

Yes

Vink et al.
(2011)

No

No

No

No

Yes

Yes

Yes

Boardman
(2009)

No

No

No

No

No (gives SE)

No

Yes

Boardman et
al. (2010)

No

No

No

No

Yes

Fletcher
(2012)

No

No

No

No

Yes

Meyers et al.
(2013)
Xie et al.
(2012)
Chen et al.
(2012)

CI = confidence interval; MTC = multiple testing correction
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Yes

No

Yes

Yes

Choice of measurement for environmental variables
The choice of measurement for environmental variables varied across studies
identified in this systematic review. Few studies from this systematic review overlapped
in their measurement of environmental constructs making it difficult to compare findings
across studies. Only two studies investigated the effects of parental monitoring 24,27 and
two other studies investigated the effect of the prevalence of smoking among youth 21,28.
However, the findings of these studies do demonstrate a general trend: increasing the
restrictiveness of an environment (e.g. increasing parental monitoring, decreasing the
prevalence of smoking among youth, increasing self-rated religiousness) decreases the
influence of genes on an individual’s behavior, such as smoking, as seen in Figure 3.1.
Moderation of the Heritability of Smoking by Environmental Measures.
Figure 3.1. Moderation of the Heritability of Smoking by Environmental Measures

Furthermore, studies investigating the same environmental constructs did not use the
same means of measurement. In the study conducted by Dick et al. (2007), parental
monitoring was measured using responses from three items, standardized and then
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treated as a semi-continuous measure24, while the study conducted by Chen et al. (2009)
used a sum score from eight items, defined the lowest quartile, and treated the measure
of parental monitoring as an ordinal variable27. As for the prevalence of adolescent
smokers, one study utilized a state-level measure of the percentage of 9th to 12th graders
reporting frequent smoking from the Youth Risk Behavior Surveillance study21, while the
other calculated the proportion of students reporting they had ever smoked a cigarette by
the date of the in-school survey28. These observations suggest that there may be “noise”
in the assessments of environments. Thus, more rigorous methods need to be
undertaken to establish both reliable and valid assessments of environmental exposures
across studies.
There was also wide variation in the timing of exposures assessed across studies in
terms of the temporal relationship between exposure and outcome (i.e. Prospective
versus cross-sectional) and the developmental period considered (i.e. Adolescence
versus adulthood). A couple of studies tried to demonstrate causality through crosslagged methodologies, but most studies measured exposures and outcomes
simultaneously. To better understand timing of environmental exposures, future studies
may want to incorporate more rigorous research designs, including experimental and
quasi-experimental approaches that utilize the longitudinal nature of the data being used
in many of these studies.
Obtaining consistent environmental variables would make it much easier to synthesize
study findings. However, as can be seen from the studies included in this systematic
review, comparable results found across slightly different environmental variables
measuring the same construct can also provide some evidence of a moderating effect.
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Additionally, it would be beneficial for future studies to focus on a broader array of
proximal environments, since very little attention was paid to protective factors, such as
neighborhood social cohesion41. However, it is important that genetic factors do not
influence these proximal environments (i.e. gene-environment correlation is limited) and
attention must be paid to developmental period of measurement, since certain
environments are more salient at specific ages (i.e. family and peer influences during
adolescence).
Testing and reporting of main and interaction effects
Few studies fully described their methods and analyses, including how tests for
interaction were conducted and the nature of the association between exposure and
outcome. Many studies indicated that they used moderated regression analysis or twin
modeling approaches, but few provided citations or details for how estimates were
calculated. Future research should report basic descriptive information that may be
suggestive of GxE, such as a data table reflecting genotype by exposure by outcome.
This recommendation is made based on the finding that some studies did not include
univariate analyses on environmental exposures and smoking outcomes.
Future studies should explicitly note the scale (i.e. additive or multiplicative) used to
detect GxE effects, as it has been previously demonstrated that the way that outcome
measure is scaled and whether the GxE effect is tested on the additive or multiplicative
scale influences whether a GxE effect is observed. Under the simple definition of geneenvironment interactions, which suggest that either a different effect of an environmental
exposure on disease risk in persons with different genotypes or a different effect of a
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genotype on disease risk in persons with different environmental exposures, the presence
or absence of interactions may depend on the scale of measurement (e.g. whether effects
are additive or multiplicative). Where risks are measured on an additive scale, the effect
of the environmental exposure differs among persons with different genotypes, but if risk
factors are measured on a multiplicative scale, the effect of the exposure differs among
people with different genotypes42. Thus, changing the scale of the outcome may create
interactions that may not have previously existed or eliminate interactions that were once
present. For example, binary outcomes have been shown through simulations to
incorrectly detect GxE effect when none existed, thus raising concerns about the validity
of results based on diagnoses43.

Most of the identified studies of GxE in smoking

behavior provided confidence intervals of effect estimates with p-values 20,22–25,27,29–34;
though, several studies provided standard error estimates with p-values instead 21,26,28.
Only a few of the studies reported the number of tests conducted 22,25,26, and all but one
of the studies reported non-significant GxE.
There remains a need for more thorough reporting standards, especially as they apply
to conducting tests for interaction. This should include regression coefficients for all
parameters included in a regression model and explicitly noting what variables were
included. Investigators should be cautious about interpreting any genotype or
environmental main effect reported in previous studies, unless authors explicitly describe
parameters in regression models.

Tests for artifactual interaction
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Only one study tested for artifactual interactions by conducting sensitivity analyses 23,
suggesting that this has not been a predominant concern. However, this remains an
important task, as it brings to question the validity of findings. There are various ways to
check for artifactual interaction, including: substituting genotype, conducting sensitivity
analyses, and running analyses with transformed variables 43,44. Substituting the genotype
entails trying to remove a significant interaction by replacing genotypic data with a
similarly distributed polymorphism that has no association with smoking behavior.
Conducting sensitivity analysis entails testing whether or not using different measures
that share construct validity for the behavior of interest still reveals an interaction 44. Had
GxE been observed in one of a set of measures, but not the other, then it would have
suggested the occurrence of a scaling artifact45. The transformation entails trying to
remove the interaction effect by re-running analyses with transformed variables and
checking to see if the detected interaction is still significant. This can be done different
ways, including monotone transformations [e.g. taking a logarithm or square root]. If the
significance of the interaction is removed through transformation, an additive relationship
between variables on different scales is implied. If not removable, the interaction effect
could be interpreted as: a robust fan-shaped interaction not removable by transformation,
a crossover effect, or a qualitative interaction 44.
Treatment of covariates
The treatment of covariates was not uniform across studies, as studies controlled for
a combination of the following: age, sex, race/ethnicity or ancestry (measured by principal
components), smoking behavior of parents, socioeconomic status, and education. The
covariates of sex, age or developmental period, and race/ethnicity or ancestry should be
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included more explicitly in future GxE research. These factors are important for
understanding the etiology of smoking behavior, as well as environmental exposure
patterns, and may be related to differences in genotypic frequency.
Sex. Most studies controlled for or stratified results, though the studies did not always
note whether they found different GxE effects for males when compared to females.
Age. Exploration of the importance of age for GxE is necessary for several reasons.
Some environmental exposures are age-specific. For example, parental monitoring
decreases over time and may peak around early adolescence. Without accounting for
explicitly exploring how age influences GxE effects, research may be biased. Added to
this, there is now substantial evidence that genetic risks for smoking problems have agedependent effects. Specifically, genetic risk of heavy smoking is greater in early-onset
smokers (i.e. Prior to 16 years) when compared to later-onset smokers (i.e. 16 years or
older). This association in early-onset smokers is consistent with the epidemiologic
observation of increased vulnerability to dependence among early-onset smokers 46.
Race/ethnicity or ancestry. By not controlling for race/ethnicity, studies may lead to
biased results. This is related to population stratification whereby different allele
frequencies may exist among different sub-populations or ancestral groups. Ideally,
research should describe methods to assess or address population stratification and
control for self-reported race/ethnicity and conduct sensitivity analyses to test whether
GxE effects vary by race.
Reporting of gene-environment correlation
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Only about half of the identified studies accounted for gene-environment correlation
(rge)20,24,28–30,35, which refers to the phenomenon where an individual’s genotype also
influences his/her exposure to the environment. This implies that individuals shape their
environments through heritable behaviors and that the relationship between
environmental exposure and behavior may be confounded by genotype. If rge is not
accounted for in studies of GxE, it is unclear whether the environment is moderating
genetic effects or if genes influencing a trait are more likely to be present in a given
environment47. Conducting tests for rge can be accomplished through simple tests of
association between environmental exposures and genotype, but may be limited by
genotypes measured. To account for rge, researchers can: limit studies to moderators
that are uncorrelated with the outcome43, utilize a moderator in means model to remove
genetic effects shared by a trait and moderator from covariance 48, or explicitly model rge
in a bivariate model. The studies accounting for rge did so in a variety of ways including
model adjustment for rge24, controlling for passive and active rge via inclusion of
maternal28,29, paternal29, and peer smoking28 as covariates, and providing Pearson’s30 or
cross-trait Spearman correlations35. However, no explanations were provided for why
these specific methodologies were used in the studies. We recommend that future
research test and report whether rge is present.
CONCLUSION
This systematic review of the literature was conducted in attempts to understand the
state of the science on GxE research of smoking behavior, focused on methodological
approaches used across studies. A total of sixteen studies were identified, with thirteen
finding at least some evidence to suggest a GxE effect. However, among these thirteen
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studies, none of the findings seemed to overlap. The heterogeneity in results is likely
related to the variation in conceptual and methodological approaches used to test for
GxE. Studies varied in the populations sampled, methods used to assess environmental
exposures, and means by which they tested for GxE effects. Methodological
heterogeneity made it difficult to interpret and summarize findings. However, we hope
that the recommendations provided will help to guide future studies towards reducing
heterogeneity and capturing the joint contribution of genetic and environmental factors to
smoking behavior.
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Supplementary Table 3.5: Twin Studies of Gene by Environment Interaction of Human Smoking Behavior
Dick et al. (2007): FinnTwin12 (Finland)
11.4 years
411 MZM
(0.3 years);
Adolescent
401 MZF
Follow-up
smoking
Parental monitoring
NR
Yes
391 DZF
at 14.1
(at age 14)
439 DZM
years (0.1
years)
Boardman et al. (2008): National Longitudinal Study of Adolescent Health (United States)

163 MZTP
240 DZTP
647 Sib
Pairs
148 HalfSib Pairs

7th to 12th
grade

Smoking
onset;
Daily
smoking

Social pressure to
smoke within schools;
Institutional control;
Prevalence of
smoking;
Racial composition of
school

SES
(maternal
education)

Yes

As parental monitoring
increases, C and A decrease,
and E increases

Social pressures within
schools moderate the
heritability of daily smoking,
but not smoking onset. As
prevalence of smoking among
popular students increased,
the heritability of daily
smoking increased. As the
proportion of non-Hispanic
Whites increased, the
heritability of daily smoking
increased.

Boardman (2009): Wave II of the National Longitudinal Study of Adolescent Health (United States)
Marketing and
As marketing and vending
vending machine
machine restrictions
248 MZTP
restrictions; Full-time
increased, genetic influences
378 DZTP
staff equivalent for
on regular smoking increased.
1066 Sib
tobacco control;
Sex;
12 to 21
Regular
Genetic influences on regular
Pairs
Prevention budget;
Age
NR
years
Smoking
smoking increased as: state368 HalfExcise Tax per pack
level excise tax on cigarettes
Sib Pairs
of Cigarettes; Adult
increased and prevalence of
Smoking Prevalence;
state-level smoking by youths
Youth Smoking
increased.
Prevalence
Boardman et al. (2010): 1995 National Survey of Midlife Development in the United States (United States)
Timing of first Surgeon
General’s Report coincides
with increase in genetic
influences on regular
smoking, while subsequent
340 MZ
legislation reduced influences.
pairs
25 to 75
Regular
National trends in
For those born in the 1940s
NR
NR
315 SSDZ
years
smoking
cigarette consumption
and 1950s, genetic factors do
pairs
not significantly contribute to
the risk of regular smoking.
While for those born in the
early 1930s and mid-1950s,
genetic influences are the
most pronounced.
Vink et al. (2011): Two birth cohorts (1993-1995 and 2009-2010) from the Netherlands Twin Register (Netherlands)
415 MZM
Heritability of smoking
363 DZM
18 to 25
Smoking
Changes in policy and
initiation did not change as a
658 MZF
NR
NR
years
initiation
smoking attitudes
function of environmental
462 DZF
exposure.
769 DZO
Timberlake et al. (2006): Wave III of the National Longitudinal Study of Adolescent Health (United States)
237 MZTP
315 DZTP
779 Sib
Pairs
233 HalfSib Pairs

22.4 years
(1.7 years)
Range:
18-27.4
years

Smoking
initiation

Religious affiliation;
Organizational
religious activity;
Self-rated
religiousness
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NR

Yes

As self-rated religiousness
increased, genetic influences
on smoking initiation
increased.

Supplementary Table 3.6: Genetic Association Studies of Gene by Environment Interaction of
Smoking Behavior (N=10)
Mean
Age
Smoking
Environment
Genotypic
Subjects
(SD)
Covariates
rGE
GxE
Behaviors
al Measure
Measure
or Age
Range
Chen et al. (2009): Population-based case-control from Collaborative Genetic Study of Nicotine Dependence (United States,
from Detroit, MI and St. Louis, MO)
Nicotine
dependence
increasedwith
risk genotype (AA
of rs16969968)
Nicotine
CHRNA5
when combined
1,032
dependence
25 to
(rs16969968);
with lowest
cases;
(current
Parental
Age;
44
CHRNA3
NR
quartile of parental
995
smokers
monitoring
Gender
years
(rs3743078);
monitoring. No
controls
with FTND
combined risk
evidence of
score > 4)
interaction
between
rs3743078 and
parental
monitoring
Ducci et al. (2011): Prospective cohort from 1966 Northern Finland Birth Cohort (Finland)
Significant
CHRNA3(rs10517
Maternal
interaction
Maternal
2,476
30); TTC12
smoking;
between maternal
14 and
Smoking
smoking
females;
(rs10502172);
Family SES;
smoking during
31
behavior at
during
NR
2,286
ANKK1(rs2734849
Maternal
pregnancy and
years
14
pregnancy;
males
); DRD2
marital
CHRNA3(rs10517
SES
(rs1076563)
status
30) for smoking at
age 14.
Hiemstra et al. (2013): Longitudinal cohort/family-based design using sibling dyads from five waves of data from the Dutch
“Family and Health” Study (Netherlands)
Older
sibling
SmokingYes,
108 boys: 14specific
DRD2
Pearson’s
boy;
16
Smoking
parenting (i.e.
(rs1800497);
correlation
Moderating effects
118 boyyears
initiation
frequency,
DRD4; 40-base
s among
of dopaminergic
girl;
Young
and
Gender
quality of
pair VNTR in
the study
genes were not
106 girler
smoking
communicati
SLC6A3 (DAT1)
variables
found.
girl;
sibling
onset
on, and
gene
were
96 girl-boy
s:
house rules)
provided.
13-15
years
Hiemstra et al. (2014): Longitudinal cohort/family-based design using sibling dyads from five waves of data from the Dutch
“Family and Health” Study (Netherlands)
Study
1:
Environment
12.52
Yes
Study 1:
al smoking,
Age;
No significant
years
rGE found
465 Boys
including
Dopamine
Gender;
interactions
(0.57
between
526 Girls
Adolescent
paternal,
receptors (DRD2
Ethnicity
between
years)
maternal/
Study 2:
smoking
maternal,
and DRD4) and
(Dutch or
environmental
Study
paternal
175 Boys
(lifetime)
sibling,
dopamine
Other);
smoking variables
2:
smoking at
190 Girls
friend’s and
transporter DAT1
Education
and dopaminergic
14.16
time 1 and
best friend’s
level
genes.
years
DAT1.
smoking
(1.07
years)
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Daw et al. (2013): Longitudinal cohort/school-based study design from Wave I and II from the National Longitudinal Study of
Adolescent Health (United States)
Race/ethnici
ty; Sex; Age;
More short alleles
14,560
11 to
Number of
Home
are associated
individuals
22
School-level
cigarettes
Serotonin
access to
with stronger
(53%
years
smoking;
smoked in
transporter gene
alcohol and
NR
response to the
female)
(mean
School-level
the past
(5-HTTLPR)
tobacco;
school health
= 16.4
drinking
month
School
behavioral
years)
penalties for
environment.
drug use
Meyers et al. (2013): Longitudinal cohort from the Detroit Neighborhood Health Study (United States)
Significant
interactions were
Traumatic
found between
events,
Genetic risk score
18 to
genetic risk score
average
consisting of
95
Yes, Tests
and the number of
neighborhood
rs2036527,
Sex;
years
of
traumatic events
778
Cigarettes
social
rs667282,
Age;
(mean
Spearman’
experienced and
individuals
per day
cohesion,
rs3101457,
Ancestry
=
s rGE were
average
average
rs938682,
52.62
conducted.
neighborhood
neighborhood
rs547843, and
years)
social cohesion,
physical
rs3813550
but not average
disorder
neighborhood
physical disorder
Chen et al. (2012): Prospective epidemiologic study and randomized placebo-controlled smoking cessation trial from the 1987
Atherosclerosis Risk in Communities Study (United States) and the Smoking Cessation Trial of the University of Wisconsin
Transdisciplinary Tobacco Research Center
Smokers with
high-risk
haplotypes had
increased
likelihood of
Age at
responding to
smoking
Gender;
pharmacologic
CHRNA545 to
cessation
Age
cessation
12,771
Treatment
CHRNA3-CHRNB4
64
and relapse,
(quartiles);
NR
treatment when
individuals
status
(rs16969968 and
years
following
CPD;
compared to lowrs680244)
attempts to
Treatment
risk haplotype. No
quit
significant
differences in
haplotypic effects
on abstinence or
relapse between
treatment groups
Belsky et al. (2013): Prospective, longitudinal study of a representative birth cohort obtained from the Dunedin Multidisciplinary
Health and Development Study (New Zealand)
GRS was
unrelated to
Smoking
smoking initiation,
initiation,
but individuals at
conversion
higher genetic risk
to daily
were more likely to
Genetic risk score,
smoking,
Adolescent
convert to daily
derived from 3
progression
development
smoking as
recent metato heavy
al
Family
teenagers,
analyses of GWAS
smoking,
phenotypes
history
progressed more
1,037
11 to
Family
using cigarettes
nicotine
mediating
score and
rapidly from
males and
38
history of
smoked per day
dependence
associations
GRS were
smoking initiation
females
years
smoking
(CHRNA5(e.g.,
between
uncorrelate
to heavy smoking,
CHRNA3Fagerström
GRS and
d.
persisted longer in
CHRNB4,
Test for
mature
smoking heavily,
CYP2A6, rs7937,
Nicotine
phenotypes
developed nicotine
rs4105144)
Dependenc
dependence more
e),
frequently, more
cessation
reliant on smoking
difficulties
to cope with
stress, and more
likely to fail
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cessation
attempts.
Fletcher (2012): Cross-sectional data of US adults from the National Health and Nutrition Examination Survey (NHANES) (United
States)
Current
Variation in
tobacco use
nicotinic
[self-report
acetylcholine
7,200
(tobacco
receptor
responden
use,
moderates the
42.83
Age, sex,
ts with
number of
State-level
influence of
years
race/ethnicit
survey
cigarettes
per-pack
CHRNA6
tobacco taxation
(SD:
y, income,
NR
and
daily) and
tobacco tax
(rs2304297)
on multiple
17.09
marital
biological
laboratoryrate
measures of
years)
status
specimen
based
tobacco use. G/G
data
serum
polymorphism
cotinine
responded to
levels
taxation while
(ng/ml)]
others did not.
Xie et al. (2012): Subjects recruited for linkage and association studies of the genetics of drugs and alcohol dependence at give
US sites: the University of Connecticut Health Center (n=1102), Yale University School of Medicine (n=866), the Medical
University of South Carolina (n=155), McLean Hospital of Harvard Medical School (n=57), and the University of Pennsylvania
School of Medicine (n=26)
Childhood
Semiadversity
Structured
increased ND risk
1771
Assessment
in both men and
subjects
for Drug
Accounted
women, with the
recruited
Dependenc
Childhood
for
38.1
effect in women
as
e and
adversity, as
Ancestry
correlated
years
being two times
substance
Alcoholism
assessed by
proportion
data from
(SD:
rs16969968
that in men.
dependen
(SSADA),
SSADDA
score, sex,
individuals
11.0
Significant
ce cases
lifetime
Environment
age
in the
years)
interactive effects
and
substance
section
same
of childhood
unaffected
dependence
family
adversity and
controls
according to
rs16969968 were
DSM-IV
observed in men,
criteria
but not women.
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CHAPTER 4:
GENETIC AND ENVIRONMENTAL INFLUENCES ON SMOKING BEHAVIOR
ACROSS ADOLESCENCE AND YOUNG ADULTHOOD IN THE VIRGINIA TWIN
STUDY OF ADOLESCENT BEHAVIORAL DEVELOPMENT AND TRANSITIONS TO
SUBSTANCE ABUSE FOLLOW-UP3
Elizabeth K. Do, Elizabeth C. Prom-Wormley, Lindon J. Eaves, Judy L. Silberg, Donna R.
Miles, Hermine H. Maes

BACKGROUND
Cigarette smoking is the leading cause of preventable death in the US and has been
associated with considerable economic, social, and personal costs. Annually, tobacco
use costs the nation an estimated $193 billion, inclusive of lost productivity and direct
health care expenditures1. Yet, 19% of all US adults, or approximately 43.8 million people,
smoke cigarettes2. Of these adult smokers, 70% began smoking regularly by age 18 3.
Despite notable declines in cigarette smoking over the past 40 years, smoking behavior
among adolescents remains a huge public health concern. Every day, about 3,900
children under the age of 18 try their first cigarette. Of these children, an estimated 950
will become new, regular daily smokers4; approximately half will die as a result of nicotine
addiction and other smoking-related causes5. Twin studies have suggested that both
genetic and environmental factors contribute to smoking behavior. However, many of

3

This chapter was previously published as an original research article in Twin Research and
Human Genetics. To cite information from this chapter, please use the following citation: Do EK;
Prom-Wormley EC; Eaves LJ; Silberg JL; Miles DR; Maes HH, 2015. Genetic and Environmental
Influences on Smoking Behavior across Adolescence and Young Adulthood in the Virginia Twin
Study of Adolescent Behavioral Development and the Transitions to Substance Abuse FollowUp. Twin Res Hum Genet 18(1):43-51
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these twin studies investigate the influences of genes and the environment on cigarette
use among adults, so less information is known regarding the genetic and environmental
influences of cigarette use in adolescents.
Early twin studies investigating the genetic and environmental influences of smoking
behavior of adolescents analyze various stages of smoking behavior such as initiation,
progression, dependence, and addiction separately6–8. These studies find that the
initiation of tobacco use in adolescence is primarily explained by shared environmental
factors9,10 while genetic factors contribute more to individual differences in other smoking
behaviors, such as daily quantity of cigarettes smoked6 or smoking progression, which
has an estimated heritability of 0.809,11,12. Furthermore, population based twin studies
provide evidence that genetic influences come to play a larger role in smoking behavior
by late adolescence, when the etiological structure of smoking initiation closely resembles
that of adult samples13,14.
Among adult samples, heritability estimates for smoking initiation range from 0.32 to 0.78,
making it a moderately heritable trait8,15–20. On average, estimates are higher in women
relative to men8,21–23, suggesting that the heritability of smoking initiation may differ by
gender. However, this finding has not been replicated across all studies 18.
As a consequence of analyzing smoking behavioral factors separately, we lack
information on whether any overlap exists across stages 20. Although we know from adult
studies that utilize multivariate analyses that significant genetic and environmental
covariance exists between initiation and dependence 8,18,24,25, it remains unclear whether
the genetic and environmental factors influencing the relationship between smoking
initiation and progression in adulthood are the same across adolescence into early
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adulthood6,21,26. We also do not know if qualitative and quantitative sex differences found
in adult samples exist in adolescent samples21–27.
Thus, this study seeks to answer these questions by: examining the relationship between
smoking initiation and current quantity smoked from adolescence to early adulthood,
determining if qualitative and quantitative sex differences exist in this relationship, and
estimating the contributions of genetic and environmental factors to smoking initiation and
current quantity smoked in this younger age group.
MATERIALS & METHODS
Sample. Data were obtained from the Virginia Twin Study of Adolescent Behavioral
Development (VTSABD) and its young adult follow-up, Transitions to Substance Use
(TSA). The VTSABD is a multi-wave, cohort-sequential prospective study of adolescent
psychopathology and its risk factors, in over 1,400 Caucasian juvenile twin pairs aged 8
to 17 years and their parents28, greater detail about the ascertained sample have been
provided elsewhere29. To be included the present study, individual twins had to have
responded to questions regarding smoking initiation and current quantity smoked. The
total sample size of this study was 2,804 twins (including 632 MZ male twins, 829 MZ
female twins, 367 DZ male twins, 389 DZ female twins, and 587 DZ opposite sex twins).
Data obtained for the 22 to 32-year age group (N = 1,074) was obtained from one wave
of the TSA, to which all participants of earlier waves of the VTSABD were invited.
Measures. Data from each of the five waves of the VTSABD were merged and then recategorized into age groups to ensure that there was an adequate sample size (i.e. 1213 years, 14-15 years, and 16-17 years). However, since there was only one assessment
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during age period from 22-32 years, subdividing the TSA sample by age was not
warranted. Two main variables of interest were recoded across each of these age groups:
one measuring whether twins had ever smoked at least one whole cigarette and another
measuring the current quantity of cigarettes smoked daily. The “ever smoke” variable was
binary, coded as 0 for those who had never smoked at least one whole cigarette and 1
for those who had indicated that they had ever smoked at least one whole cigarette. If
respondents indicated that they had “ever smoked” in a given age group (i.e. 14-15 years),
they would be given a value of 1 for “ever smoke” in that age group and every subsequent
age group (i.e. 14-15 years, 16-17 years, and 22-32 years). Otherwise, if the respondents
indicated that they had not “ever smoked” across all age groups, they were given a value
of 0 for “ever smoke”. To measure current quantity smoked, respondents had to indicate
the number of cigarettes smoked daily, in the past three months. Free responses were
coded into three categories. These categories indicated: zero cigarettes smoked daily
(“non-current smoker”), one to five cigarettes smoked daily (“current, light smoker”), and
five or more cigarettes smoked daily (“current, heavy smoker”). Only responses where
twins indicated that they had smoked before under the “ever smoke” variable were
included in the quantity of cigarette use variable. Otherwise, responses for individuals
who had indicated that they had never tried cigarettes were coded as missing for the
quantity of cigarette use variable.
Descriptive Statistics. Prevalence estimates for smoking initiation and quantity are
reported using percentages.
Genetic Analyses. All data analyses were conducted using the open-source structural
equation modeling software OpenMx30,31. Due to inadequate sample size for smoking
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quantity in 12-13-year-olds, only univariate genetic analysis on smoking initiation was
conducted in this age group. Causal-common-contingent (CCC) models were fit,
individually, for smoking initiation and smoking quantity across all other age groups (i.e.
14-15 years and 16-17 years in the VTSABD, and 22-32 years in the TSA).
Using the causal-common-contingent (CCC) model originally developed by Kendler and
colleagues (1999) [Are you sure? I think it’s Neale (2006)], smoking behavior was
conceptualized as a two-stage process incorporating initiation and current quantity
smoked. This model was chosen because it allows for estimating the relative magnitude
of the contributions of genetic and environmental factors to smoking liability, as well as
for testing the strength of the association between initiation and current quantity smoked
stages for smoking via a beta pathway between the two stages 18,24,26,32,33.
The significance of an estimated beta pathway between the two stages is used to assess
whether the two stages are independent or correlated processes. Specifically, if an
estimated beta coefficient is found to be not significant, the liabilities for initiation and
current quantity smoked are said to be independent of one another, implying that smoking
initiation and current quantity smoked have separate genetic and environmental risk
factors. Otherwise, if the estimated beta coefficient is significant, the liabilities for smoking
initiation and current quantity smoked are said to share genetic and environmental risk
factors. In this case, the beta coefficient provides an estimate of the magnitude of strength
of association between smoking initiation and current quantity smoked. The greater the
estimated beta coefficient, the larger the magnitude of the strength of the association
between smoking initiation and current quantity smoked (i.e. beta coefficient of zero
suggests that the two stages do not share genetic and environmental risk factors while a
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beta coefficient of one suggests that the genetic and environmental risk factors for these
two stages are identical). The estimated 95% confidence intervals around the beta
coefficient give further information regarding the degree of overlap between the two
stages. Again, lower limits approaching zero (or below) support independent liabilities and
upper limits approaching 1 provide support for identical liabilities.
Using this model also allows for the direct estimation of additive genetic effects (a 2),
shared/common environmental effects (c2), and unique environmental effects (e2) on both
smoking initiation and current quantity smoked. However, since current quantity smoked
is modeled conditionally upon smoking initiation, the genetic and environmental
influences unique to current quantity smoked are estimated after those on initiation are
taken into account. Thus, the proportion of variance in current quantity smoked explained
by the respective influences on initiation can be calculated by multiplying them by the
squared beta coefficient. The proportion of the variance in liability to current quantity
smoked that is explained by genetic factors is the sum of the proportion of variance in
initiation explained by genetic factors multiplied by the squared beta parameter and the
proportion of variance explained by unique genetic factors contributing only to the current
quantity smoked stage, with the same principle applied for environmental factors.
Nested models were fitted to test specific hypotheses about the nature of association
between the two stages of smoking initiation and current quantity smoked. More explicitly,
to determine whether qualitative sex differences exist in the relationship between smoking
initiation and current quantity smoked, we tested the significance of the genetic and
shared environmental correlations between male and female factors. A model
constraining the correlation between males and females to 1, suggesting that the same
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factors contribute to male and female smoking behavior, was compared to a model that
freely estimated correlations between male and female factors, suggesting that different
factors contribute to male and female smoking behavior. This was done separately to test
whether the same genes or same environmental factors contribute to the liability of
smoking initiation and current quantity smoked in males and females.
Quantitative sex differences were tested for simultaneously to answer the question of
whether genetic and environmental factors explain the same proportion of the liability of
smoking initiation and current quantity smoked in males and females. To test for
quantitative sex differences, a model equating all parameters (i.e. genetic, shared
environmental and unique environmental factors, but not thresholds) for males and
females and was compared to one allowing for free estimation of parameters for males
and females separately. If the model equating parameters between males and females fit
the data best, it was concluded that quantitative sex differences did not exist. This process
was repeated for each age group.
Following these tests for qualitative and quantitative sex differences, other alternative
models were fit to the data. Specifically, nested models were created to test if there is a
direct relationship between smoking initiation and current quantity smoked and whether
genetic or common environmental factors could be dropped from initiation and current
quantity smoked stages. Where the beta pathway could be dropped from the model
without significant loss to goodness-of-fit to the data, it was determined that smoking
initiation and current quantity smoked had independent liabilities. Alternatively, when
dropping the beta pathway led to significant loss to goodness-of-fit, smoking initiation and
current quantity smoked were said to have shared liabilities. Regardless of whether this
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finding was significant, we moved on to test whether we could drop genetic or shared
environmental factors from either initiation or current quantity smoked. Where genetic or
environmental factors could not be dropped without significant loss to goodness-of-fit, the
factor was said to contribute significantly to the smoking phenotype.
Nested models were compared using likelihood ratio chi-square (LRC) statistics, in which
the degrees of freedom equal the difference between the degrees of freedom of the full
and nested sub models. LRC is calculated as the difference in -2 log likelihood (-2LL of a
comparison model and the -2LL of a reduced nested model34,35. Where the LRC
comparing the two models is non-significant, the reduced model is selected as the better
fitting model. Akaike Information Criterion (AIC) was also used as an index of model fit,
as well as an index of parsimony36,37.
RESULTS
Smoking prevalence. At age 12-13 years, 10.4% of the total sample had indicated that
they had ever smoked. This increased to 27.4% by age 14-15 years, 46.6% by age 1617 years, and 79.1% by age 22 to 32 years. Across all age groups, most respondents
indicated that they were not current smokers (i.e. indicated that in the past 3 months, they
smoke zero cigarettes daily). Although the majority (approximately 71%) of adolescents
who tried smoking did not become ‘current, heavy smokers’, the proportion of ‘current,
light smokers’ and ‘current, heavy smokers’ did increase consistently from the younger to
the older age groups (Table 4.1).
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Table 4.1: Smoking Initiation and Current Quantity Smoked Prevalence of Sample

Qualitative and quantitative sex differences. Genetic analyses indicated that no
significant qualitative or quantitative sex differences existed in the contribution of genetic
or environmental factors to liability of smoking initiation and current quantity smoked, and
in the relationship between smoking initiation and current quantity smoked for any of the
age groups in this sample (Table 4.2). More specifically, the same genes and
environmental factors contributed to the liability of smoking initiation and current quantity
smoked in males and females, and genetic and environmental contributions could be
equated across sex across ages 14-15, 16-17, and 22-32. (Ages 12-13 were not included
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in these analyses due to inadequate sample size and ages 22-32 were combined to
ensure adequate sample size for analyses.)
Table 4.2: Model Fit Statistics from CCC Models

Relationships between smoking initiation and current quantity smoked. The
relationship between smoking initiation and current quantity smoked could not be
assessed for ages 12-13, due to inadequate sample size for the smoking quantity
variable. Instead, univariate genetic analysis was conducted on the smoking initiation
variable. The best fitting model for this age group did not include additive genetic factors,
suggesting that common environmental (71.7%; 95% CI: 58.7%, 81.8%) and unique
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environmental factors (28.2%; 95% CI: 18.2%, 41.2%) best explained the variance in
smoking initiation at age 12 to 13 years.
Across ages 14-15 and 16-17 years, dropping the beta parameter from the CCC model
did not result in significantly worse model fit. This implied that smoking initiation and
smoking quantity had independent liabilities at these age groups. The best fitting models
were not the same across these age groups, however. For age 14 to 15 years, the best
fitting models were an ACE model for smoking initiation and a CE model for current
quantity smoked, suggesting that genetic (53.5%) and environmental factors (shared:
28.6%; unique: 17.8%) contributed to smoking initiation while environmental factors
contributed to current quantity smoked (shared: 84.8%; unique: 15.2%), as measured by
quantity smoked. For age 16 to 17 years, the best fitting model for smoking initiation was
an AE model, while a CE model still fitted the data best for current quantity smoked,
suggesting that genetic (84.8%) and unique (15.2%) environmental factors contributed to
smoking initiation, while environmental factors (shared: 88.7%; unique: 11.3%)
contributed to current quantity smoked (Figure 4.1).
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Figure 4.1: Best Fitting CCC Models and Variance Component Estimates

For ages 22-32 years, the beta parameter between the initiation and current quantity
smoked stages was significant, and the best fitting model was an AE model for both
initiation and current quantity smoked. This suggested that smoking initiation and smoking
current quantity smoked shared liabilities to a moderate extent (β = 0.48) and was no
longer independent, as with the earlier age groups. Additionally, genetic and unique
environmental factors contributed to both smoking initiation and current quantity smoked,
but shared environmental factors no longer exerted a signification impact on liability to
smoking. Thus, of the genetic variance in liability to current quantity smoked,
approximately 77.3% of the genetic variance was specific to current quantity smoked and
23.0% was shared with smoking initiation. In other words, mostly different genetic factors
contributed to the liabilities of smoking initiation and current quantity smoked across
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adolescence, but in young adulthood, there was some overlap between the factors
influencing initiation and current quantity smoked.
DISCUSSION
No qualitative or quantitative differences were found between males and females
regarding the genetic and environmental influences on individual differences in smoking
initiation and current quantity smoked across adolescence into early adulthood, lending
support for similar findings in other studies 6,18. However, at age 22-32, when testing for
qualitative sex differences, models constraining the genetic correlation to 1, indicating the
same genes influence smoking initiation and current quantity smoked in males and
females, fitted the data only slightly better than models that allowed for the free estimation
of the genetic correlation. Thus, it is possible that qualitative sex differences do exist in
later adulthood and that we did not have the power to detect them in the current sample.
This might explain why other studies utilizing adult samples have found qualitative sex
differences in the genetic and environmental influences in smoking behavior 8,16,21,27.
Unfortunately, due to sample size constraints, we were unable to determine whether
genetic or environmental factors contributed more significantly during the earliest ages of
adolescence (ages 12-13). However, we did find that different factors contribute to
smoking initiation and current quantity smoked across mid-adolescence into early
adulthood. More specifically, smoking initiation and current quantity smoked seemed to
have independent liabilities until adulthood, when liabilities were shared. Genetic, shared
and unique environmental factors were found to significantly contribute to smoking
initiation during early adolescence (i.e. ages 14-15), but not during later adolescence (i.e.
ages 16-17) or adulthood (i.e. ages 22-32 years), when genetic and unique environmental
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factors significantly contribute. Shared environmental influences may be more important
for 14-15 year olds relative to older age groups because they experience greater
limitations on the access to and availability of cigarettes. Although 14-15 year olds and
16-17 year olds experience the same legal age restriction on the purchasing of cigarettes,
14-15 year olds might still have a harder time in gaining access to cigarettes among their
peer groups if they have fewer friends who are of the legal age to buy cigarettes.
Additionally, genetic influences were not found to contribute significantly to smoking
initiation until later adolescence into adulthood (beginning at age 14-15 years), much in
the same way other studies suggest9,10,13. However, contrary to other findings, which find
greater genetic influence on heavier/problem substance use, we found that genetic
factors do not contribute significantly to the variance in current quantity smoked across
all age groups until young adulthood (i.e. ages 22-32 years). Interestingly, it is also during
this time that the liabilities of smoking initiation and quantity smoked are no longer
independent of one another, but rather correlated. Again, this might be a function of
access and availability to cigarettes. As access and availability of cigarettes increase, the
expression of genetic predispositions towards increased smoking frequency and potential
addiction may also increase, following initiation. Or, it could be the case that using a
recent estimate of quantity smoked rather than an estimate from heaviest period of use
is less stable and representative of adolescent youth relative to adults, and that our choice
of measures for the analysis in this study could influenced the estimate of the variance
components.
Limitations and Strengths. Results of this study must be interpreted in the context of a
couple of limitations. First, due to low prevalence of smoking behavior among early
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adolescents in this sample, the power of the current study was limited. This was apparent
when we found that only univariate genetic analysis could be conducted on the smoking
initiation variable among 12-13 year olds as there were too many missing values for the
current quantity smoked variable and consequently, a CCC model could not be fit. It is
also possible that using self-reported data underestimated the prevalence for smoking
behaviors, because of social desirability bias, which could have also influenced genetic
analysis. Furthermore, this study is not generalizable to all populations, as the sample
included only Caucasians.
Despite these limitations, the present study does include both males and females. It is
also one of only a few studies investigating the relationship between smoking initiation
and current quantity smoked within an adolescent sample and adds to the literature by
investigating this relationship across various age groups. Future studies could include the
use of measures related to smoking progression, other than current quantity smoked to
investigate their effects on the relationship between smoking initiation and current
quantity smoked. It would also be interesting to see if the same relationships are found
among other adolescent datasets, using different populations than the one described in
the present study and if these relationships are affected by the addition of environmental
covariates, such as parental monitoring or peer influences.
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CHAPTER 5:
A TWIN STUDY OF THE GENETIC AND ENVIRONMENTAL RELATIONSHIP OF
STRESSFUL LIFE EVENTS AND SMOKING INITIATION USING THE VIRGINIA TWIN
STUDIES OF ADOLESCENT BEHAVIORAL DEVELOPMENT
Elizabeth K. Do and Hermine H. Maes

INTRODUCTION
Tobacco use is the leading cause of preventable morbidity and mortality. Despite
substantial decreases in the prevalence of smoking in the last 50 years, on average, one
in three adults under the age of 26 continues to use tobacco and nearly half of current
users - equivalent to approximately 12.8% of the population in the United States - are
nicotine dependent. The direct medical costs due to tobacco-related morbidity totals $130
billion annually1. Given this expenditure of public resources, a better understanding of the
etiology of tobacco use is essential for the development of effective prevention efforts.
Smoking, in particular, has been identified as a mechanism for coping with stress 2,3
among young users4 and adults2,3. Smoking initiation for adult users typically occurs
during adolescence5, when unhealthy and maladaptive behaviors can develop as a result
of life changes and stress6. Although smoking initiation may occur because it is fun and
pleasurable, it can also be a mechanism by which adolescents cope with stressful life
events. Additionally, retrospective accounts of life events reveal that smokers report more
stressful life events relative to non-smokers4,7–9. Added to this, stressful life events (SLEs)
have been associated with smoking initiation and smoking progression 6,10–12. Specific
SLEs, such as adverse childhood experiences13, parental divorce14, sexual abuse, a
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vulnerable family environment, and parental death during childhood are associated with
lifetime history of smoking initiation15.
Some studies investigating stress and smoking initiation suggest that these effects may
be sex limited. For example, one study determined that the effect of early life stress on
the risk of smoking initiation by adolescents was only significant among girls at high
incidence of stressful life events. Specifically, girls who experienced high levels of stress
at 7 years of age had nearly three times higher odds of tobacco use (OR = 2.94, 95% CI
= 1.26, 6.83), relative to those that did not. This association was not observed for boys 16.
Another study found that the association between family related stress and smoking
initiation seems to be stronger for girls11.
However, the causes underlying these associations remain unclear and to our knowledge,
no genetically informed studies of the association between stressful life events and
smoking initiation have been conducted. This study seeks to address this limitation in the
literature by examining a large population-based sample of Virginia twins to assess
whether SLEs and smoking initiation (SI) are influenced by shared genetic and/or
environmental factors. Specifically, we seek to address the following questions: (1) Is
there evidence of a shared genetic and/or environmental liability for the association
between SLEs and SI, (2) Does the structure of genetic and environmental influences on
these traits differ by sex, and (3) Does this structure differs in early adolescence and
young adulthood?
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MATERIALS & METHODS
Sample. Data were obtained from the Virginia Twin Studies of Adolescent Behavioral
Development, which includes the Virginia Twin Study of Adolescent Behavioral
Development (VTSABD) and its two follow-up studies, which drew upon participants from
the VTSABD: The Young Adult Follow-Up (YAFU) and Transitions to Substance Abuse
(TSA) Follow-Up studies. The VTSABD is a cohort-longitudinal epidemiological study of
the development and maintenance of childhood psychiatric disorders using a genetic twin
design16. Adolescent male and female twins aged 8 to 16 years were ascertained through
Virginia schools. In the first wave, 1412 Caucasian families participated (2775 individual
twins in 1384 complete pairs). Twins under age 18 were followed every 18 months up to
4 times. All twins were targeted for a young adult assessment. 1185 pairs have been
followed up in YAFU at a median age of 21 years; 399 pairs (1084 individuals) in TSA at
a median age of 25 years. More details regarding the ascertainment of the sample is
given elsewhere17. To be included in the present study, individual twins had to have
provided responses to the Life Experiences Interview regarding questions on stressful life
events and smoking initiation. Analytic samples included: 319 monozygotic male (MZM),
418 monozygotic female (MZF), 180 dizygotic male (DZM), 193 dizygotic female (DZF),
and 293 dizygotic opposite sex (DZO) twins from the VTSABD; 263 MZM, 347 MZF, 144
DZM, 158 DZF, and 225 DZO twins from the YAFU, and 106 MZM, 201 MZF, 55 DZM,
70 DZF, and 53 DZO twins from the TSA.
Measures. The two variables of interest included smoking initiation and stressful life
events. Smoking initiation was measured by the question, “Have you ever smoked, even
if you were trying just one cigarette?” Responses included: no (coded as 0), yes (coded
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as 1), and no answer provided (coded as missing). Stressful life events included
measures regarding major family conflict, divorce/separation, and death. Responses to
each of these stressful life events items was: yes (coded as 1), no (coded as 0) or missing.
Since the items used to measure stressful life events differed between VTSABD, YAFU,
and TSA, we summed relevant item responses and then the variables were categorized
to be ordinal.
Statistical Analyses
Prior to conducting analyses, data were cleaned and recoded using SAS 9.3 (SAS
Institute Inc., 2003). Data were then prepared for use as raw ordinal data and analyzed
using the statistical modeling package OpenMx18. This approach assumes that the ordinal
categories are representative of an underlying normal distribution of liability, with
thresholds in liability discriminating between categories. For twin models, the liability to
traits can be attributed to several latent sources of variance: additive genetic factors (A);
shared environment (C), or environmental factors that lead to similarity between twin
pairs; and non-shared environment (E), or environmental factors that lead to dissimilarity
between twin pairs. Estimates of each of these variance components are calculated by
comparing the phenotypic correlation between monozygotic twins, who share all their
genes, with dizygotic twins, who share half of their genes, on average, identical by
descent.
Bivariate analyses examining the association between stressful life events and smoking
initiation were conducted separately for data from the VTSABD and its two follow-up
studies, the YAFU and TSA. Cholesky bivariate decompositions were used to decompose
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the variance of smoking initiation into genetic and environmental influences common with
stressful life events and genetic and environmental influences unique to smoking
initiation. Using this approach, we were also able to test for both quantitative and
qualitative sex-limitation19 with the following nested models: (1) qualitative for genetic
factors and quantitative sex differences, (2) qualitative for shared environmental factors
and quantitative sex differences, (3) quantitative sex differences but not qualitative sex
differences, and (4) no quantitative and no qualitative sex differences, showed in the
figures below.
Figure 5.1a: Quantitative and Qualitative Sex Differences for Genetic Factors: Male
and Female Cholesky Paths and Female Specific A Paths
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Figure 5.1b: Quantitative and Qualitative Sex Differences for Genetic Factors:
Male and Female Cholesky Paths and Male Specific A Paths
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Figure 5.2a: Quantitative and Qualitative Sex Differences for Genetic Factors:
Male and Female Cholesky Paths and Female Specific C Paths
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Figure 5.2b: Quantitative and Qualitative Sex Differences for Genetic Factors:
Male and Female Cholesky Paths and Male Specific C Paths
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Figure 5.3: Quantitative Sex Differences for Genetic Factors: Male and Female
Cholesky Paths without Male/Female Specific Paths
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Figure 5.4: Quantitative or Qualitative Sex Differences: One Set of Parameters,
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The fit of the nested models was assessed as a function of the change in the value of
twice the log likelihood of the data, which is distributed as a chi-square statistic with
degrees of freedom equal to the difference in the number of parameters estimated
between models. A significant change in Chi Square indicates a significant deterioration
in model fit. We also used Akaike’s Information Criterion (AIC)20 to select models, such
that a lower AIC value indicates a better balance between the explanatory power of a
model and parsimony. We did not test sub models dropping genetic and environmental
paths in the Cholesky decomposition models to allow for comparability between the
VTSABD, YAFU, and TSA samples.
RESULTS
After testing for quantitative and qualitative sex differences, it was determined that the
homogeneity model, reflecting neither quantitative nor qualitative sex differences, fit the
data best for the VTSABD, YAFU, and TSA samples (see Figure 5.4). Thus, no sex
specific A or C factors significantly contributed to the covariance between stressful life
events and smoking initiation, and the parameters between males and females could be
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equated to be the same in each final model. In the VTSABD, common genetic (2%) and
common shared environmental (30%) influences between stressful life events and
smoking initiation contributed to the variance in smoking initiation, while common nonshared environmental influences did not. Genetic (30%), shared environmental (21%) and
unshared environmental (17%) influences unique to smoking initiation also contributed to
the variance in smoking initiation.
Figure 5.5: Model of Best Fit and Proportions of Variance (VTSABD)

Meanwhile, in the YAFU, common genetic (9%), shared environmental (3%), and nonshared environmental (1%) contributed to the variance in smoking initiation at median
age of 21 years. Genetic (69%) and non-shared environmental (18%) influences unique
to smoking initiation also contributed to the variance in smoking initiation.
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Figure 5.6: Model of Best Fit and Proportions of Variance (YAFU)

Finally, in the TSA, common genetic (16%) and common shared environmental (13%)
influences contributed to the variance in smoking initiation at median age of 25 years.
Genetic (45%) and non-shared environmental (26%) influences unique to smoking
initiation contributed to the variance in smoking initiation.
Figure 5.7: Model of Best Fit and Proportions of Variance (TSA)
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DISCUSSION
Although many studies have examined the relationship between stressful life events and
tobacco use, none have investigated this relationship using a genetically informed
sample. To our knowledge, this is the only study that includes stressful life events and
smoking initiation. In conducting these analyses, we sought to address three major
questions: (1) Is there evidence of a shared genetic and/or environmental liability for the
association between SLEs and SI, (2) Does the structure of genetic and environmental
influences on these traits differ by sex, and (3) Does this structure differ in early
adolescence and young adulthood?
Findings from our study suggest that there is evidence of shared genetic and
environmental liability for the association between SLEs and smoking initiation and that
this structure differs in early adolescence and young adulthood. Moreover, the structure
of genetic and environmental influences on these traits does not seem to differ by sex.
This suggests that the same genes and environments are influencing both stressful life
events and smoking initiation in males and females, which differs from previous
population based studies that have found stronger associations between specific stressful
life events and smoking initiation among females relative to males. These findings may
differ because this study aggregated the effects of multiple stressful life events and tested
the association between the ordinal measure of stressful life events, rather than testing
the association with each specific stressful life event.
We also find that most of the variance in smoking initiation is accounted for by genetic
and environmental influences unique to smoking initiation. However, genetic and
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environmental influences common to stressful life events and smoking initiation do
contribute to the covariance between stressful life events and smoking initiation. While
common shared environmental influences contribute more to the variance in smoking
initiation during late adolescence (i.e. VTSABD), common genetic influences contribute
more to the variance in smoking initiation in young adulthood (i.e. YAFU & TSA). In other
words, underlying factors influencing stressful life events and smoking initiation are
different for adolescent and young adult twins, such that stressful life events and smoking
initiation is influenced by the same, shared environmental factors in young adolescents
and by the same, genetic risk factors in young adulthood. This could suggest that once
an individual is exposed to the effects of stressful life events, genetic factors come into
play, and only individuals with a certain set of genes will initiate tobacco use.
Some shared environmental factors that might be involved in the association between
stressful life events and smoking initiation have been identified in previous studies 4,7–
9,namely

the influence of peers and family. Peer influence is one of the most important

determinants of smoking initiation and it is possible that the same peers experiencing
stressful life events are involved with the initiation of smoking. Meanwhile, the influence
of family members can be seen as both an environmental factor and influenced by genetic
factors. For example, parents at high genetic risk for stressful life events may be more
likely to show negative parenting behaviors, including substance use, and then transmit
their genetic predisposition for substance use to their children.
Like other studies, this study is not without its limitations. Firstly, the analytic sample
included only Caucasians from the Mid-Atlantic region of the United States. This limits the
generalizability of the findings and future studies need to be conducted to confirm whether
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the same relationships exist in other population samples. Furthermore, the measures of
smoking initiation used in the current study were based upon self-report and no secondary
validation measures were used. Although assurances that answers would be kept
confidential were given to respondents during administration of surveys to prevent bias
[and have shown to be effective in studies conducted in the United States 21], desirability
bias could have affected the way in which respondents answered questions regarding
their tobacco use. To protect against this bias, future studies may consider validation of
smoking behavior measures using biomarkers, such as cotinine. Similarly, different
measures for stressful life events were used at each of the survey time points. To
overcome this obstacle, we tried to harmonize the measures through the inclusion of
related items for stressful life event measures (i.e. including measures on familial conflict,
divorce/separation, and death/loss).
Despite these limitations, the study yields novel information in so much that it suggests
that stressful life events and smoking initiation are associated among Caucasian
adolescents and that both genetic and environmental factors play a role in the covariation
between these traits. Future research should consider how these genetic and
environmental factors influence the covariation between stressful life events and other
tobacco use phenotypes, such as smoking progression and nicotine dependence.
CONCLUSION
This study suggests that stressful life events and smoking initiation are associated due to
a common set of environmental factors during young adolescence and common set of
genetic factors during young adulthood. Prevention and intervention programs for

96

smoking initiation should look towards targeting stressful life events, potentially through
the implementation of coping strategies with stress and incorporate environmental
influences of parents and peers.

97

CHAPTER 6:
PREVALENCE AND CORRELATES OF NICOTINE DELIVERY SYSTEMS AMONG
YOUNG ADULTS IN UNIVERSITY SETTING
Elizabeth K. Do; Megan E. Cooke; Elizabeth C. Prom-Wormley; Danielle M. Dick;
Kenneth S. Kendler; Hermine H. Maes

INTRODUCTION
Tobacco use is the leading preventable cause of morbidity and mortality in the United
States and worldwide1. Among users, it can lead to several adverse outcomes, including
nicotine dependence, cancer, and lung disease in later life. Each of these adverse
outcomes comes with an associated cost, such as lost productivity and wages due to
hospitalization or premature death. This is a key point to consider, especially when
thinking about the tobacco use behaviors of young adults. Given the broader range of
tobacco products available on the market, the tobacco use behaviors of young adults may
be considerably higher than what has been detected by previous studies limited to the
use of cigarettes2,3. As with cigarette smoking, the use of alternative nicotine delivery
systems is associated with serious health problems, such as cardiac, pulmonary and
reproductive conditions4. Further, their use may hinder efforts to reduce population-level
tobacco use and risk for nicotine dependence. This is especially problematic, given the
escalating trend for dual (e.g. using cigarettes and an alternative tobacco product) and
polytobacco use (e.g. using three or more tobacco products)5,6. According to the Tobacco
Use Supplements to the Current Population Survey, administered by the U.S. Census
Bureau, alternative tobacco use occurs more often in combination with cigarette smoking
than in isolation, as demonstrated by 51.3% of college students aged 18-24 years
reporting concurrent use2,7. Concurrent use has the potential to increase exposure to
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nicotine and risk for adverse health effects8 and nicotine dependence9. Concurrent users
also tend to ingest more nicotine daily and are less likely to stop using tobacco, relative
to individuals who use only one tobacco product7,10.
Despite public health efforts to decrease its prevalence, tobacco use remains common,
especially among young adults. Young adulthood is a critical time during which individuals
are exploring and/or solidifying their tobacco use patterns. Currently, the prevalence of
occasional use among college students is higher compared to other adult users of
tobacco11. Since currently available cessation services are not ideally suited for
occasional users of tobacco12,13, a better understanding the factors contributing to the
patterns and nuances of tobacco use among college students could aid the design of
better prevention and interventions for young adults. Most studies focus on cigarette use,
which has declined from 45.5% in 1965 to 24.4% in 2005, and leveled out to about 20%
within the United States. Within the past couple of years, the use of alternative tobacco
products (e.g. smokeless tobacco, cigars, waterpipe/hookah, and e-cigarettes) has been
increasing, particularly among adolescents and young adults.
Factors affecting tobacco use across various age groups include parental autonomy
granting, parental involvement, and the experience of stressful life events. Higher levels
of autonomy granting are related to lower levels of drug use 14, while associations between
parental involvement and smoking suggest that young adults whose parents spend more
time with them and communicate with them more frequently are less likely to use
tobacco15. Meanwhile, studies identify tobacco use as a potential mechanism by which
individuals cope with (anticipated) stress16. Higher levels of life stress are associated with
risk of cigarette smoking initiation within adolescents17 and retrospective accounts of life
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experiences demonstrate that smokers often report more stressful life events, relative to
non-smokers18–20. Studies of both adolescents and college students demonstrate that
increased involvement with smoking is found among those experiencing negative affect,
often because of stress21. However, it is unclear whether these factors are associated
with other nicotine delivery use in young adults as well.
This study evaluates the patterns of use across nicotine delivery systems among young
adults in a sample of college students attending an urban four-year university.
Specifically, we want to determine: (1) age of first use for each tobacco product or nicotine
delivery system, (2) the prevalence of lifetime and current use and whether this differs by
sex or race/ethnicity, and (3) the degree to which use of these products are associated
with environmental factors, such as parental environment as well as with experiencing
stressful life events.
MATERIALS AND METHODS
Sample. Data were collected as a part of Spit for Science, an effort being led by
researchers at a large, diverse, public urban university in the Mid-Atlantic region, to
understand how genetic and environmental factors come together to contribute to the
development of problems associated with the use of substances and emotional health.
Incoming freshman (≥18 years) were invited to participate in the longitudinal cohort study,
which involves multiple waves of survey data collection, including: two collection periods
during the freshman year (fall and spring) and spring follow-ups conducted annually
thereafter. Participants were given a $10 incentive for their participation in each of the
surveys.
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The study is ongoing, and the results from this study reflect the data available for cohorts
one through four from Fall 2012 to Spring 201522. Each cohort is followed across time,
from freshman year when they are enrolled into the study. All information collected was
managed using an electronic data capture tool hosted at the university called Research
Electronic Data Capture (REDCap)23. Currently, four cohorts have enrolled in the study:
2707 enrolled in Fall 2011, 2481 enrolled in Fall 2012, 2391 enrolled in Fall 2013, and
2310 enrolled in Fall 2014 (Total N = 9,889). DNA collection is also a part of the study
protocol, but not involved in the present analyses. The university Institutional Review
Board (IRB) approved all Spit for Science protocols.
Measures.

Demographic characteristics include

race/ethnicity,

sex,

and age.

Race/ethnicity was collected, since the prevalence of tobacco use in young adulthood is
expected to differ across race/ethnicity groups. Participants were asked to select from
“American Indian/Alaska Native”, “Asian”, “Black/African American”, “Hispanic/Latino”,
“More than one race”, “Native Hawaiian/Other Pacific Islander”, “Unknown”, “White”, or “I
choose not to answer” to answer the question: “Which one of these groups’ best describes
you?” The types of tobacco products and nicotine delivery systems used are also
expected to differ by sex, of which participants could select: “male”, “female”, or “I choose
not to answer.” The age of respondents ranged from 18 to 35 years, with the mean age
of respondents being 19.6 years.
Lifetime and recent use of cigarettes, smokeless tobacco (chaw/dip/snus), cigars
(including little cigars and cigarillos), hookah, and e-cigarettes were treated as binary
variables (i.e. yes = 1; no = 0).
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Age of onset of tobacco use was measured using: “How old were you when you smoked
a cigarette or used tobacco for the first time (including just one or two puffs)?” This
variable was coded as an ordinal variable, with those who had not initiated smoking coded
as zero, those who had initiated after age 18 as 1, gradually increasing to those who
initiated prior to age 12 (2: 15-18 years, 3: 12-14 years, 4: <12 years). For cohort 4,
measures for tobacco product-specific age of onset were available, asking “How old were
you when you [smoked a cigarette/used smokeless tobacco/ smoked cigars, little cigars,
cigarillos/ smoked hookah/ used an e-cigarette] for the first time?” Participants responded
to this question by inputting their age in years in a free response. Responses that were
missing for the age of onset of tobacco use were substituted by measures for tobacco
product-specific age of onset.
Exposure to stressful life events prior to university enrollment were calculated as a sum
score from five yes/no items. The items asked specifically whether before the past 12
months, the following events happened to the participant: natural disaster (flood,
hurricane, tornado, earthquake, fire or explosion), physical assault (being attacked, hit,
slapped, kicked, beaten up, shot, or stabbed), sexual assault (rape, attempted rape, made
to perform any type of sexual act through force or threat of harm), other unwanted or
uncomfortable sexual experience, transportation accident (car accident, boat accident,
train wreck, plane crash). Greater values indicate higher levels of stressful life events
experienced prior to university and all responses were included in analyses.
Parental involvement was measured using three items: “My parents helped me with
schoolwork if there was something I didn’t understand”, “My parents knew who my friends
were”, and “My parents spent time just talking with me” from the Steinberg Parental Style
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Scale. Each of these items were reverse-coded and then summed. Greater values
indicate higher levels of involvement. Only responses where participants answered at
least 50% of the items were included in analyses.
Parental autonomy granting was measured using three items: “My parents said I should
give in on arguments rather than making people angry”, “My parents told me that their
ideas were correct and I should not question them”, and “My parents acted cold and
unfriendly if I did something they didn’t like” from the Steinberg Parental Style Scale.
Greater values indicate lower levels of autonomy granting. Only responses where
participants answered at least 50% of the items were included in analyses.
Statistical Analysis. Frequencies of the relevant variables were described with
percentages, while Chi-square tests and independent sample t-tests were used to assess
the relationship between age of onset of tobacco use and demographic characteristics,
stressful life events experienced prior to attending university, parental involvement, and
parental autonomy granting. Tetrachoric and polychoric correlations were used to
examine specific and overall tobacco product use by parental environment and stressful
life events experienced prior to attending university. Multivariate logistic regression
models were fitted to examine the associations between tobacco use (lifetime and recent
use) and stressful life events experienced prior to attending university, parental
involvement, and parental autonomy granting. Analyses were performed using SAS 9.3
(SAS Institute).
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RESULTS
Descriptive characteristics of the sample. The total analytic sample included 9,889
individuals. Females made up 61.5% (N = 6060) of the sample. Approximately half
(50.1%; N = 4881) identified as White, 19.2% (N = 1873) identified as Black/AfricanAmerican, 16.6% (N = 1614) identified as Asian, 6.3% (N = 617) identified as more than
one race, 6.1% (N = 594) identified as Hispanic/Latino, 0.7% (N = 67) identified as Native
Hawaiian/Other Pacific Islander, 0.5% (N = 51) identified as American Indian/Alaska
Native, and 0.4% (N = 39) identified as unknown race.
Age of Onset of Tobacco Use. Over half (68.4%) of students have initiated any tobacco
use. Of those who had initiated, 18.4% did not report an age of onset, while more than
40% had initiated by age 18. Of those that initiated by 18, most students started using
tobacco products between ages 15 to 18 years (25.6%). On average, the age of onset for
smokeless tobacco was 15.82 years, followed by cigarettes at 15.96 years, cigars and
hookah at 16.15 and 16.18 years, followed by e-cigarettes at 17.26 years (Table 6.1).
Table 6.1 Tobacco Use – Age of Initiation
Overall Tobacco Use

N

%

Did Not Initiate

3091

31.26

Initiated, but did not report age of initiation

1815

18.35

> 18 years

1109

11.21

15 – 18 years

2531

25.59

12-14 years

1094

11.06

< 12 years

249

2.52

N

Mean

SD

662
185
640
918
591

15.96
15.82
16.15
16.18
17.26

2.65
3.43
3.14
3.81
1.84

By Tobacco Product
Cigarettes
Smokeless
Cigars
Hookah
E-Cigarettes
Note: Average age of tobacco use initiation was 15 years (SD = 1.2 years)
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Changes in the prevalence of lifetime tobacco use. Figure 6.1 shows the prevalence
in lifetime use of tobacco by nicotine delivery system (e.g. cigarettes, snus, cigars,
hookah, and e-cigarettes), separated by sex and time in college by cohort. Generally, the
lifetime use of tobacco products increased as the time enrolled in college increased for
both males and females. On average, 30% of females and 40% of males had ever used
cigarettes; less than 10% of females and 20% had ever used snus; and 50 % of males
and females had ever used hookah in their lifetime, by their freshman year of college.
While the percentages endorsing lifetime use of cigars, and hookah remained consistent
from freshman year to senior year, the endorsement of lifetime use of cigarettes increased
across all cohorts. Interestingly, the lifetime use of snus and e-cigarettes differed by
cohort; however, this might be a function of availability and when this item was measured
in the survey. Figure 6.2 demonstrates this point by displaying the prevalence of lifetime
tobacco use by nicotine delivery system, as a function calendar time, separated by sex.
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Figure 6.1: Prevalence of Lifetime Tobacco Use by Nicotine Delivery System, Sex, and Time in College – Separated by Cohort
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Figure 6.2: Prevalence of Lifetime Tobacco Use by Nicotine Delivery System and Time in College – Separated
by Sex
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Tobacco use prevalence and differences by sex and race/ethnicity. Aggregated
measures of lifetime tobacco use from Table 6.2 demonstrates that the lifetime
prevalence of tobacco use was highest for hookah (49.6%), followed by cigarettes
(49.2%), cigars (34.9%), e-cigarettes (25.5%), and smokeless tobacco (15.1%). Overall,
a higher percentage of males reported using tobacco, relative to females, across each
tobacco product. The largest difference between the percentages of males vs. percentage
of females using a tobacco product was found for smokeless tobacco, where 27.8% of
males and 7.2% of females endorsed ever using smokeless tobacco (Χ2 = 767.46, df = 1,
p-value <0.0001) (Table 6.2). The prevalence of lifetime use of tobacco products differed
by race/ethnicity (Table 6.3).
The tobacco product with the highest prevalence for recent use was cigarettes (48.1%),
followed by e-cigarettes (27.6%), hookah (24.3%), smokeless tobacco (18.6%), and
cigars (18/3%). Looking at recent tobacco use by sex, we found that a significantly higher
percentage of males used tobacco products, relative to females across all tobacco
products. More than 40% of students have indicated that they used tobacco products in
the past 30 days, at the time of their most recent follow-up survey (Table 6.2). The
prevalence of recent use of tobacco products was similar across race/ethnicity, for
hookah/waterpipe and e-cigarettes (Table 6.3).

108

Table 6.2: Lifetime and Recent Tobacco Use by Sex

Lifetime Tobacco Use

Male

Female

Total

n/total n (%)

n/total n (%)

n/total n (%)

Χdf=1value, p-value

Overall Tobacco Use

2705/3793 (71.3)

4036/6060 (66.6)

6741/9853 (68.4)

23.99, <0.0001*

Cigarettes

2113/3793 (55.7)

2731/6060 (45.1)

4844/9853 (49.2)

105.71, <0.0001*

Smokeless

1054/3793 (27.8)

438/6060 (7.2)

1492/9853 (15.1)

767.46, <0.0001*

Cigars

1645/3793 (43.4)

1795/6060 (29.6)

3440/9853 (34.9)

194.06, <0.0001*

Hookah

1895/3793 (50.0)

2995/6060 (49.4)

4890/9853 (49.6)

E-Cigarettes

1199/3793 (31.6)

1312/6060 (21.7)

2511/9853 (25.5)

n/total n (%)

Recent Tobacco Use

n/total n (%)

0.27, 0.6033
121.88, <0.0001**

n/total n (%)

Overall Tobacco Use

1880/3520 (53.4)

2164/5599 (38.7)

4044/9119 (44.4)

190.76, <0.0001*

Cigarettes*

1167/2139 (54.6)

1195/2758 (43.3)

2362/4897 (48.2)

60.84, <0.0001*

Smokeless*

334/1289 (25.9)

86/958 (9.0)

420/2247 (18.7)

103.70, <0.0001*

Cigars

874/3346 (26.1)

679/5148 (13.2)

1553/8494 (18.3)

226.96, <0.0001*

Hookah

993/3411 (29.1)

1165/5455 (21.4)

2158/8866 (24.3)

68.54, <0.0001*

E-Cigarettes*

419/1203 (34.8)

301/1419 (21.2)

720/2622 (27.5)

60.61, <0.0001*

* skip pattern – if indicated no lifetime use, then skipped question
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Table 6.3: Lifetime and Recent Tobacco Use by Race/Ethnicity
1

2

3

4

5

6

7

Total

Χdf=7
value, pvalue

3501/4881
(71.7)
2827/4881
(57.9)
936/4881
(19.2)
1890/4881
(38.7)
2377/4881
(48.7)
1453/4881
(29.8)

1221/1873
(65.2)
610/1873
(32.6)
146/1873
(7.8)
621/1873
(33.2)621
970/1873
(51.8)
284/1873
(15.2)

930/1614
(57.6)
605/1614
(37.5)
181/1614
(11.2)
368/1614
(22.8)
732/1614
(45.4)
347/1614
(21.5)

434/594
(73.1)
328/594
(55.2)
88/594
(14.8)
208/594
(35.0)
337/594
(56.7)
171/594
(28.8)

462/617
(74.9)
332/617
(53.8)
91/617
(14.8)
239/617
(38.7)
329/617
(53.3)
177/617
(28.7)

50/67
(74.6)
40/76
(59.7)
15/67
(22.4)
31/67
(46.3)
39/67
(58.2)
19/67
(28.4)

33/51
(64.7)
21/51
(41.2)
11/51
(21.6)
20/51
(39.2)
24/51
(47.1)
17/51
(33.3)

6659/9736
(68.4)
4787/9736
(49.2)
1475/9736
(15.2)
3396/9736
(34.9)
4827/9736
(49.6)
2478/9736
(25.4)

140.37,
<0.0001*
464.88,
<0.0001*
164.56,
<0.0001*
149.43,
<0.0001*
34.46,
<0.0001*
174.58,
<0.0001*

2216/4544
(48.8)
1518/2847
(53.3)
257/1345
(19.1)
790/4293
(18.4)
1045/4389
(23.8)
429/1491
(28.8)

637/1746
(36.5)
211/624
(33.8)
44/271
(16.2)
327/1614
(20.3)
395/1713
(23.1)
64/303
(21.1)

524/1436
(36.5)
251/619
(40.6)
59/271
(21.8)
169/1305
(13.0)
352/1406
(25.0)
103/387
(26.6)

261/561
(46.5)
144/332
(43.4)
23/150
(15.3)
96/505
(19.0)
150/547
(27.4)
52/179
(6.9)

281/579
(48.5)
159/331
(48.0)
20/140
(14.3)
110/537
(20.5)
148/567
(26.1)
51/185
(27.6)

281/579
(48.5)
19/39
(48.7)
1/21
(4.8)
16/59
(27.1)
18/61
(29.5)
4/18
(22.2)

23/46
(50.0)
12/22
(54.5)
4/10
(40.0)
11/43
(25.6)
14/43
(32.6)
8/16
(50.0)

2216/4544
(48.8)
2328/4837
(48.1)
412/2218
(18.6)
1531/8389
(18.3)
2131/8759
(24.3)
713/2587
(27.6)

126.4,
<0.0001*
101.1,
<0.0001*
14.5,
0.0426*
42.9,
<0.0001*
9.0,
0.2553
12.08,
0.0980

Lifetime Tobacco Use
Any Tobacco Use
N = 9736
Cigarettes
N = 9736
Smokeless
N = 9736
Cigars
N = 9736
Hookah
N = 9736
E-Cigarettes
N = 9736
Recent Tobacco Use
Any Tobacco Use
N = 9008
Cigarettes*
N = 4837
Smokeless*
N = 2218
Cigars
N = 8389
Hookah
N = 8759
E-Cigarettes*
N = 2587

1=White/Caucasian; 2 = Black/African American; 3 = Asian; 4 = Hispanic/Latino; 5 = More than one race; 6 = Native Hawaiian/Other
Pacific Islander; 7 = American Indian/Alaska Native
* skip pattern – if indicated no lifetime use, then skipped question (explains why so many missing)

More than 40% of students have used two or more tobacco products within their lifetime.
Among recent tobacco users, 49.4% used only one tobacco product, 14.3% used two
tobacco products, 3.3% used three tobacco products, and 0.8% used four or more
tobacco products concurrently. Among those who only used one tobacco product, hookah
use was the most popular (44.4%), followed by cigarettes (22.3%), and cigars (22.0%). A
combination of cigarettes, hookah, cigars, and e-cigarettes was common among those
who reported using two products or more concurrently.
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In the total sample, 15.5% had ever smoked ≥100 cigarettes in their lifetime. Relative to
females, more males reported smoking at least 100 cigarettes or more in their lifetime
(21.6% of males vs. 11.7% of females; Χ2 = 202.1, df = 2, p-value <0.001). Differences in
the reported prevalence of lifetime smoking of 100 or more cigarettes were also found
across race/ethnicity (Χ2 = 605.7, df = 14, p-value <0.001). Compared to
White/Caucasians, fewer Blacks/African Americans, Asians, and Hispanics/Latinos
reported smoking ≥100 cigarettes in their lifetime.
Of the full sample, 4.9% (N = 487) met criteria for nicotine dependence, when using a cutoff score of four for the Fagerström Test for Nicotine Dependence. Males were more likely
to meet criteria for nicotine dependence, relative to females (7.4% vs. 3.4% respectively;
Χ2 = 83.3, df = 1, p-value <0.0001).
Lifetime tobacco use, parental involvement, and autonomy granting. Parental
involvement was negatively correlated with the use of each tobacco product, while
parental autonomy granting was positively correlated with the use of any tobacco product,
cigarettes, smokeless tobacco, hookah, and e-cigarettes.
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Table 6.4: Lifetime and Recent Tobacco Use Correlations

Parental Involvement

Parental Autonomy
Granting

Natural Disaster

Physical Assault

Sexual Assault

Other Unwanted
Sexual Experiences

Transportation/
Accident

Any Stressful Life
Event

Lifetime Tobacco Use
Any Tobacco

-0.023 (-0.054, 0.007)

0.058 (0.029, 0.088)

-0.016 (-0.090, 0.059)

0.197 (0.114, 0.280)

0.177 (0.063, 0.290)

0.185 (0.095, 0.275)

0.076 (0.001, 0.152)

0.038 (-0.041, 0.116)

Cigarettes

-0.049 (-0.078, -0.020)

0.049 (0.021, 0.078)

-0.031 (-0.102, 0.040)

0.284 (0.208, 0.359)

0.264 (0.162, 0.368)

0.257 (0.175, 0.339)

0.096 (0.024, 0.167)

0.069 (-0.006, 0.144)

Smokeless

-0.065 (-0.101, -0.030)

0.044 (0.009, 0.055)

-0.030 (-0.115, 0.056)

0.241 (0.152, 0.330)

0.007 (-0.121, 0.135)

0.057 (-0.045, 0.159)

0.101 (0.015, 0.187)

0.062 (-0.029, 0.153)

Cigars

-0.033 (-0.063, -0.003)

0.029 (-0.001, 0.059)

0.044 (-0.030, 0.118)

0.203 (0.123, 0.282)

0.138 (0.031,0.245)

0.146 (0.060, 0.232)

0.070 (-0.005, 0.144)

0.086 (0.008, 0.164)

Hookah

-0.031 (-0.060, -0.001)

0.058 (0.030, 0.087)

-0.028 (-0.100, 0.042)

0.082 (0.002, 0.161)

0.126 (0.020, 0.231)

0.126 (0.041, 0.210)

0.010 (-0.062, 0.082)

0.00 (-0.075, 0.075)

E-Cigarettes

-0.042 (-0.076, -0.009)

0.062 (0.030, 0.095)

-0.016 (-0.093, 0.061)

0.146 (0.063, 0.230)

0.251 (0.146, 0.366)

0.203 (0.116, 0.291)

0.022 (-0.055, 0.100)

0.027 (-0.055, 0.108)

Recent Tobacco Use
Any
Tobacco

-0.053 (-0.082, -0.023)

0.064 (0.035, 0.093)

-0.21 (-0.095, 0.053)

0.225 (0.145, 0.304)

0.168 (0.060, 0.275)

0.173 (0.087, 0.260)

0.064 (-0.010, 0.139)

0.052 (-0.026, 0.131)

Cigarettes

-0.048 (-0.088, -0.007)

0.029 (-0.011, 0.069)

-0.026 (-0.126, 0.073)

0.226 (0.124, 0.328)

0.165 (0.032, 0.299)

0.119 (0.007, 0.231)

0.038 (-0.061, 0.139)

0.056 (-0.051, 0.162)

Smokeless

-0.043 ( -0.113, 0.026)

-0.007 (-0.075, 0.061)

-0.132 (-0.294, 0.029)

-0.003 (-0.176, 0.169)

-0.072 (-0.321, 0.176)

-0.06 (-0.53, 0.133)

-0.098 (-0.262, 0.066)

-0.069 (-0.242, 0.134)

Cigars

-0.061 (-0.096, -0.026)

0.041 (0.006, 0.076)

0.010 (-0.080, 0.099)

0.242 (0.150, 0.334)

0.148 (0.014, 0.269)

0.048 (-0.058, 0.154)

0.054 (-0.036, 0.144)

0.076 (-0.020, 0.171)

Hookah

-0.061 (-0.093, -0.028)

0.072 (0.041, 0.104)

0.031 (-0.052, 0.113)

0.115 (0.025, 0.205)

0.002 (-0.121, 0.125)

0.046 (-0.053, 0.144)

0.020 (-0.063, 0.104)

-0.009 (-0.097, 0.078)

-0.058 (0.126, 0.009)

-0.007 (-0.074, 0.059)

-0.004 (-0.150, 0.143)

0.069 (-0.087, 0.224)

-0.044 (-0.126, 0.038)

-0.063 (-0.226, 0.101)

0.047 (-0.099, 0.195)

-0.012 (-0.168, 0.145)

E-Cigarettes

Boldface indicates significance at p-value ≤0.05.

112

Significant correlations were small in effect (Table 6.4). For example, negative
correlations between parental involvement and lifetime use of tobacco products ranged
from -0.065 (95%CI: -0.101, -0.030) to -0.031 (95% CI: -0.060, -0.001). Meanwhile,
parental autonomy granting was statistically, positively correlated with the lifetime use of
any tobacco product, cigarettes, smokeless tobacco, hookah, and e-cigarettes. These
significant, positive correlations ranged from 0.044 (95% CI: 0.021, 0.078) to 0.062 (95%
CI: 0.030, 0.95).
Lifetime tobacco use, physical and sexual assault. The experience of natural disaster
was not significantly correlated with the use of any tobacco product (Table 6.4). However,
the experience of physical assault, sexual assault, other unwanted sexual experiences or
transportation/accident was significantly, positively associated with the lifetime use of
tobacco products, except for the association between: sexual assault and other unwanted
sexual experiences and smokeless tobacco use, and transportation/accident and lifetime
cigar, hookah, and e-cigarette use. On average, these correlations ranged from 0.082
(95% CI: 0.002, 0.161) to 0.264 (95% CI: 0.162, 0.368).
Recent tobacco use, parental involvement and autonomy granting. Correlations
between parental environment and recent tobacco use followed a similar pattern to those
found between parental environment and lifetime tobacco use, such that significant
correlations between parental involvement and recent tobacco use were negative and
significant correlations between parental autonomy granting and recent tobacco use were
positive. Significant negative correlations were found between parental involvement and
the recent use of any tobacco product, cigarettes, cigars, and hookah, which ranged from
-0.068 (95% CI: -0.082, -0.023) to -0.048 (95% CI: -0.083, -0.007). Significant positive
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correlations were found between parental autonomy granting and the recent use of any
tobacco product, cigars, and hookah, which ranged from 0.041 (95% CI: 0.006, 0.078) to
0.084 (95% CI: 0.036, 0.093).
Recent tobacco use, physical assault and sexual assault. The experience of physical
assault, sexual assault, and other unwanted sexual experiences was correlated with the
recent use of any tobacco product, and cigarette use. The experience of physical assault
was also correlated with the recent use of cigars and hookah, while the experience of
sexual assault was correlated with the recent use of cigars. However, the significant
correlations were slightly weaker, relative to lifetime measures of tobacco use, ranging
from 0.116 (95%CI: 0.025, 0.206) to 0.242 (95% CI: 0.170, 0.334).
DISCUSSION
Despite public health successes in reducing the consumption of cigarettes, the increasing
popularity of alternative tobacco products poses new challenges. More than 40% of
students reported tobacco use in the past 30 days at the time of their most recent followup survey. This is important since studies demonstrate that alternative tobacco products
contribute to negative outcomes, similar to the use of cigarettes. For example, smokeless
tobacco is addictive and its use has been associated with an increased risk of cancer;
myocardial infarction and stroke; oral disease; and reproductive problems24. Hookah, or
waterpipe, tobacco smoking has also been previously associated with higher odds of lung
cancer, respiratory illness, low birth weight, and periodontal disease 25. Cigar smoke
contains higher concentrations of toxic and carcinogenic compounds relative to
cigarettes; does not reduce the risk of nicotine addiction, and is known to cause cancers
of the lung and upper aero digestive tract26. Additionally, individuals who use alternative
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tobacco products may face the same challenges in quitting and experiencing negative
tobacco-related health consequences in their futures, as those who only smoke
cigarettes. Furthermore, concurrent use of tobacco products and cigarettes may make it
more difficult to quit tobacco use overall24.
It remains unclear whether alternative forms of tobacco use may serve as an initial
pathway to nicotine addiction, with or without the use of cigarettes 27. From pairwise
comparisons of reported age of onset, it seems to be the case that cigarette use precedes
the use of other tobacco products, such as cigars, smokeless tobacco, hookah, and ecigarettes. However, a sizeable number of individuals reported using these substances
within at least the same year. Cigar use appears to precede the use of smokeless
tobacco, while smokeless tobacco use appears to precede or occur around the same time
as first use of hookah or e-cigarettes. The timing of onset of the initiation of cigars,
hookah, and e-cigarette use was more difficult to discern. In part, this could be attributed
to the growing availability of these substances since students enrolled in S4S.
Differences by sex and race/ethnicity across lifetime and recent tobacco vary by tobacco
product. In general, men had higher prevalence of tobacco use than women 28. This
finding is similar to another study that found that men used smokeless tobacco products
and snus significantly more frequently than women24. Underlying causes for differences
in tobacco product use across race/ethnicity are complex and multifactorial. It is possible
that differences among certain racial/ethnic groups are related to cultural factors, such as
social disapproval of smoking, particularly among women29. This could signal underlying
cultural norms related to the use of specific tobacco products, as well as change in
availability of tobacco products.
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Parental environment prior to university enrollment has a small, but significant influence
on tobacco use. In part, this could be attributed to the fact that as adolescents grow into
young adults, protective parental influences become less important in adolescents’ use
of tobacco. This finding is consistent with findings from twin and epidemiological studies,
which suggest that parental environment plays a smaller role in young adulthood. One
study suggested that parental influences of connectedness and punishment for smoking
remains important until mid-adolescence and parental monitoring continues to be
important in protecting against smoking at age 16 30. Our study suggests that parental
involvement may be protective against both lifetime and recent tobacco use, while
parental autonomy granting is positively associated with lifetime and recent tobacco use.
This is aligned with another study by the same research group that found that a higher
levels of family involvement is protective against recent smoking31.
Experience of stressful life events prior to university might have lasting effects on tobacco
use. Prior research suggests that stressful life events are associated with smoking and
that stressful life events might have a differential effect on smoking among women versus
men32. In this study, moderate correlations were found between experience of stressful
life events prior to university and tobacco use, with the strongest correlations found
between the experience of physical abuse and sexual abuse and tobacco use. It is
possible that tobacco use functions as a coping behavior for these stressors, as previous
observational studies have demonstrated that the experience of acute stressful events
are associated with higher smoking prevalence. However, tobacco use is an ineffective
stress-reducing strategy and perpetuates a stress response in users, which can also
result in diminished self-regulation to control the urge to use. Experimental studies
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demonstrate that induced stress reduces an individual’s ability to resist tobacco use and
increases tobacco use intensity and reward33.
There are, however, a few limitations to note. We are unable to infer causality, despite
trying to limit the exposure time for the experience of stressful life events and parental
environment to prior to enrollment at university, due to the use of correlations in this study.
Another potential limitation could be recall bias, since students are asked to
retrospectively report their parental environment and stressful life events. Recall of
information is solely dependent upon memory, which can be imperfect and potentially
unreliable. Additionally, since the university has a diverse population of students, the
findings from this study might not be representative of all universities of its size, or of all
young adults outside of the college setting.
Despite these limitations, this study contributes to the existing literature by demonstrating
that tobacco use was prevalent among college students and that tobacco use was not
limited to the use of cigarettes. The use of smokeless tobacco, hookah, and e-cigarettes
was also common. The use of tobacco products was correlated with other environmental
factors, such as parental involvement and parental autonomy granting, physical assault,
and sexual assault experienced prior to enrollment at university. Our study also
demonstrated that these associations may persist over time. Given these potentially longstanding effects, it may be useful to view university enrollment as an opportunity for
potential intervention or prevention of tobacco use as a coping mechanism for these
stressful life events34. Furthermore, the endorsement of lifetime use of tobacco products
and nicotine delivery systems increased across freshman to senior year, suggesting that
college is a time when many individuals are trying a range of tobacco products and
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nicotine delivery systems. This is important since the use of tobacco products put
individuals at risk of developing nicotine dependence and lead to many negative health
risks. There are few regulations associated with the marketing, sale and use of emerging
tobacco products that can encourage young adults to start using tobacco products, if they
have not by the time they start college35. Thus, further research on the prevalence,
correlates, and risk factors for the use of alternative tobacco products is needed,
especially as use continues to gain popularity36.
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CHAPTER 7:
INITIAL EXPERIENCES WITH NICOTINE AND ITS ASSOCIATION WITH RECENT
USE OF TOBACCO AND NICOTINE DEPENDENCE
Elizabeth K. Do; Elizabeth C. Prom-Wormley; Danielle M. Dick; Kenneth S. Kendler;
Hermine H. Maes

BACKGROUND
It has been suggested that initial experiences during first exposure to tobacco may be
indicative of individuals’ sensitivity to nicotine 1 and vulnerability to nicotine dependence 2.
However, whether innate sensitivity to nicotine dependence either enhances or inhibits
the likelihood of established patterns in smoking behavior remains an area of debate 3.
Both adverse experiences, such as coughing, dizziness, and nausea, and positive
experiences such as relaxation or experiencing a pleasurable rush or buzz can result from
experimentation with tobacco products containing nicotine 4. Generally, positive effects
have been found to have a stronger association with smoking behavior 1,5. Though,
unpleasant reactions due to symptoms of dizziness or nausea during the initial experience
of tobacco use are not necessarily protective against subsequent smoking 5–7. Thus, a
clearer understanding of the factors influencing initial experiences with tobacco use and
of how these initial experiences affect subsequent use of tobacco products and the
development of nicotine dependence is needed 5.
Many factors are likely to influence initial experiences with tobacco use. One such factor
is the age of onset of tobacco use. One study found that pleasurable sensations upon
initial exposure to tobacco use were significantly linked to the age at first cigarette,
whereby the earlier the first tobacco use occurred, the higher the probability of pleasant
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feelings during initial smoking. The same study reports a trend towards experiencing
higher relaxation in those with an earlier age at first cigarette, and no relation between
the age at first cigarette and experience of unpleasant sensations. In this study conducted
by Buchmann et al. (2011), an earlier age at first cigarette is also associated with a greater
likelihood of becoming a regular smoker by age 22 8.
Since previous studies have primarily focused on initial experiences with cigarette use,
the present study seeks to contribute to the literature by determining: (1) the prevalence
of initial experiences with tobacco, recent tobacco use, and nicotine dependence in two
different samples: the Spit for Science9 and the Virginia Twin Studies of Adolescent
Behavioral Development10, (2) whether or not initial experiences with tobacco use differ
according to tobacco product used, (3) whether there is an association between initial
experiences with tobacco use and recent tobacco use, or nicotine dependence, and (4)
whether these associations differ by sex.
MATERIALS AND METHODS
Samples
Spit for Science. Data were collected from Spit for Science, a research study examining
how genetic and environmental factors come together to contribute to the development
of problems associated with the use of alcohol, the use of other substances, and
emotional health. Incoming freshman, 18 years of age and older, were invited to
participate in the study which included an electronic survey designed to collect broadbased information about substance use and mental health outcomes. Additionally, the
study design involves multiple waves of data collection, including: two collection periods
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during the freshman year occurring upon arrival on campus in the fall and again during
the middle of the spring semester. Further waves of data were collected annually during
the spring semester. Data collection for this study is ongoing, and results from this study
reflect a subset of the total Spit for Science sample who answered questions about initial
experiences with tobacco use, current tobacco use, and completed the Fagerström Test
for Nicotine Dependence (FTND).
For the purposes of this study, those who did not provide information on initial experiences
with tobacco were excluded from analyses. Due to small sample size, individuals who
reported their self-identified race category as: Native Hawaiian or Other Pacific Islander
and American Indian or Alaskan Native were excluded (n=67 & 51 respectively). Thus,
data was available for 2,081 individuals. All survey information collected was managed
using an electronic data capture tool hosted at Virginia Commonwealth University called
Research Electronic Data Capture (REDCap). REDCap is a secure, web-based
application designed to support data capture for research studies11. Participants were
given a $10 incentive for their participation in each of the surveys. DNA collection is also
a part of the study protocol, but not used in the present analysis. The VCU Institutional
Review Board (IRB) approved all S4S protocols.
Virginia Twin Studies of Adolescent Behavioral Development (VTSABD). The VTSABD is
a cohort-longitudinal epidemiological study that uses the genetic twin design to study the
development and maintenance of child psychiatric disorders12. It is comprised of three
studies: the Virginia Twin Study of Adolescent Behavior Development, the Young Adult
Follow-Up, and the Transitions to Substance Abuse follow-up. It is the first populationbased, multi-wave, cohort-sequential twin study of adolescent psychopathology and its
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risk factors. Included within this study are Caucasian families of male and female
monozygotic and dizygotic twins and their parents to assess the role of genes and the
environment in developmental trajectories of behavior from childhood to young adulthood.
The sample was ascertained through Virginia schools and assessment of the children
involved semi-structured and face-to-face interviews with both twins and both parents
using the Child and Adolescent Psychiatric Assessment (CAPA). Self-report
questionnaires were also completed by parents, children, and teachers 13.
Measures
Demographic characteristics. Within the Spit for Science study, participants were asked
to select from “American Indian/Alaska Native”, “Asian”, “Black/African American”,
“Hispanic/Latino”, “More than one race”, “Native Hawaiian/Other Pacific Islander”,
“Unknown”, “White”, or “I choose not to answer” to answer the question: “Which one of
these groups’ best describes you?” For sex, participants could select: “male”, “female”, or
“I choose not to answer”. Participants in VTSABD were predominantly White.
Age of onset of tobacco use. Within Spit for Science, age of onset was measured using
the following question: “How old were you when you smoked a cigarette or used tobacco
for the first time (including just one or two puffs)?” This variable was coded as an ordinal
variable, with those who had not initiated smoking coded as 0, those who had initiated
after age 18 as 1, gradually increasing to those who initiated prior to age 12 (2: 15-18
years, 3: 12-14 years, 4: <12 years). For cohort 4 of Spit for Science, measures for
tobacco product-specific age of onset were available, asking “How old were you when
you [smoked a cigarette/used smokeless tobacco/ smoked cigars, little cigars, cigarillos/
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smoked hookah/ used an e-cigarette] for the first time?” Participants responded to this
question by inputting their age in years in a free response. Age of onset was coded
similarly for responses from the VTSABD.
Initial sensitivity to tobacco products. Initial sensitivity was measured by asking eight
questions about the sensations experienced when the participant first used a specified
tobacco product. Each question was worded “how much [insert sensation here] … did
you feel?” with potential responses being: none, slight, moderate, or intense. The eight
questions asked about feeling pleasant sensations, unpleasant sensations, nausea,
relaxation, dizziness, pleasurable rush or buzz, coughing, and difficulty inhaling. These
measures were the same in Spit for Science and the VTSABD.
Recent use of tobacco products. For the Spit for Science sample, recent use of tobacco
products (e.g. use of tobacco products in the last 30 days) was treated as binary variables,
similarly coded to lifetime use of tobacco products. Measures for recent use of cigarettes,
smokeless tobacco, cigars, hookah, and e-cigarettes included the following, respectively:
“How frequently did you smoke cigarettes in the past 30 days?”, “How frequently did you
use a smokeless tobacco product (dip/chaw/snus) in the last 30 days?”, “During the last
30 days, on how many days have you smoked cigars, little cigars, or cigarillos?”, “During
the last 30 days, on how many days have you smoked a hookah?”, and “During the last
30 days, on how many days did you use e-cigarettes?” For each of these measures, if
the participant indicated ‘I choose not to answer’, the answer was coded as missing. If
the participant indicated that he/she had not used the tobacco product, the answer was
coded as 0 (no); otherwise, if the participant had indicated that he/she had used the
tobacco product at least once, the answer was coded as 1 (yes). An aggregate measure
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of recent use of tobacco products was also calculated by summing across each of the
recent use measures of tobacco products, with 0 coded as no, and 1 or greater coded as
yes. A similar approach was taken for VTSABD data, which focused on cigarette use.
Nicotine Dependence (ND). Nicotine dependence was measured using the Fagerström
Test for Nicotine Dependence. A threshold of ≥4 was used to determine whether an
individual met criteria for ND.
Statistical Analysis
Polychoric correlations were computed to examine the relationship between initial
experiences with tobacco and recent tobacco use and nicotine dependence. Multivariate
analyses relied on multiple regressions to determine whether sex was an important
contributor to the association between initial experiences with tobacco use, recent
tobacco use and nicotine dependence, taking into account the covariates of age of onset,
race/ethnicity, first tobacco product used, and any significant in teraction effects into account.
RESULTS
Descriptive Statistics
Responses regarding initial experiences with tobacco products were only available for a
subset of participants from cohorts 2 (n=645), 3 (n=650), and 4 (n=786) in Spit for
Science. The remaining analytic sample (n=2,081) was predominantly female (n=1388;
66.7%) and nearly half identified as White/Caucasian (n=978; 47.6%), as shown in Table
7.1. The age at first tobacco use varied by tobacco product; average age of first use was
15.6 years (SD:2.8) for cigarettes, 15.2 years (SD:4.1) for smokeless tobacco, 16.0 years
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(SD:2.9) for cigars, 16.8 years (SD:1.8) for hookah, and 17.1 years (SD:1.9) for ecigarettes. On average, most participants in the study indicate cigarettes as the product
that they first used (44.0%), followed by hookah (34.3%), cigars (14.6%), e-cigarettes
(3.8%), smokeless tobacco (2.5%), and other tobacco product (0.9%).
Findings from the VTSABD are similar to S4S in that most the sample was female
(59.2%), White/Caucasian (98.8%), and most tobacco users had initiated use by age 18.
Table 7.1: Prevalence of recent tobacco use and nicotine dependence
S4S
(n = 2081)
Sex
Male
Female
Race/Ethnicity
White/Caucasian
Black/African American
Asian
Hispanic/Latino
More than one race
Unknown
Cohort
Fall 2012
Fall 2013
Fall 2014
Age of Initiation (Any Tobacco use)
Did not Initiate
>18 years
15-18 years
12-14 years
<12 years
Initiated but did not report age
Age of Initiation (Specific Tobacco Use)
Cigarettes (S4S n = 494)
Smokeless, Snus, Dip, Chaw (S4S n = 133)
Cigar (S4S n = 496)
Hookah (S4S n = 685)
E-cigarettes (S4S n = 449)
Recent Tobacco Use
Any tobacco product (S4S n = 2081)
Cigarettes (S4S n = 1383)
Smokeless (S4S n = 398)
Cigar (S4S n = 1829)
Hookah (S4S n = 1991)
E-cigarette (S4S n = 1149)
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VTSABD
(n = 850)

N

%

N

%

692
1388

33.3
66.7

343
497

40.8
59.2

978
443
337
148
147

47.6
21.6
16.4
7.2
7.2

840

98.8

10

1.2

9
138
396
229
78

1.1
16.2
46.6
26.9
9.2

N
300

%
35.3

645
650
786

31.0
31.2
37.7

6
289
929
325
90
442
Mean

0.3
13.9
44.6
15.6
4.3
21.2
SD

15.97
15.98
16.34
16.58
17.32
N
984
544
398
330
422
270

2.39
2.84
2.56
2.84
1.43
%
47.3
39.3
24.6
18.0
21.2
23.5

Fagerström Test for Nicotine Dependence
(S4S n=1924; range=0-10)
Meets criteria for nicotine dependence

0.70

1.50

2.2

2.2

N
132

%
6.9

181

21.0

The highest proportion of students, who indicated that they used tobacco in the last 30
days at the most recent survey of Spit for Science, reported using cigarettes (39.3%),
followed by smokeless tobacco (24.6%), e-cigarettes (23.5%), hookah (21.2%), and
cigars (18.0%), as shown by Table 7.1. When comparing recent tobacco use across
males and females, significant differences were found for cigarette, cigar, and e-cigarette
use, such that males were more likely to endorse the recent use of all tobacco products
relative to females within S4S. No significant sex differences were found for current use
of cigarettes within the VTSABD. A little less than 7% of the total sample met criteria for
nicotine dependence in S4S and 35.3% of the VTSABD sample. Significant differences
in meeting criteria for nicotine dependence were found between males and females, such
that a larger proportion of males met criteria for nicotine dependence, relative to females
(10.4% vs. 5.2% in S4S; 42.5% vs. 31.6% in VTSABD), as shown in Table 7.2.
Table 7.2: Sex Differences in Endorsement of Recent Tobacco Use and Nicotine Dependence
Males
Recent Tobacco Use (S4S)
N
%
Any tobacco product (n = 2079)
407 58.9
Cigarettes (n = 1382)
251 47.5
Smokeless (n = 398)
70 27.2
Cigar (n = 1828)
153 24.0
Hookah (n = 1990)
171 26.1
E-cigarette (n = 1148)
154 32.6
Current Use (VTSABD; n=839)
128 37.4
Fagerström Test for Nicotine Dependence
FTND ≥4 (S4S; n = 1923)
66 10.4
FTND ≥4 (VTSABD; n = 497)
90 42.5

Females
N
%
576 41.5
293 34.3
28 19.9
177 14.9
251 18.8
115 17.0
168 33.8
66
90

5.2
31.6
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Chi-Square, df, p-value
56.0, 1, <0.0001*
23.9, 1, <0.0001*
2.7, 1, 0.1022
23.5, 1, <0.0001*
14.0, 1, 0.0002*
37.3, 1, <0.001*
1.2, 1, 0.2804
18.7, 1, <0.0001*
6.2, 1, 0.0126*

Initial experiences by age of onset
Within the S4S sample, age of onset of tobacco use was associated with stronger initial
responses to tobacco across positive experiences (e.g. pleasurable buzz, pleasant
sensation, relaxation), negative experiences (e.g. unpleasant sensation, dizziness,
nausea), and difficulties with breathing (e.g. difficulty inhaling, coughing), even after
adjusting for race/ethnicity and sex. More specifically, age of onset was associated with:
relaxation (beta = 0.066, p-value = 0.040), pleasurable rush or buzz (beta = 0.107, pvalue = 0.0011), unpleasant sensation (beta = 0.062, p-value = 0.0482), nausea (beta =
0.149, p-value <0.0001), dizziness (beta = 0.140, p-value <0.0001), and difficulty inhaling
(beta = 0.074, p-value <0.0001).
Age of onset of tobacco use was also associated with stronger initial responses to tobacco
within the VTSABD sample. Corresponding numbers were: pleasurable rush or buzz
(beta = 0.098, p-value = 0.0167), unpleasant sensation (beta = 0.092, p-value = 0.0313),
nausea (beta = 0.187, p-value <0.0001), dizziness (beta = 0.193, p-value <0.0001),
coughing (beta = 0.159, p-value = 0.0002), and difficulty inhaling (beta = 0.16, p-value =
0.0003).
Factor structure of initial experiences with tobacco use
An exploratory factor analysis was performed on the eight items measuring initial
sensitivity to tobacco products and eigenvalues showed that two factors could be
selected. According to Kaiser’s criteria, only factors with eigenvalues equal to or greater
than 1 should be selected for factor analysis. The two-factor model using varimax rotation
showed that the first factor was related to positive experiences during initial tobacco use
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(e.g. pleasant sensation, relaxation, pleasurable rush or buzz), the second factor was
related to negative experiences during initial tobacco use (e.g. unpleasant sensation,
nausea, dizziness, coughing, and difficulties inhaling). Interestingly, the item measuring
dizziness cross-loaded onto positive experiences, though not as highly as it did on
negative experiences. This implies that many users rated lesser amounts of dizziness as
a positive experience. This factor structure was the same across S4S and the VTSABD
samples, and was used to create factor scores for use in linear regressions testing
whether initial positive or negative experiences with tobacco use are predictive of recent
tobacco use and/or nicotine dependence – as described later in this manuscript.
Table 7.3: Varimax Rotated Factor Patterns for Initial Experiences with Tobacco Use
SPIT FOR SCIENCE
Initial
Experiences
Pleasant
Sensations
Relaxation
Pleasurable Rush
or Buzz
Unpleasant
Sensation
Dizziness
Nausea
Coughing
Difficulty Inhaling
Variance
Explained

VTSABD

Factor 1

Factor 2

Communality

Factor 1

Factor 2

Communality

0.873

0.065

0.766

0.761

-0.135

0.597

0.851

0.038

0.725

0.646

-0.118

0.432

0.870

0.148

0.778

0.821

0.001

0.674

0.038

0.730

0.534

-0.212

0.639

0.453

0.413
0.189
-0.007
0.012

0.600
0.693
0.622
0.658

0.530
0.516
0.387
0.434

0.396
0.067
-0.051
-0.139

0.443
0.610
0.640
0.550

0.352
0.376
0.412
0.321

2.451

2.220

1.899

1.720

Initial experiences with tobacco by sex
Initial experiences with tobacco use differed by sex, as depicted by Table 7.4. However,
significant differences in initial experiences with tobacco use by sex were not the same
across samples. Whereas there were sex differences across all initial experiences, apart
from difficulty inhaling in S4S, sex differences were only detected across the initial
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experiences of: pleasurable rush or buzz, unpleasant sensations, and difficulty inhaling
in VTSABD.
Associations between initial experiences and recent tobacco use
Significant correlations were found between initial experiences with tobacco and recent
tobacco use, as depicted in Table 7.5. Initial positive experiences (pleasant sensations,
relaxation, and pleasurable rush or buzz) were moderately correlated with recent use of
all tobacco products. Smaller but significant correlations were observed between nausea
and/or dizziness and the recent use of most tobacco products. The strongest correlations
with negative initial experiences were with the recent use of smokeless tobacco products.
The largest correlations were found between positive initial experiences with tobacco use
and recent use of cigarettes.
Associations between initial experiences and nicotine dependence
The initial experiences of pleasant sensations, relaxation, pleasurable rush or buzz,
nausea, coughing, dizziness, and difficulty inhaling were positively and significantly
correlated with meeting criteria for nicotine dependence within the S4S sample. These
correlations ranged in value from 0.11 (95% CI: 0.01, 0.10) to 0.38 (95% CI: 0.29, 0.46).
The highest significant correlation was found between experiencing a pleasurable rush or
buzz and meeting criteria for nicotine dependence, as depicted in Table 7.5. Within the
VTSABD, only initial experiences of relaxation and pleasurable rush or buzz were
positively and significantly correlated with meeting criteria for nicotine dependence. The
correlations were lower, relative to the S4S sample, ranging from 0.15 (95% CI: 0.02,
0.27) to 0.16 (95% CI: 0.04, 0.21).
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Table 7.4: Sex Differences in Initial Experiences with Tobacco Use in S4S and VTSABD
Full

Pleasant
Sensations
None
Slight
Moderate
Severe

N

%

939
543
448
119

45.8
26.5
21.9
5.8

Relaxation
None
Slight
Moderate
Severe
Pleasurable
Rush or
Buzz
None
Slight
Moderate
Severe

877
557
469
155

42.6
27.1
22.8
7.5

S4S
Males
Females
Full
POSITIVE EXPERIENCES
ChiN
%
N
%
square,
N
%
df, p
24.9, 3,
<0.0001*
270 39.8 669 48.8
400 47.3
175 25.8 367 26.8
232 27.5
187 27.6 261 19.1
160 18.9
46
6.8
73
5.3
53
6.3
30.6, 3,
<0.0001*
245 36.0 632 45.9
458 54.7
178 26.2 378 27.5
200 23.9
199 29.3 270 19.6
146 17.4
58
8.5
97
7.0
33
3.9

972
504
387
192

47.3
24.5
18.8
9.3

256
170
171
84

37.6
25.0
25.1
12.3

1080
502
331
147

1061
494
369
124

52.4
24.4
16.1
7.1

51.8
24.1
18.0
6.1

316
165
140
63

303
184
152
41

46.2
24.1
20.5
9.2

44.6
27.1
22.4
6.0

Nausea
None
Slight
Moderate
Severe

1288
377
277
114

62.7
18.3
13.5
5.5

375
153
117
39

54.8
22.4
17.1
5.7

Coughing
None
Slight
Moderate
Severe
Difficulty
Inhaling
None
Slight
Moderate
Severe

N

%

N

%

145
96
77
24

42.4
29.1
22.5
7.0

249
132
83
29

50.5
26.8
16.8
5.9

761
715
408
180

1147
506
295
106

36.9
34.6
19.8
8.7

55.8
24.6
14.4
5.2

257
250
137
40

385
168
102
26

37.6
36.6
20.0
5.9

56.5
24.7
15.0
3.8

716 52.2
337
333 24.3
232
216 15.7
190
108 7.9
80
NEGATIVE EXPERIENCES
26.0, 3,
<0.001*
763 55.5
283
337 24.5
214
191 13.9
220
84
6.1
120
24.4, 3,
<0.0001*
757 55.4
171
310 22.7
202
217 15.9
283
83
6.1
190
29.1, 3,
<0.0001*
912 66.5
411
224 16.3
179
160 11.7
160
75
5.5
86
10.9, 3,
0.0120*
503 36.5
172
465 33.7
294
271 19.7
193
140 10.2
167
3.9, 3,
0.2694
761 55.5
209
338 24.6
221
193 14.1
238
80
5.8
160
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Chisquare,
df, p
6.7, 3,
0.0804

7.4, 3,
0.0603
170
85
72
12

50.2
25.1
21.2
3.5

281
114
72
21

57.6
23.4
14.8
4.3

51.5, 3,
<0.0001*

Dizziness
None
Slight
Moderate
Severe
Unpleasant
Sensations
None
Slight
Moderate
Severe

VTSABD
Males
Females

11.2, 3,
0.0106*
40.2
27.7
22.7
9.5

118
92
94
38

34.5
26.9
27.5
11.1

213
137
96
41

43.7
28.1
19.7
8.4
4.0, 3,
0.2622

33.8
25.6
26.3
14.3

107
84
91
58

31.5
24.7
26.8
17.1

172
128
126
61

35.3
26.3
25.9
12.5
10.6, 3,
0.0144*

20.2
23.9
33.5
22.5

68
101
108
66

19.8
29.5
31.5
19.2

102
99
172
120

20.7
20.1
34.9
24.3
0.2, 3,
0.9728

49.2
21.4
19.1
10.3

169
71
66
34

49.7
20.9
19.4
10.0

236
108
93
49

48.6
22.2
19.1
10.1
7.1, 3,
0.0685

20.8
35.6
23.4
20.2

74
133
73
56

22.0
39.6
21.7
16.7

96
158
118
109

20.0
32.9
24.5
22.7
15.1, 3,
0.0017*

25.2
26.7
28.7
19.3

106
81
98
51

31.6
24.1
29.2
15.2

101
136
138
107

21.0
28.2
28.6
22.2

Table 7.5. Correlations Between Initial Experiences, Recent Tobacco Use, and Nicotine Dependence
Pleasant
Sensations

Relaxation

Pleasurable
Rush or
Buzz

Dizziness

Unpleasant
Sensations

Nausea

Coughing

Difficulty
Inhaling

SPIT FOR SCIENCE
Any Tobacco
0.42
0.41
0.47
0.28
0.07
0.17
0.13
0.04
(0.36, 0.47) (0.36, 0.46)
(0.42, 0.52) (0.22, 0.33) (0.01, 0.13) (0.11, 0.24) (-0.02, 0.10) (0.07, 0.19)
Cigarettes
0.31
0.34
0.37
0.23
0.11
0.09
0.03
-0.03
(0.25, 0.38) (0.27, 0.30)
(0.30, 0.43) (0.16, 0.30) (-0.05, 0.10) (0.03, 0.19) (-0.10, 0.04) (0.01, 0.16)
Smokeless
0.25
0.26
0.16
0.32
0.24
0.28
0.16
0.27
(0.11, 0.39) (0.12, 0.40)
(0.02, 0.31) (0.19, 0.46)
(0.10, 0.38) (0.14, 0.42) (0.02, 0.30) (0.13, 0.42)
Cigars
0.18
0.21
0.15
0.10
0.16
0.08
0.11
0.06
(0.10, 0.25) (0.13, 0.28)
(0.08, 0.23) (0.03, 0.18) (-0.01, 0.14) (0.08, 0.23) (0.01, 0.16) (0.04, 0.19)
Hookah
0.19
0.23
0.21
0.12
0.01
0.06
0.05
0.05
(0.13, 0.26) (0.17, 0.30)
(0.14, 0.27) (0.05, 0.19) (-0.06, 0.08) (-0.01, 0.14) (-0.02, 0.12) (-0.02, 0.13)
E-Cigarettes
0.26
0.28
0.29
0.20
0.09
0.15
0.13
0.06
(0.18, 0.35) (0.20, 0.36)
(0.21, 0.37) (0.11, 0.29) (0.00, 0.18) (0.06, 0.24) (-0.03, 0.14) (0.04, 0.22)
Nicotine
0.26
0.30
0.38
0.26
0.24
0.11
0.25
0.08
Dependence
(0.17, 0.35) (0.21, 0.38)
(0.29, 0.46) (0.17, 0.35) (-0.01, 0.18) (0.14, 0.33) (0.01, 0.10) (0.15, 0.34)
VIRGINIA TWIN STUDIES OF ADOLESCENT AND BEHAVIORAL DEVELOPMENT
Cigarettes
0.38
0.30
0.35
0.30
-0.18
-0.13
0.06
-0.06
(0.30, 0.47) (0.20, 0.39)
(0.26, 0.44) (0.21, 0.39) (-0.27, -0.09) (-0.04, 0.16) (-0.16, 0.03)
(-0.22, 0.03)
Nicotine
0.15
0.16
0.12
0.10
0.00
0.05
0.10
0.03
Dependence (-0.01, 0.24) (0.02, 0.27)
(0.04, 0.21) (-0.02, 0.22) (-0.12, 0.12) (-0.08, 0.17) (-0.02, 0.22) (-0.09, 0.15)

Boldface indicates significant correlation.

Sex differences in correlations between initial experiences with tobacco and recent
tobacco use and/or nicotine dependence
Within the S4S sample, significant correlations were found between positive experiences
and recent use of cigarettes in both sexes; cigars and e-cigarette use in males; hookah
use in females; and, nicotine dependence in both sexes, but more strongly in females.
Meanwhile, significant correlations were found between negative initial experiences with
tobacco use and recent use of smokeless tobacco and between difficulty breathing during
initial experience with tobacco use and recent use of smokeless tobacco, in females.
Significant correlations between dizziness and recent cigarette use and nicotine
dependence were found in both sexes.
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Significant sex differences in the correlations between initial experiences and recent
tobacco use and/or nicotine dependence were also found within the VTSABD sample.
Specifically, the correlation was higher among males than females for the association
between the initial experiences of pleasant sensations (0.47 in males, 0.31 in females, zstatistic = 2.68, p=0.004) and dizziness (0.38 in males, 0.24 in females, z-statistic = 2.19,
p=0.014) and recent cigarette use. Correlations were higher among females than males
for the association between: the initial experiences of relaxation (0.04 in males, 0.23 in
females, z-statistic = -2.11, p=0.017) and of coughing and current cigarette use (-0.14 in
males, 0.01 in females, z-statistic = 2.11, p=0.017).
Predictors of tobacco use and nicotine dependence
Across both samples, positive initial experiences predicted both recent tobacco use and
meeting criteria for nicotine dependence, after adjusting for sex and age of initiation (and
race/ethnicity and first tobacco product used within the S4S sample). The direction of
these effects was the same, such that higher levels of positive initial experiences
predicted both recent tobacco use and meeting criteria for nicotine dependence. Having
negative initial experiences with tobacco use was also predictive of meeting criteria for
nicotine dependence within the S4S sample, but not in the VTSABD. Sex was also found
to be a predictor of meeting criteria for nicotine dependence, such that being female
reduced the likelihood of meeting criteria for nicotine dependence (as demonstrated by
the negative direction of the effect). The magnitude of the sex effect was similar across
samples (e.g. beta = -0.22 in S4S and -0.28 in VTSABD). Age of initiation also had a
significant effect on meeting criteria for nicotine dependence, such that earlier ages of
initiation were predictive of meeting criteria for nicotine dependence.
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Table 7.6a: Predictors of Recent Tobacco Use and Nicotine Dependence in Spit for Science
Recent Tobacco Use (Any)

Intercept
Positive Initial Experience
Negative Initial Experience
Race – More than one race vs. White/Caucasian
Race – Asian vs. White/Caucasian
Race – Hispanic/Latino vs. White/Caucasian
Race – Black/AA vs. White/Caucasian
Sex – Female vs. Male
Age of Initiation – Did not initiate vs <12 years
Age of Initiation - >18 years vs <12 years
Age of Initiation 15-17 years vs <12 years
Age of Initiation – 12 -14 years vs <12 years
First Product Used – Other vs Cigarettes
First Product Used – E-cigarettes vs Cigarettes
First Product Used – Hookah vs Cigarettes
First Product Used – Cigars vs Cigarettes
First Product Used – Smokeless vs Cigarettes

Beta
-2.06
0.71
0.06
0.05
0.13
-0.22
0.07
-0.19
-10.05
2.21
2.50
2.78
0.84
-0.12
-0.45
-0.21
0.13

SE
85.23
0.06
0.06
0.17
0.13
0.17
0.13
0.06
340.9
85.2
85.2
85.2
0.71
0.28
0.19
0.21
0.15

p-value
0.9807
<0.0001*
0.3069
0.7721
0.3105
0.1928
0.5775
0.0019*
0.9765
0.9793
0.9766
0.9740
0.2388
0.6759
0.0167*
0.3075
0.7013

Meets Criteria for
Nicotine Dependence
(FTND≥4)
Beta
SE
p-value
-2.81
0.29 <0.0001*
0.57
0.11 <0.0001*
0.24
0.11
0.0290*
-0.48
0.43
0.2686
0.38
0.26
0.1427
-0.22
0.40
0.5825
0.07
0.30
0.8085
-0.22
0.11
0.0470*
NA
NA
NA
-0.84
0.28
0.0026*
-0.43
0.18
0.0156*
0.42
0.19
0.0252*
1.30
0.74
0.0793
-0.11
0.57
0.8405
-0.13
0.32
0.6980
-0.02
0.32
0.9578
-1.23
0.65
0.0605

Table 7.6b: Predictors of Recent Tobacco Use and Nicotine Dependence in VTSABD
Recent Tobacco Use (Any)

Intercept
Positive Initial Experience
Negative Initial Experience
Sex – Female vs. Male
Age of Initiation - >18 years vs <12 years
Age of Initiation 15-17 years vs <12 years
Age of Initiation – 12 -14 years vs <12 years

Beta

SE

p-value

Meets Criteria for
Nicotine Dependence
(FTND≥4)
Beta
SE
p-value

-0.74
0.74
-0.17
-0.02
-0.89
-0.01
0.22

0.10
0.10
0.10
0.08
0.20
0.13
0.15

<0.0001*
<0.0001*
0.0867
0.7897
<0.0001*
0.9279
0.1339

-0.07
0.34
0.12
-0.28
-0.58
-0.20
0.31

0.14
0.12
0.13
0.10
0.28
0.17
0.18

<0.0001*
0.0044*
0.3225
0.0074*
0.0416*
0.2273
0.0864

Discussion
The current study examined associations between initial experiences with tobacco use
and recent tobacco use and nicotine dependence. We estimated the factor structure of
initial experiences with tobacco products, concluding that the best fitting model was one
with two factors: positive experiences (e.g. pleasant sensation, relaxation, and
pleasurable rush/buzz), negative experiences (e.g. unpleasant sensation, nausea,
dizziness, coughing, and difficulties inhaling). This factor structure was similar to that
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found from a construct validity analysis conducted using confirmatory factor analysis by
Rodriguez and Audrain-McGovern (2004), which identified two factors: pleasant (e.g.
pleasant, relaxation, and rush or buzz) and unpleasant (e.g. unpleasant, coughing,
difficulty inhaling, and nausea). The ‘pleasant’ factor overlaps with our ‘positive
experiences’ factor and the ‘unpleasant’ factor overlaps with our ‘negative experiences’
factor14. Another study investigating the factor structure of early smoking experiences
conducted by Baggio et al. (2013) tested associations with smoking behavior in two and
three-factor models15. Similar to the current study and the study conducted by Rodriguez
and Audrain-McGovern14, this study identified a positive experiences factor (e.g. like the
experience and felt relaxed) and negative experiences factor (e.g. did not feel very well,
headache, stomach upset, heart pounding, nauseous, dizzy/lightheaded, coughed, and
irritation eyes, bad taste) in the two-factor model. In the three-factor model proposed by
Baggio et al. (2013) negative experiences were split into negative experiences of
dizziness (e.g. did not feel very well, headache, stomach upset, heart pounding,
nauseous, dizzy/lightheaded) and negative experiences of irritation (e.g. coughed,
irritation eyes, bad taste)15. Differences in the factor structure between the current study
and that conducted by Baggio et al. (2013) may be attributed to the use of different
measures of initial experiences with tobacco use, limited to cigarette smoking, and the
age of participants.
In the current study, we found that earlier age of onset of tobacco use was associated
with stronger initial responses to tobacco across both positive and negative experiences.
Given that Buchmann et al. (2011) also finds that the age of first cigarette use and
pleasure experienced from cigarette use predicts smoking at age 228, it seems that the
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age of onset of tobacco use and initial experiences with tobacco use should be considered
in tobacco use interventions. In a study by Klein et al. (2013), 50.7% of study participants
indicated that their experience with smoking was more negative than they expected,
30.2% indicated that the experience was about the same as they expected, and 19.1%
indicated it was more positive than expected, demonstrating the variability in the
immediate reaction to tobacco use. In the same study, 77.9% of participants remember
the first cigarette making them feel calm and relaxed, 66.9% remember becoming dizzy,
52.1% remember coughing extensively, and 16.1% decided to continue smoking because
they thought their subsequent experiences would be better than the first – suggesting that
there is a small window of opportunity to intervene on the subsequent patterns of tobacco
use following initial experience16.
Like other studies, the current study found that regular use of tobacco products was
related to initial experiences with tobacco use. Both negative and positive experiences
seemed to have effects on regular use of tobacco products, which supports findings from
previous studies2,7,17. Initial experiences during first tobacco use are believed to reflect
the physiological and pharmacological effects of nicotine, as well an individual’s sensitivity
to and tolerance for nicotine. Generally, those who become regular users experience
greater positive and negative reactions to nicotine compared to nonsmokers, while
positive experiences may play a stronger role than unpleasant experiences in the
transition to regular use18. This is important given the significant correlations found
between initial experiences with tobacco and recent tobacco use in the current study –
particularly stronger correlations found between positive experiences and recent use of
cigarettes, cigars, hookah, and e-cigarettes (though the effect was not large). It has been
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suggested elsewhere that social perceptions surrounding tobacco use may play a larger
role in normalizing opinions regarding patterns of tobacco use, which could lead some
individuals to be less resistant to experiment with tobacco 16. Unfortunately, these findings
do little to address the debate regarding whether positive reinforcement is sufficient to
establish a trajectory towards nicotine dependence, or if negative reinforcement must
come into play before an individual is past a ‘point of improbable return’ 19.
Initial sensitivity to nicotine, as measured by initial experiences with tobacco use, is only
one factor associated with nicotine dependence explored in multiple studies, including the
current study. The development of nicotine dependence symptoms is complex and can
vary in timing of onset, level of escalation, duration, and remission of symptoms20. From
the literature, those who progress to regular tobacco use may be sensitive to the
rewarding effects of nicotine, as evidenced by the strong correlations between positive
symptoms and different measures of continued use of tobacco. However, few studies
have investigated how initial experiences might differ by tobacco product 18. The current
study finds that initial experiences do differ by the first tobacco product used. Another
study examining the initial experiences with e-cigarette use found that few current ecigarette users/triers had a negative first experience and that positive perceptions about
first experiences were higher among current e-cigarette users when compared to former
users19. Given the perception that e-cigarettes could be useful in cigarette cessation and
the generally positive first experiences that users have with e-cigarette use, we must
wonder what the downstream effects of nicotine from e-cigarettes might be on nicotine
dependence. This is an especially important point to consider given the recent increase
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in alternative tobacco use among youth; though, more research is needed to make more
definitive conclusions.
Since data for the current study was collected using self-report measures of initial
experiences with first use of tobacco products, it may be affected by recall bias –
especially if recollection of initial experiences is influenced by current or continuous use.
Previous studies have demonstrated that current smokers have a generally more positive
recollection of their first tobacco use than former smokers1,7,21. Additionally, since we only
had information on initial experiences for three of the four cohorts, it is unclear how
missing data impacts the results. However, the findings of the current study are consistent
with prior research and contribute to the literature through its assessment of multiple
tobacco products. Even more importantly, our findings highlight the need for more
expansive research on initial experiences with tobacco and alternative tobacco products.
Unmeasured behavioral, social, and environmental factors may play a role in shaping
initial reactions to nicotine and the subsequent adoption of regular use of tobacco 22.
Social influences of peers and family may have an effect on initial experiences with
tobacco use17, as individuals with higher levels of exposure to smoking from peers and
family members are more likely to report positive symptoms of initial smoking
experience22. Exposure to smoking from peers and family members has also been found
to be associated with individual reports of feeling: dizzy, relaxed, good, and high upon
initial use of tobacco. Thus, initial experiences by individuals with greater exposure to
smoking may be influenced by socially mediated expectancies, derived from the
experience of others23.
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Alternatively, frequent or prolonged exposure to nicotine absorbed from environmental
tobacco smoke may alter neurophysiology in the brain, which may be reflected by altered
responses to nicotine among non-smokers24. Whereas a study conducted by Kozlowski
& Harford (1976) found that non-smokers who were tempted to smoke were more likely
than current smokers to report discomfort from smoking, possibly due to their physical
reaction to cigarettes, which could discourage future use 25. A study by Pomerleau et al.
(1993) found that the initial sensitivity to noxious effects of smoking also reflects sensitivity
to the reinforcing effects which may encourage future smoking2. Marked individual
differences in the response to drugs, such as nicotine, may be attributed to both heritable
contributions and unique environmental experiences 26.
Yet, few studies have investigated these genetic differences contributing to initial
experiences with nicotine. One study by Sherva et al. (2008) finds an association between
genetic variant CHRNA5 and enhanced pleasurable responses to initial cigarette use
among regular users27. Another study links a person’s initial experience with smoking and
their current smoking status with variation in a gene that encodes a nicotine receptor in
the brain28. Adolescents with higher exposure to maternal smoking report lower number
of unpleasant symptoms during initial smoking29. Genetic variation in two candidate genes
has been previously associated with initial responses to nicotine. Individuals with the Gvariant of OPRM1 A118G SNP are more likely to report liking of initial smoking, though
findings are inconsistent30. Adolescents homozygous for the C-variant D4D2 Taq1A
polymorphism report a lower number of unpleasant symptoms during initial smoking,
indicating lower sensitivity to nicotine 31. Those homozygous for the T-variant shows
stronger perceptions of nicotine effects, indicating higher nicotine sensitivity among T138

allele carriers and may be associated with reduced feelings for reward due to reduced
receptor availability24,32.
Conclusion
We have demonstrated that current users of tobacco may be sensitive to the rewarding
effects of nicotine. Additionally, initial reactions to tobacco differed by tobacco type, as
well as by sex. Age of onset, sex, and positive initial experiences predicted both recent
use and meeting criteria for nicotine dependence. Negative initial experiences played less
of a role in meeting criteria for nicotine dependence. Thus, further research is needed to
identify genetic and biological pathways influencing initial experiences with nicotine, and
the social contexts that influence initial experiences with tobacco use, in efforts to
potentially delay the overall age of onset for tobacco use and reduce individual’s risk for
nicotine dependence.

139

CHAPTER 8:
SEX DIFFERENCES IN FAGERSTRÖM TEST FOR NICOTINE DEPENDENCE ITEMS
Elizabeth K. Do; Danielle M. Dick; Kenneth S. Kendler; Hermine H. Maes

INTRODUCTION
The Fagerström Test for Nicotine Dependence (FTND), comprised of four dichotomous
and two multi-response items1, is the most commonly used measure of nicotine
dependence. It is calculated by adding together scores for the six items, and has a range
of 0 to 10. A score of four or greater is indicative of nicotine dependence. Using a sum
score typically assumes a unidimensional trait. However, factor analyses of FTND items
have yielded inconsistent results: while some studies indicate that the measure is
comprised of only one factor, others have identified two. Single-factor model specification
implies a simple linear combination of all FTND items, while two-factor model
specifications propose “smoking pattern” and “morning smoking” factors2. Previous
studies also suggest that the psychometric properties of these items may differ by sex
and race/ethnicity. Psychometric studies of the FTND are necessary to gain greater
insight into the structure of the test and the assessed dimensions3. The current study was
conducted to compare sex differences in the response to FTND items within African and
White/Caucasian Americans and evaluate the factor structure of FTND across these
groups.
METHODS
Study Sample. The study sample was obtained through Spit for Science, a longitudinal
study of college students’ behavioral and emotional health. To be included in this study,
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participants had to have reported ever using tobacco in their lifetime, provide responses
to the Fagerström Test for Nicotine Dependence, and self-report either “Black/African
American” or “White/Caucasian’ when asked about which race/ethnicity group best
describes them. Of the 9889 participants of the Spit for Science study, 6907 individuals
met study criteria.
Measures. Tobacco use was measured across the following tobacco products: cigarettes,
cigarillo’s/small cigars, smokeless tobacco (dip/chaw), hookah/waterpipe, and electronic
cigarettes. Items of the FTND were adjusted accordingly and include four dichotomous
and two multi-response items – we will use the abbreviations in square brackets: (1) How
soon after you woke up did you smoke your first cigarette/use tobacco? [wake] (2) Did
you find it difficult to refrain from smoking/using tobacco in places where it is forbidden
(e.g. in church, at the library, in cinema, etc.)? [refrain] (3) Which cigarette/dip/chaw would
you hate most to give up? [giveup] (4) How many cigarettes/smokeless tobacco products
per day did you smoke/use? [cpd] (5) Did you smoke/use tobacco more frequently during
the first hours after waking than during the rest of the day? [morning] and (6) Did you
smoke/use tobacco if you were so ill that you were in bed most of the day? [whenill].
Responses to the wake question included: >60 minutes, 31-30 minutes, 6-30 minutes,
and ≤5 minutes. Responses to the refrain, morning and whenill questions were no or yes.
Responses to the giveup question 3 was the first one or any other. Responses to the cpd
question included: <10 cigarettes, 11-20 cigarettes, 21-30 cigarettes, or >31 cigarettes.
Since these measures were collected from the start of freshman year for all cohorts, a
maximum reported FTND score was calculated across all waves for each participant. The
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items from this maximum reported FTND score were included in this study, and used for
statistical analyses.
Statistical Analyses. Since we were interested in determining whether males and females
were statistically different in how they responded to each of the items of the FTND, chisquare tests were conducted. Scree plots, incremental variance accounted for, and
interpretability were used to determine the factor structure. Exploratory factor analyses
(EFA) were conducted separately by race/ethnicity and sex (e.g. African American males
(AAM), African American females (AAF), White/Caucasian males (WCM), and
White/Caucasian females (WCF)). Promax rotation was selected based upon findings
from prior studies conducted on the FTND, suggesting the presence of correlated
factors1. Exploratory factor analyses were performed to determine the structure of
confirmatory factor analyses. Criteria for acceptable model fit included non-significant
model chi-square, comparative fit index (CFI) ≥ 0.9, and a root-mean-square error of
approximation (RMSEA) ≤ 0.08. Coding and chi-square tests were conducted using SAS
9.4 (SAS Institute: Cary, NC). Exploratory factor analyses were conducted using the
psych and GPArotation packages, and the fa () command in R. Confirmatory factor
analyses were conducted using MPlus (Muthen & Muthen).
RESULTS
Descriptive characteristics. Of the study sample of 6907 individuals (1873 African
American or AA, and 4881 White/Caucasian American or WCA), 2539 (540 AA; 1999
WCA) were male and 4197 (1332 AA; 2865 WCA) were female.
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Statistical differences in FTND item response by sex, separated by race/ethnicity group.
Within African Americans, differences in response rates by sex were found for all items,
except for three of the binary items: two related to morning smoking and one to smoking
when ill. Within White/Caucasian Americans, differences in response rates by sex were
found for all items, except for the cigarettes per day item.
Exploratory factor analysis. Consistent with prior studies of the factor structure of the
FTND, a principal component analysis with promax rotation was conducted. The criterion
for item inclusion was a factor loading of 0.30 or more4. Items with loadings on other
factors were interpreted as belonging to the factor on which they had the highest loading.
Scree plots demonstrated that a two-factor solution fit the data best across each of the
four groups and accounted for 100% of the variance for each group. However, the factor
loadings across groups differed.
Factor loadings (F1 and F2), communalities (H2), and uniqueness (U2) for each group
are shown in the table below. Extracted communalities ranged from 0.12 to 0.77 and
factor correlations ranged from 0.58 to 0.68 across all groups. Lowest communalities
were observed for the giveup item in AA, and the morning item in WCA. The factor
structure was similar across AA males, WCA males and females. This factor structure
was such that the wake, refrain, cpd and whenill items loaded on factor 1 and the giveup
and morning items loaded on factor 2, with factor loadings of 0.30 or greater. Factor 1
can be interpreted as a ‘smoking pattern’ factor, while factor 2 reflected a ‘morning
smoking’ factor. Results within AA females were rather different with a separate factor
being extracted for the refrain and whenill items.
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Table 8.1. Factor structure of FTND Items by Race/Ethnicity Group
AFRICAN AMERICAN
AFRICAN
WHITE/CAUCASIAN
WHITE/CAUCASIAN
FEMALES
AMERICAN MALES
FEMALES
MALES
ITEM
F1
F2
H2
U2
F1
F2
H2
U2
F1
F2
H2
U2
F1
F2
H2
U2
WAKE 0.00 0.43 0.18 0.82 0.43 0.14 0.28 0.72 0.44 0.17 0.32 0.68 0.46 0.12 0.29 0.71
REFRAIN 0.97 -0.16 0.77 0.23 0.61 0.22 0.58 0.42 0.62 0.00 0.38 0.62 0.53 0.07 0.33 0.67
GIVE UP 0.14 0.24 0.12 0.88 -0.08 0.47 0.19 0.81 -0.01 0.87 0.75 0.25 -0.12 0.86 0.61 0.39
CPD 0.09 0.62 0.40 0.53 0.63 -0.02 0.39 0.62 0.57 0.01 0.33 0.67 0.64 -0.13 0.32 0.68
MORNING -0.14 0.82 0.54 0.46 0.09 0.56 0.38 0.62 0.00 0.52 0.27 0.73 0.23 0.33 0.26 0.74
WHENILL 0.59 0.13 0.47 0.53 0.97 -0.22 0.74 0.26 0.74 -0.07 0.49 0.51 0.71 0.03 0.54 0.46
Values are highlighted in yellow to indicate what factors items are loading on that are higher than 0.30.

Confirmatory Factor Analysis. CFA was conducted separately for sex and race/ethnicity,
with two-correlated factors (e.g. “smoking patterns” and “morning smoking”, respectively).
The wake, refrain, cpd and whenill items loaded on factor 1 (“smoking patterns”) and the
giveup and morning items loaded on factor 2 (“morning smoking”). The results for CFA
analyses, using unstandardized estimates, are displayed in the table below.
Table 8.2. Results from Confirmatory Factor Analyses
AAF

AAM

WCF

WCM

13.116 (8)

5.973 (8)

13.390 (8)

8.465 (8)

Fit indices
Model X2 (df)

0.1079

0.6503

0.0991

0.3894

CFI ≥ 0.9

0.985

1.000

0.997

1.000

RMSEA ≤ 0.08
F1 Loadings: Smoking Patterns

0.053

0.000

0.028

0.009

wake

1.000

1.000

1.000

1.000

refrain

1.356

1.321

1.017

1.088

cpd

1.265

1.111

0.982

0.954

whenill

1.388

1.304

1.104

1.299

giveup

1.000

1.000

1.000

1.000

morning

1.416

1.952

0.686

1.008

Correlation between F1 & F2

0.361

0.230

0.600

0.434

wake

0.411

0.496

0.588

0.480

refrain

0.756

0.865

0.609

0.568

giveup

0.299

0.239

0.517

0.613

p-value

F2 Loadings: Morning Smoking

Item R2

cpd

0.657

0.611

0.568

0.437

morning

0.599

0.910

0.508

0.622

whenill

0.792

0.843

0.718

0.810

Mean variance explained

0.586

0.659

0.5982

0.588

AAF = African American Females; AAM = African American Males; WCF = White/Caucasian Females; WCM =
White/Caucasian Males
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Results from these analyses indicated that each of these models fitted the data well,
apparent from the non-significant chi-square model fit statistics. Based on the cut-off
criteria for relatively good fit (CFI ≥ 0.9, RMSEA ≤ 0.08), the comparison of measures of
approximate fit also supported conclusions based on chi-square tests of relative fit. Thus,
a correlated, two-factor model fitted the data across each of these groups.
However, we also saw that the correlation between the two factors was different across
each of the four groups, such that the correlations were lower within Black/African
American females and males (0.361 and 0.230), when compared to White/Caucasian
females and males (0.60 and 0.434, respectively).
DISCUSSION
This study employed EFA to determine the factor structure of FTND, and then used CFA
to test model fit for a two correlated factors model. The results confirmed that the factor
structure of FTND was not one-dimensional. Within this sample of college students, the
first factor was characterized by the wake, refrain, cpd and whenill items and the second
factor was characterized by the giveup and morning items. Across each group, the
correlations between the factors ranged from 0.23 to 0.60, with the highest correlation
found within WCA females. The correlated two-factor model suggested by the exploratory
factor analyses and tested with confirmatory factor analyses was like one conducted
within young smokers entering US Air Force Basic Military Training 2 and another sample
of smokers enrolled in a Veteran’s Affairs Medical Center Smoking Cessation Clinic 5.
Despite the consistency of our findings with these studies, the factor structure we found
using our college age sample was different than what is found in studies of older adult
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smokers. These studies still demonstrate two correlated factors, but items differentially
load on the factors3,6,7. Specifically, in one study of patients admitted for pre-surgical
assessments, the first factor is still characterized by morning smoking (refrain & giveup
items), while the second factor assesses the degree of urgency to restore nicotine levels
to a given threshold after nighttime abstinence (cpd, morning and whenill items), and the
wake item permitted to load on both factors6.
The difference in factor structure across these samples might be attributed to the age of
the samples being assessed. The samples that demonstrate similar factor structures to
the current study are younger. Older adults have a longer period during which they might
be exposed to nicotine, and so the effects of nicotine on dependence symptoms might be
different relative to younger samples who have been exposed for less time. In other
words, FTND items may perform differently when used with younger, less addicted
smokers relative to more mature smokers being assessed in cessation clinics.
In addition to providing another younger sample to test psychometric properties of FTND
items, this study contributes to the literature by examining factor structure across sex and
racial/ethnic groups. Chi-square tests indicated that differences existed across FTND
items by sex. Results from the CFA conducted in this study demonstrated that a
correlated, two-factor structure fit the data for African American and White/Caucasian
males and females – suggesting that the factor structure of FTND items was not
necessarily different by race/ethnicity, even though it did differ by sex. However, EFA
suggested that the factor structure of FTND items may be different for African American
females, relative to the other groups in this sample, even though a correlated, two-factor
model fit the data for all groups. If the factor structure of FTND items were different for
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African American females, relative to the other groups in this sample, it would mean that
the constructs being measured within the FTND are biased, and scores from the FTND
would interpreted differently for this group 8. Thus, this factor structure needs to be tested
in other samples, to determine its validity.
Other racial/ethnic groups were available for analyses, but not assessed in this study due
to concerns over sample size. It has been suggested elsewhere that necessary sample
sizes for factor analyses are dependent upon: the range of communalities, number of
factors, and number of indicators. This sample had low communalities (e.g.
communalities under 0.5) and two factors, including a factor which was weakly
determined by two items. To achieve good recovery of population factors, it is suggested
that sample sizes over 500 are needed9. Thus, larger samples are needed to assess
whether the findings of this study generalize to other groups of young adults, who selfidentify with other race/ethnicity groups not described in the current study.
Finally, other studies identifying a two-factor structure to the FTND have raised concerns
that simplistic scoring of the six items of the FTND might not reflect the subtle differences
between individual dependence profiles – especially if study participants score higher on
one dimension and lower on the other. Using a single total score of the items – which
would suggest that there is one underlying factor of nicotine dependence, as some other
studies have found - produces an ‘average’ of dimension-specific scores. However, a
single total score of the items may lack the ‘sensitivity’ to identify differences in
dependence profiles, which could limit the potential for tailoring interventions 6. Thus, more
research needs to be conducted to determine whether using factor scores derived from

147

a correlated, two-factor model or the more traditional single total score of FTND derived
from a one-factor model is the best approach moving forward.
CONCLUSIONS
Sex differences exist in the responses to FTND items, and their psychometric properties.
Further studies are needed to determine how nicotine dependence measures perform
across sex, race/ethnicity, and age and to assess whether the factor structure identified
in this study and those previously conducted is generalizable to other populations.
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CHAPTER 9: GENETIC ANALYSES OF TOBACCO USE BEHAVIORS AMONG AN
ETHNICALLY DIVERSE UNIVERSITY SAMPLE
Elizabeth K. Do; Arden A. Moscati; Roseann E. Peterson; Bradley T. Webb; Danielle M.
Dick; Kenneth S. Kendler; Hermine H. Maes
INTRODUCTION
Tobacco use encompasses a range of complex behavioral traits that are influenced, at
least in part, by genes. Studies of adult twins have been useful in inferring genetic
influences by comparing phenotypic similarities between monozygotic and dizygotic
twins, and suggest that genetic factors account for approximately 50% of the variance in
adult smoking behaviors overall. When looking at tobacco use behaviors separately, the
estimates for heritability are more wide-ranging. Approximately 60% of the variance in
smoking initiation is attributed to genetic factors, while genetic factors account for 55-69%
of the variation for smoking persistence, 40 to 56% in smoking quantity, 60-76% in
nicotine dependence, and about 50% in smoking cessation 1–3. Generally, initiation of use
is more strongly influenced by environmental factors, whereas progression to higher
levels of use and dependence is more strongly influenced by genetic factors4.
Additionally, the heritable components of tobacco use become increasingly expressed
over the transition from adolescence, when many individuals initiate use, into adulthood 5.
Since each of tobacco use behavior constitutes steps along the trajectory towards
possible nicotine dependence and problem use, it is important to try and elucidate their
genetic etiology and answer such questions as: What genes are influencing tobacco use
behaviors? And are the genes influencing individual tobacco use behaviors separate or
overlapping? In efforts to answer these questions, many genome-wide association
studies (GWAS) have been conducted to identify genes underlying susceptibility to
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tobacco use behaviors (in addition to linkage and candidate gene studies). Yet, only a
handful of genes, with generally small effects, have been identified. The most robust
finding from the few genome wide association studies of smoking phenotypes is the
association between smoking quantity and the nicotinic receptor gene cluster CHRNA5A3-B4, located on chromosome 156.
Most genetic analyses on tobacco use behaviors have been conducted in adults of
predominantly European descent, and so, less is known regarding the role of genes to
tobacco behavior in adolescence and young adulthood, and among other populations.
For this reason, we examine several measures of tobacco use [e.g. initiation, age of
onset, current use, regular use, cigarettes per day, time to first tobacco use, and the
Fagerström Test for Nicotine Dependence (FTND)] among a diverse sample of young
adults attending university to: (1) calculate the heritability of tobacco use behaviors
among this group, and (2) identify genetic variants contributing to tobacco use behaviors
during young adulthood.
SAMPLE AND METHODS
Study population. Individuals included in this study were participants of Spit for Science
(‘S4S’), a longitudinal study of college students enrolled in a large, urban university in the
Mid-Atlantic region of the United States. S4S is aimed at understanding how genes and
environments impact substance use and mental health outcomes across time in college
students7. To be eligible to participate in this study, incoming students had to be 18 years
or older. Freshmen participants completed phenotypic assessments, covering a wide
range of topics, including tobacco use. Each subsequent spring semester, students were
invited to complete follow-up assessments. Students who did not participate in the first
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wave of data collection (including those who turned 18 after the end of the first wave of
data collection) had the opportunity to enroll in the study the following spring. Data for this
study was collected and managed using REDCap electronic data capture tools 8.
Those who completed phenotypic assessments were also eligible to provide a DNA
sample. A total of 9,889 university students have enrolled in S4S, including four cohorts,
which matriculated from Fall 2011 to Fall 2014. Of those that enrolled into the study, 98%
provided a DNA sample. Of the entire sample, 6754 indicated that they had ever used
tobacco in their lifetime. Of those that indicated they had ever used tobacco in their
lifetime, 5990 had provided DNA passing quality control steps, were and included in the
current study, which utilizes data released in Spring 2016. The university Institutional
Review Board approved study protocols and informed consent was obtained from all
participants prior to participant enrollment into the study.
Tobacco Use Phenotypes. For the current study, multiple tobacco use behaviors were
examined, including: ever tobacco use (e.g. indicated they had ever used tobacco in their
lifetime), age of initiation, current use, regular use (e.g. indicated they had used ≥100
cigarettes in their lifetime or the equivalent), tobacco use quantity (e.g. cigarettes per
day), time to first tobacco use after waking, and FTND scores. Ever, current, and regular
tobacco use were treated as binary phenotypes (ever versus never). Smoking quantity,
age of tobacco use initiation, and FTND were treated as continuous variables. These
variables were evaluated among ever users.
Genotyping, Pre-imputation Quality Control, and Imputation. As reported and described
in greater detail elsewhere9, 6534 samples passed DNA and initial genotyping quality
control (QC). Genotyping was performed at Rutgers University Cell and DNA Repository
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using the Affymetrix BioBank array (653k), which contains both common GWAS
framework variants (296k) for imputation, and functional variants (357k), including: rare
high impact exome variants (272k), indels (18k), eQTLs (16k), and miscellaneous (51k).
Off target variants were identified using SNPolisher. Variants were excluded due to: high
missingness of SNPs (5%), high missingness of samples (2%), and high missingness in
post-sample filtering (2%), similar to the Psychiatric Genomics Consortium (PGC) 10. Preimputation QC removed 209 samples, which left 6325 samples and 560138 variants for
imputation. Imputation was conducted using SHAPEIT2 11 / IMPUTE212 and the 1000
Genomes Phase 3 reference panel (n=2504).
Population Stratification. Given the ethnic diversity within this sample, we had to account
for potential genetic heterogeneity, or when a single phenotype is caused by any one of
a multiple number of alleles or non-allele mutations, caused by population stratification.
Population stratification occurs when both the prevalence and allelic frequency
differences exist within the population sampled for analyses. Such stratification may lead
to false positive associations of genetic signals, especially when millions of markers are
tested across the genome.
Genomic inflation can occur when many markers show allele frequency differences
between populations and the overall distribution of test statistics is inflated. A
consequence of genomic inflation can be an increase in false positives. To measure the
extent of inflation due to population stratification or other potential sources of confounding,
genomic control (e.g. λ, λ1000) is computed. Genomic control is defined as a the median
χ2 (1 degree of freedom) association statistic across SNPs divided by its theoretical
median under the null distribution, with a value of 1 indicative of no stratification and a
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value of >1 indicative of stratification, family structure, cryptic relatedness, differential
bias, or potential other confounders. Generally, values <1.05 are considered benign;
though, it is important to note that inflation in genomic control is proportional to sample
size13.
Meanwhile, methods inferring genetic ancestry have been used to correct for potential
population stratification13.The most common approach to assessing ancestry and
population structure is to apply principal components analyses (PCA) to genotype data,
and infer continuous axes of genetic variation. The resulting axes of variation are used to
reduce the data to a small number of dimensions, or principal components, that describe
as much variability as possible. These principal components are the top eigenvectors of
a covariance matrix between samples and are later used in regression analyses as
covariates14. The goal of using this approach is to maximize power for discovering
etiologically relevant genetic variants, while minimizing false positive associations due to
population stratification.
Ancestry Principal Components. Ancestry principal components (PCs) can be estimated
either from the sample itself or from external references. Both approaches were taken in
the current set of analyses. As explained by Webb et al. (2017), 1000 Genomes Project
(1KGP) phase 3 variants were merged together with post quality control filtered
genotypes from Spit for Science. Regions with high linkage disequilibrium were excluded,
and then the common set of variants was pruned (r2<0.1) using PLINK1.9 to yield 109,259
semi-independent variants for ancestry analyses. EIGENSOFT and smartPCA 14,15 were
used to perform PCA using only the 1KGP phase 3 reference panel to determine SNP
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weights for each eigenvector. The solution from the PCA was then projected onto the S4S
data to generate 10 PCs9.
Genetic Based Population Assignment. Participants were empirically assigned to 1KGP
based ancestry super-populations [AFR, Africa; AMR, Americas; EAS, East Asia; EUR,
Europe; and SAS, South Asia]. Using all 10 ancestry PCs, the Mahalanobis distance
between the S4S sample and 1KGP population without reference population outliers
(>4SD from population median, n=61) was calculated. Each subject was then assigned
to the 1KGP population with the minimum Mahalanobis distance and collapsed into their
respective super-population assignment. This empirically-based ancestry has several
advantages to self-identified race/ethnicity including the reduction of within group
variance and the ability to include “Unknown”, “More than one race”, and small groups in
the analysis without an increase in genomic inflation 9.
Within Group Quality Control. To account for the diversity found in the S4S sample,
filtering by Hardy-Weinberg Equilibrium (HWE), minor allele frequency (MAF), and
relatedness were performed within the empirically assigned super populations. Genomewide IBD (Π ̂) was calculated using PLINK 1.9. For each group, the mean cross-sample
Π ̂ was calculated to find samples showing cryptic relatedness to other samples. 194
samples were excluded (>2.5 standard deviations above the mean) as outliers for
average relatedness with all other samples. Clusters of probable relatives were defined
using Π ̂ > 0.1, Z0 >= 0.825, and Z1 < 0.175. The inclusion of Z0/Z1 is important since Π ̂
> 0.1 can be due to artifacts where Z2 > 0 is extremely unlikely for cryptic relatives. Then
the best performing sample for each relative cluster was retained which resulted in an
additional 180 samples being excluded from the GWAS sample 9.
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Within Ancestry Group PCA. As an added step to adjust for potential fine structure within
each super population, within ancestry group PCA was conducted. Again, EIGENSOFT
and smartPCA14,15 were used to perform PCA for each super population found in the Spit
for Science sample. Additional filtering excluded regions with high linkage disequilibrium
and PLINK 1.9 was used to prune variants (r2< 0.1, MAF>0.01, HWE>5*10-8). This yielded
the following number of semi-independent variants: 71,873 (EUR); 137,042 (AFR);
84,774 (AMR); 62,046 (EAS); and 80,654 (SAS). Ten distinct PCs were generated for
each super population9.
Covariates. Within ancestry group PCs and covariates (e.g. sex and age) to include in
genetic analyses were determined by stepwise linear regression for each tobacco use
behavior phenotype being analyzed. Non-ancestry covariates of sex and age are kept in
each model, while ancestry covariates were kept if they were retained in the best fitting
model per AIC9.
Genome-wide Complex Trait Analysis. Genome-wide Complex Trait Analysis (GCTA)16
was used to estimate the proportion of phenotypic variance attributable to non-imputed,
and directly genotyped, genetic variants [V(G)/V(P) or h 2SNP]. Genetic relationship
matrices, or GRMs, were derived for each ancestry group, as described in a previous
study9. Within a mixed linear model, GCTA fits the effect of SNPs as random effects,
includes the effect of sex, age, and significant within ancestry group PCs as fixed effects.
The variance explained by all SNPs (e.g. the SNP-based heritability) is estimated, with
heritability calculated separately by ancestry group. An ancestry group-specific minor
allele frequency (MAF) cut-off of 0.01 was applied, and only unrelated individuals were
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included in GRMs, resulting in the following sample sizes: N = 1339 (AFR), N = 582
(AMR), N = 557 (EAS), N = 3018 (EUR) and N=455 (SAS).
Genome Wide Association Study. Genome wide association studies (GWAS) were
conducted using SNPTest17, separately for each tobacco use behavior phenotype. Each
GWAS was conducted separately by ancestry group. Association analyses were
conducted under an additive model, only including markers with a minimum MAF of 0.005
and INFO of 0.5. Post-GWAS filtering was performed using ancestry specific HWE and
sample size based MAFs. Rather than using a fixed MAF threshold for each group, the
minimum observed minor allele count (MAC) was used, as prior research has shown a
MAC of ~40 is robust for most association analyses performed in GWAS18. Additionally,
post-filtered GWAS results were meta-analyzed using METAL 19, where sample sizes
within ancestry groups were ≥400 for each tobacco use behavior phenotype. Metaanalyses using METAL implements a fixed effect model and inverse variance weighting
based on sample size. Estimation of genomic inflation (λ and λ1,000) for within superpopulation GWAS and meta-analyses was performed in R20. False Discovery Rate (FDR)
analysis was performed using the “q-value” package (https://github/jdstorey/qvalue) using
Bioconductor 3.221. Genomic bins were defined for follow-up, starting with all markers
with a q-value < 0.25. Initially, markers were collapsed into bins if they were within 10kb;
however, post-hoc inspection showed several adjacent bins <75kb apart which were then
collapsed into reported bins. The web-based plotting tool, LocusZoom 22, was used to
visually display regional information regarding the strength and extent of the association
signals relative to genomic position, local linkage disequilibrium, and recombination
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patterns and positions of genes in the region, was used to inspect genome-wide
significant SNPs.
Individual Variant Replication. Summary statistics from GWAS results of the Tobacco and
Genetics (TAG) Consortium were extracted and compared to the corresponding
phenotypes found in S4S. Due to differences in allele frequencies across the discovery
and replication, summary statistics were not available for all markers. Replication was
attempted for genome-wide significant SNPs found in TAG; however, only results based
on equivalent phenotypes were examined. Nominal associations were found where pvalue <0.05.
RESULTS
Descriptive statistics. Within the genetic sample, the sample was mostly female (61.2%),
and had indicated that they had used any tobacco product at least once in their lifetime
(67.9%). Frequencies and percentages for tobacco use behaviors within the entire
sample and genetic sample only are presented in Table 9.1 below. [Though the
frequencies and percentages are not shown, cohorts were equally represented.] Sex,
age, and significant PCs were included as covariates in genetic analyses.
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Table 9.1: Tobacco Use Behaviors of the Spit for Science Sample
ENTIRE SAMPLE
N=9889
N
%
6754
68.3%

Tobacco Use Phenotype
Ever Tobacco Use
Age of Initiation
Did not initiate
>= 18 years
15-18 years
12-14 years
<12 years
Current Use
Regular Use
Never Used
<100 cigarettes/lifetime
>=100 cigarettes/lifetime
Regular Use Among Smokers
<100 cigarettes/lifetime
>=100 cigarettes/lifetime
Cigarettes Per Day
<10 cigarettes
11-20 cigarettes
21-30 cigarettes
>31 cigarettes
Time to First Tobacco Use
>60 minutes
31-60 minutes
6-30 minutes
Within 5 minutes
Fagerström Test for Nicotine Dependence

GENETIC SAMPLE
N=5990
N
%
4069
67.9%

3091
1109
2531
1094
249
4049

31.3%
11.2%
25.6%
11.1%
2.5%
40.9%

1839
806
1282
673
114
2490

39.0%
17.1%
27.2%
14.3%
2.4%
61.3%

1909
3316
1529

19.3%
33.5%
15.5%

2855
2094
959

48.3%
35.4%
16.2%

5225
1529

52.8%
15.5%

3110
959

76.4%
23.6%

3220
375
112
69

32.6%
3.8%
1.1%
0.7%

1870
241
67
42

31.4%
4.0%
1.1%
0.7%

3230
448
470
200
Mean
0.82

32.7%
4.5%
4.8%
2.0%
Range
0-10

1915
267
296
115
Mean
0.84

73.9%
10.3%
11.4%
4.4%
Range
0-10

GCTA/Heritability estimates. Heritability estimates for each tobacco use behavior were
calculated using GCTA16, separately by ancestry group, as shown in Table 9.2. The
heritability of ever tobacco use ranged from 0.00 to 0.28, but was only significant amongst
those of East Asian (h2 =0.13, p=0.0480) and European ancestry (h2 =0.28, p=0.0133).
Significant heritability was observed for age of initiation in those of European ancestry (h 2
=0.30, p=0.0288). None of the heritability estimates were significant for current use,
regular use, and time to first tobacco use after waking across any ancestry group, while
the heritability of regular use among smokers within those of European ancestry (h 2 =0.50,
p=0.0041), cigarettes per day and FTND scores within the Americas ancestry group
(CPD: h2 =1.00, p=0.0212; FTND: h2 =1.00, p=0.0211) were statistically significant at a p158

value of ≤ 0.05. However, after corrections for multiple testing, none of these results were
significant at the adjusted threshold of p-value ≤ 0.00125 (or p-value ≤0.05/40 tests;
where 40 tests account for eight phenotypes x five ancestry groups). Additionally, the
sample sizes for the AMR, EAS, and SAS ancestry groups were smaller than suggested
for GCTA analyses23; so those results should be interpreted with caution.
Table 9.2: Heritability Estimates for Tobacco Use Behaviors, by Ancestral Group
Tobacco Use
Behavior
Ever Tobacco
Use

Age of Initiation

Current Use

Regular Use

Regular Use
Among
Smokers

Cigarettes Per
Day

Time to First
Tobacco Use
After Waking

Fagerström
Test for

Ancestry
Group
AFR
AMR
EAS
EUR
SAS
AFR
AMR
EAS
EUR
SAS
AFR
AMR
EAS
EUR
SAS
AFR
AMR
EAS
EUR
SAS
AFR
AMR
EAS
EUR
SAS
AFR
AMR
EAS
EUR
SAS
AFR
AMR
EAS
EUR
SAS
AFR
AMR
EAS

N

h2SNP

SE

p-value

1329
577
552
2980
453
897
487
460
2523
334
884
412
297
2172
284
1329
577
552
2980
453
886
412
297
2175
285
402
224
148
1307
139
471
269
173
1519
157
670
324
233

0.00
0.00
0.13
0.28
0.00
0.44
0.00
0.52
0.30
0.00
0.00
0.49
0.00
0.00
0.99
0.20
0.13
0.00
0.26
0.00
0.16
0.40
0.00
0.50
0.90
0.53
1.00
0.00
0.06
0.48
0.00
0.13
0.00
0.25
0.63
0.23
1.00
1.00

0.26
0.44
0.59
0.13
0.71
0.37
0.51
0.72
0.16
0.97
0.38
0.56
1.22
0.18
1.11
0.25
0.46
0.61
0.13
0.74
0.35
0.59
1.18
0.18
1.05
0.61
1.01
2.03
0.30
1.86
0.59
0.85
1.82
0.25
1.78
0.48
0.68
1.31

0.5000
0.5000
0.0480
0.0133
0.5000
0.1214
0.5000
0.2258
0.0288
0.5000
0.5000
0.2046
0.5000
0.5000
0.1027
0.2045
0.3949
0.5000
0.0221
0.5000
0.3152
0.2728
0.5000
0.0041
0.1911
0.1758
0.0212
0.5000
0.4181
0.3980
0.5000
0.4450
0.5000
0.1520
0.3651
0.3248
0.0021
0.1449
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Nicotine
Dependence

EUR
SAS

1773
217

0.31
1.00

0.22
1.40

0.0832
0.1510

Primary GWAS results. Prior to applying filtering, 17,461,305 markers were available for
analyses. The number of available markers following the application of filtering and metaanalyses are shown in Table 9.3, in addition to the sample size, and measures of genomic
inflation (and 1000). To be included in the meta-analyses, sample sizes had to be ≥400
within a given ancestry group.
Table 9.3: Sample Sizes, Marker Counts, and Genomic Inflation Estimation

Ever Use

AFR

AMR

EAS

EUR

SAS

Metal

n

1329

577

552

2980

453

>1000

n
Markers

14466464

10909721

6835923

10333295

7361150

16638242



1.0095

1.0220

1.0238

1.0178

1.0031

1.0034

1000

1.0016

1.0037

1.0040

1.0030

1.0005

1.0034

N

897

487

460

2523

>1000

n
Markers

12797220

10213567

6598175

10106533

10332814



0.9900

0.9617

1.0171

0.9970

1.0150

1000

0.9977

0.9912

1.0039

0.9993

1.0000

N

884

412

2172

>1000

n
Markers

12731483

9542115

9855533

9941997



1.0057

1.0513

1.0020

1.0019

1000

1.0016

1.0147

1.0005

1.0000

N

1329

577

552

2980

453

>1000

n
Markers

14462978

8037689

6833967

10336157

7361674

16941407



0.9819

0.9738

0.9943

1.0069

0.9788

0.9934

1000

0.9969

0.9956

0.9990

1.0012

0.9964

1.000

N

886

412

2175

>1000

n
Markers

12717222

7339884

9856239

9941327



1.0385

1.0073

1.0206

1.0136

1.0110

1.0021

1.0059

1.000



Age of Initiation



Current Use



Regular Use



Regular Use Among
Smokers


CPD



1000

N

402

1307

>1000

n
Markers

6874724

6874724

6861522
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0.9982

0.9999

1.0008

1000

0.9989

0.9999

1.0000

N

471

1519

>1000

n
Markers

4839510

4839810

4835232



0.9923

1.0047

0.9958

1000

0.9933

1.0016

0.9999

N

670

1773

>1000

n
Markers

7497960

7497960

7486766



1.0032

0.9904

1.0014

1000

1.0013

0.9960

1.0000



TFT



FTND



The meta-analyses showed no evidence of genomic inflation, as demonstrated by with
s shown in Table 9.3. Analyses were adjusted for sex, age, and significant
within ancestry group principal components (identified by step-wise linear regression).
Figure 9.1, depicts the QQ- and Manhattan Plots for each of the tobacco use behaviors.
Figure 9.1: QQ-Plots and Manhattan Plots for Tobacco Use Behaviors
Ever Tobacco Use

161

Age of Initiation

Current Use

162

Regular Use

Regular Use Among Smokers

163

Cigarettes Per Day

Time to First Tobacco Use After Waking

164

FTND

No genome-wide significant SNPs were identified for ever tobacco use, age of initiation,
regular use, regular use among smokers, TFT and FTND. Significant findings were found
for current use and cigarettes per day, which are described in further detail below, and
shown in Table 9.4. Across the measures of current use and cigarettes per day, FDR
analysis showed 38 markers with q<0.25. Each of these markers are listed in
Supplementary Tables 9.7a-9.8b, with summary statistics and information on nearby
genes within 75kb. These 37 markers map to 20 genomic bins, with seven genomic bins
containing at least one genome-wide significant marker (p-value ≤ 5 x 10 -8). Regional
association plots (Figures 9.2a and 9.2b) are only shown for the genome-wide significant
SNPs that are found to be located within genes (e.g. rs148027841 and rs9653371).
Current Use. Three SNPs (rs148027841, rs73111343, rs73111344) were found to be
associated with current use, at the significance threshold level of p-value < 5 x 10 -8. SNP
rs148027841 is located on chromosome 16 within the protein coding gene RAB11 Family
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Interacting Protein 3 or (RAB11FIP3) that has a regulatory role in the formation, targeting,
and fusion of intracellular transport vesicles24. Figure 9.2a depicts the regional association
plot for RAB11FIP3, and displays other markers that are not in high linkage disequilibrium
with rs148027841, but have low p-values. rs148027841 is rare (MAF ≤ 0.02) in each of
the ancestry groups. The direction of the effect was consistent across the African and
European ancestry groups (e.g. negative), but in the opposite direction across the
Americas ancestry group (e.g. positive). The strength of the association varied by
ancestry group (e.g. -0.35 in AFR; 0.13 in AMR; and -1.40 in EUR). The other two
genome-wide significant SNPs, rs73111343 and rs73111344, are common in each of the
listed ancestry groups and are in high LD with one another, but are not located within any
genes.
Cigarettes Per Day. Six SNPs were found to be associated with cigarettes per day
(rs9653371, rs34731037, rs71427733, rs75714873, rs41319146, and rs371955890) at
the genome-wide significance level. rs9653371 mapped onto a gene located on
chromosome 2 (PID1), and is rare within those of European ancestry (MAF = 0.14) and
is common within those of African ancestry (MAF = 0.02). Figure 9.2b depicts the regional
association plot for PID1, which suggests that rs9653371 is a lone SNP, with no linkage
disequilibrium with other SNPs. The direction of the effect is consistent across these two
ancestry groups, but the strength of association is greater within those of European
ancestry, relative to African ancestry. Although SNP rs34731037, located on
chromosome 13, did not map onto any genes, it is common within those of African and
European ancestry (MAF = 0.06, 0.07 respectively). The direction of the effect is
consistent across these two groups, but the strength of association is greater within those
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of African ancestry relative to those of European ancestry. Genome-wide significant SNPs
(rs71427733, rs75714873, and rs41319146) located on chromosome 2 were also not
located within any genes (or nearby any genes within 75kb) and are common within those
of African and European ancestry (MAF = 0.06 for both ancestry groups). The direction
of the effect is consistent across the two ancestry groups, but the strength of association
is greater within the African ancestry group. rs371955890, located on chromosome 9, is
not located within any genes, but is nearby to AK096159 and LOC100132352. However,
the direction of the effect is not consistent across African and European ancestry groups,
and the effect size is greater within the African ancestry group – even though the SNP
has a higher MAF within the European ancestry group.

167

Table 9.4: Genome-wide significant SNPs for Current Use and Cigarettes Per Day
Phenotype

Current Use

Ancestry
Group

N

AFR

884

Missing
INFO MAF
HWE
Proportion
rs148027841 (chromosome 16)
1.7E-06
0.69
0.01
1.00

P-value

Beta

SE

0.58

-0.35

0.62

AMR

412

NA

0.79

0.01

1.00

0.85

0.13

0.71

EUR

2172

1.8E-06

0.75

0.02

1.00

5.5E-09

-1.40

0.24

rs73111344 (chromosome 4)
Current Use

AFR

884

5.1E-06

0.87

0.10

0.85

3.2E-06

0.84

0.19

AMR

412

4.8E-06

0.92

0.06

0.63

1.0E-04

1.30

0.35

EUR

2172

3.2E-06

0.91

0.08

1.00

5.5E-09

0.33

0.13

AFR

884

5.1E-06

0.87

0.10

0.85

3.2E-06

0.84

0.19

AMR

412

6.1E-06

0.92

0.06

0.63

1.0E-04

1.30

0.35

EUR

2172

3.2E-06

0.91

0.08

1.00

5.5E-09

0.33

0.13

rs73111343 (chromosome 4)
Current Use

rs9653371 (chromosome 2)
Cigarettes Per
Day

AFR

402

1.1E-05

0.84

0.14

0.84

0.76

0.04

0.11

EUR

1307

1.1E-06

0.51

0.02

1.00

2.0E-22

3.26

0.20

rs34731037 (chromosome 13)
Cigarettes Per
Day

AFR

402

1.9E-05

0.53

0.06

1.00

1.9E-27

2.52

0.17

EUR

1307

1.1E-05

0.67

0.07

0.52

0.02

0.27

0.10

AFR

402

1.2E-06

0.96

0.06

1.00

4.6E-05

0.64

0.16

EUR

1307

1.2E-06

0.96

0.06

0.62

1.4E-05

0.36

0.08

rs71427733 (chromosome 2)
Cigarettes Per
Day

rs75714873 (chromosome 2)
Cigarettes Per
Day

AFR

402

1.2E-06

0.96

0.06

1.00

4.6E-05

0.64

0.16

EUR

1307

1.2E-06

0.96

0.06

0.62

1.4E-05

0.36

0.08

rs41319146 (chromosome 2)
Cigarettes Per
Day

AFR

402

3.4E-16

0.95

0.06

1.00

4.7E-05

0.64

0.16

EUR

1307

7.7E-07

0.96

0.06

0.62

1.4E-05

0.36

0.08

rs371955890 (chromosome 9)
Cigarettes Per
Day

AFR

402

2.0E-05

EUR

1307

2.8E-05

0.50

0.05

0.61

6.4E-37

3.00

0.12

0.60

0.11

0.27

0.52

-0.05

0.08
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Figure 9.2a: Locus Zoom plot for rs148027841 on chromosome 16, associated with current use
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Figure 9.2b: Locus Zoom Plot for rs9653371 on chromosome 2, associated with cigarettes per day
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Table 9.5: Individual Variant Replication Summary

Tobacco and Genetics Consortium (EUR)
Phenotype

CPD

Regular
Use

SNP

CHR

BP

Alleles

Spit for Science (EUR)

N

Coded
AF

INFO

OR

SE

P

N

MAF

INFO

Beta

SE

P

rs1051730

15

76681394

G/A

38,181

0.65

1.00

-1.02

0.09

8.0E-33

1,307

0.33

1.00

0.04

0.04

0.27

rs16969968

15

76669980

G/A

38,181

0.65

1.00

-1.02

0.09

4.5E-33

1,307

0.33

1.00

0.05

0.04

0.16

rs1329650

10

93338100

T/G

38,181

0.28

1.00

-0.43

0.09

2.3E-06

1,307

0.27

1.00

-0.07

0.04

0.11

rs1028936

10

93339777

C/A

37,284

0.18

1.00

-0.55

0.12

1.6E-06

1,307

0.17

0.95

-0.04

0.05

0.49

rs3733829

19

46002411

G/A

38,181

0.36

1.00

0.35

0.09

7.7E-05

1,307

0.35

1.00

-0.06

0.04

0.11

rs6265

11

27636492

T/C

74,035

0.21

1.00

-0.06

0.01

1.7E-05

2,980

0.19

1.00

-0.001

0.03

0.97

rs1013442

11

27535522

T/A

74,035

0.26

1.00

-0.06

0.01

3.4E-05

2,980

0.24

0.99

0.02

0.03

0.57

rs4923457

11

27605156

T/A

74,035

0.23

1.00

-0.06

0.01

2.1E-05

2,980

0.21

0.99

0.03

0.03

0.27

rs4923460

11

27613365

T/G

74,035

0.23

1.00

-0.06

0.01

2.2E-05

2,980

0.21

0.99

0.03

0.03

0.27

rs4074134

11

27603861

T/C

74,035

0.23

1.00

-0.06

0.01

1.9E-05

2,980

0.21

1.00

0.03

0.03

0.27

rs1304100

11

27528179

G/A

74,035

0.26

1.00

-0.06

0.01

4.9E-05

2,980

0.24

0.99

0.02

0.03

0.53

rs6484320

11

27659764

T/A

74,035

0.24

1.00

-0.06

0.01

2.0E-05

2,980

0.22

0.97

-0.03

0.03

0.39

rs879048

11

27595510

C/A

74,035

0.23

1.00

-0.06

0.01

2.3E-05

2,980

0.21

0.98

-0.03

0.03

0.27
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Identification of Novel Genetic Variants and Replication of TAG SNPs in S4S. Despite
being able to identify nine genome-wide significant SNPs contributing to either current
use or cigarettes per day in the S4S sample, none have been associated with tobacco
use behaviors in any previous studies. In attempts to replicate findings for individual
variants from the TAG Consortium using the S4S dataset, only results based on
equivalent phenotypes were examined (e.g. markers associated with cigarettes per day
and regular use (e.g. which is like the current study’s measure of ever use), as shown in
Table 9.5. None of the individual variants from the TAG Consortium demonstrated
nominal associations (p-value < 0.05) in S4S.
DISCUSSION
Study findings support previous research on complex, polygenic nature of tobacco use
behaviors, and suggest the need for additional research investigating the role of genes
contributing to tobacco use behaviors. More specifically, by using a population-based
study of university students, we found that there are common SNPs contributing to
tobacco use behaviors. Estimates of SNP-based heritability using GCTA indicate that
tobacco use behaviors are moderately heritable, but only within those of the European
ancestry group. Although these estimates are generally lower than those estimated from
twin studies, they were non-zero and significant those of European ancestry (at least
before applying multiple testing corrections), indicating that the existing sample sizes
should be adequate for calculations of SNP-based heritability. The expected range
heritabilities for smoking phenotypes are between 0.4 and 0.7 - at least according to twin
and family studies of individuals of European ancestry. However, prior research suggests
that SNP-based heritabilities using GCTA are typically 50% of that of found within twin
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studies. For this reason, Table 9.6 shows a range of heritabilities from 0.2 to 0.7. From
power calculations using the GCTA-GREML Power Calculator, there was sufficient (e.g.
>80% power) to detect SNP-based heritabilities between 0.5 and 0.7, with sample sizes
of >1,500 individuals (Supplementary Table 9.6).
Meanwhile, ancestry groups with smaller sample sizes often yielded nonsignificant
heritability estimates close to zero. This could mean that either the sample sizes for these
groups are too small and we do not have enough power to calculate heritability using
GCTA, or that the phenotypic traits being measured are weakly (or not at all) affected by
genetic variation within this sample. Since published evidence suggests these tobacco
use behaviors are similarly heritable across different populations 25, it could be that larger
sample sizes are needed to estimate heritability across South Asian, American, and East
Asian ancestry groups. What this means is that to get the statistical power needed to
determine associations between the aggregate effect of genetic variants and tobacco use
behaviors for the remaining ancestry groups, larger samples may be needed.
Like other studies, the current study is not without limitations. Firstly, all the tobacco use
behaviors used within this study (and all the studies included within this dissertation
thesis) is based upon self-report data. Thus, the findings from this (and subsequently, all
studies included in this dissertation thesis) are subject to potential reporting bias and does
not offer the possibility for any external verification (e.g. outsider reporting, or verification
using biomarkers, such as cotinine levels). To mitigate potential reporting bias, we
examined tobacco use variables across each wave of individual data and recoded
variables to maintain consistency.
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Additionally, the current study was not able to replicate findings from the larger metaanalyses of tobacco use behavior. Failures to replicate significant GWAS hits from the
TAG Consortium could be due to many reasons, including: variability in phenotype
definitions across independent samples, inadequate sample size, false positive results,
and population-specific effects19, as described in fuller detail on the next page.
Variability in phenotype definitions can result from differences in measurement protocols
across studies. The definitions used in the current study are different than definitions used
in previous studies. For example, within the studies included within larger consortiums,
“ever use” was defined as having used at least 100 cigarettes in a lifetime, which matches
more closely with our “regular use” variable. Meanwhile, “ever use” within the context of
the current study is defined as having used any tobacco product during a lifetime. This
means that individuals within previous studies will have had more exposure to nicotine,
relative to individuals within the current study which could influence association findings.
Another potential contributor to the failure to replicate SNP associations (even when
comparing similar phenotypes of “regular use” in our study to “ever use” of previous
studies) is inadequate sample size. Studies finding significant SNP associations with
tobacco use phenotypes report larger sample sizes than that found in this study. For
example, the ENGAGE Consortium includes more than 30,000 genotyped participants
for each of the tobacco-related phenotypes20. Sample size is important because it directly
impacts power, or the chance of discovering effects. Generally, low-powered studies
produce more false negatives relative to higher-powered studies and have reduced
probabilities of observing effects that pass the required threshold of claiming discovery
(e.g. reaching statistical significance threshold). Additionally, even when true effects are
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found within low powered studies, it is likely that the estimate of the magnitude of the
effect is exaggerated21. Potentially, what this means for the current study is that because
the study was underpowered (as evidenced by a post-hoc power calculation
demonstrating that we have <80% power to replicate findings from the larger TAG
Consortium), the sample sizes were not large enough to find any associations across
certain tobacco use behaviors (e.g. ever tobacco use, age of initiation, regular use, and
regular use among smokers) and/or the effect of the significant associations found for
current use, time to first tobacco use after waking, cigarettes per day, and the Fagerström
Test for Nicotine Dependence may be exaggerated. Alternatively, in the case where effect
sizes are already small, false positives are likely. To correct for any false positives driven
by population stratification, we conducted genetic analyses separately by ancestry and
included principal components as covariates in the models. Furthermore, we calculated
lambda inflation factors and implemented a false discovery rate correction.
Despite these precautions, it is also possible that our failure to replicate GWAS hits from
previous studies is due to population-specific effects, or the possibility that detected
effects are stronger within a specific sample, rather than the general population. Given
that most tobacco-related GWAS have been conducted within older adults of European
ancestry and focused on cigarette use, it is possible that the findings from previously
conducted genetic studies of tobacco use behaviors are limited to that subset. This study
diverges from these studies in that it includes younger individuals of varied ancestral
backgrounds and has a broader definition of tobacco use. Participants were included in
analyses if they had indicated they had ever used any of the following tobacco products:
cigarettes, snus, cigars, hookah and e-cigarettes. The reason why these measures were
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aggregated into the broader umbrella of tobacco, was that the sample sizes across each
tobacco product, except for cigarettes, were not adequate to conduct separate analyses.
Perhaps future studies, with larger samples of individuals who use alternative tobacco
products and electronic nicotine delivery systems, will be able to identify genetic variants
influencing the use of different tobacco products, or assess whether this is primarily driven
by the availability of specific products. Although it is possible that the associations found
within this study might not be generalizable to other genetic studies of tobacco use
behaviors, a couple of associations not previously reported were found between tobacco
use behaviors and markers localized within or near genes of possible biological interest.
However, the robustness of these findings is limited, and require further investigation.
Finally, given that sample is representative of university students, it is relatively young
and participant’s behaviors may change with time. This means is that the estimated
heritability, accounted for by genetic variants may change. Previous studies suggest that
genetic factors may become more influential as participants mature, so we would expect
the contribution of genes to increase over time, if we were to follow these individuals as
they grow older. But again, further research is required.
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Supplementary Table 9.6: Power Calculation Summary

TOBACCO USE
BEHAVIOR

Ancestry
Group

N

h2 = 0.70

h2 = 0.60

h2 = 0.50

h2 = 0.40

h2 = 0.30

h2 = 0.20

ALL

5891

1.000

1.000

1.000

1.000

1.000

0.961

EVER USE

AGE OF
INITIATION

CURRENT USE

REGULAR USE

REGULAR USE
AMONG
SMOKERS

CPD

TFT

FTND

AFR

1329

0.837

0.713

0.556

0.390

0.243

0.134

AMR

577

0.248

0.195

0.149

0.113

0.085

0.065

EAS

552

0.231

0.182

0.141

0.108

0.082

0.064

EUR

2980

1.000

1.000

0.997

0.965

0.807

0.470

SAS

453

0.171

0.138

0.111

0.088

0.071

0.060

ALL

4367

1.000

1.000

1.000

1.000

0.986

0.789

AFR

897

0.510

0.398

0.294

0.206

0.136

0.088

AMR

487

0.190

0.152

0.120

0.095

0.075

0.061

EAS

460

0.175

0.141

0.113

0.090

0.072

0.060

EUR

2523

1.000

0.998

0.979

0.891

0.668

0.358

ALL

3468

1.000

1.000

1.000

0.992

0.908

0.592

AFR

884

0.358

0.389

0.287

0.358

0.134

0.087

AMR

412

0.149

0.122

0.100

0.082

0.068

0.058

EUR

2172

0.998

0.985

0.930

0.785

0.540

0.279

ALL

5891

1.000

1.000

1.000

1.000

1.000

0.961

AFR

1329

0.837

0.713

0.556

0.390

0.243

0.134

AMR

577

0.248

0.195

0.149

0.113

0.085

0.065

EAS

552

0.231

0.182

0.141

0.108

0.082

0.064

EUR

2980

1.000

1.000

0.997

0.965

0.807

0.470

SAS

453

0.171

0.138

0.111

0.088

0.071

0.060

ALL

3473

1.000

1.000

1.000

0.993

0.909

0.594

AFR

886

0.501

0.390

0.288

0.202

0.134

0.087

AMR

412

0.149

0.122

0.100

0.082

0.068

0.058

EUR

2175

0.998

0.985

0.930

0.786

0.541

0.280

ALL

1709

0.966

0.990

0.771

0.580

0.368

0.191

AFR

402

0.145

0.119

0.097

0.080

0.067

0.057

EUR

1307

0.825

0.698

0.543

0.380

0.236

0.131

ALL

1990

0.993

0.965

0.882

0.711

0.471

0.242

AFR

471

0.181

0.145

0.116

0.092

0.073

0.060

EUR

1519

0.920

0.822

0.671

0.485

0.302

0.161

ALL

2443

1.000

0.996

0.972

0.871

0.640

0.339

AFR

670

0.317

0.246

0.185

0.136

0.097

0.071

EUR

1773

0.975

0.920

0.801

0.611

0.391

0.202

Boldface indicates power ≥80%
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Supplementary Table 9.7a: SNPs Contributing to Current Use, Following FDR Correction
AFRICAN ANCESTRY

AMERICAN ANCESTRY

EUROPEAN ANCESTRY

SNP

CHR

A1

A2

WEIGHT

ZSCORE

P

DIRECTION

Q_1K

rs148027841

16

a

g

INFO
0.695

MAF
0.009

HWE
1.000

P
0.5754

INFO
0.795

MAF
0.014

HWE
1.000

P
0.852

INFO
0.746

MAF
0.024

HWE
1.000

P
0.000

2172

5.832

5.48E-09*

??+

0.054

rs73111343

4

c

g

0.872

0.103

0.855

3.17E-06

0.925

0.059

0.628

0.000

0.909

0.083

0.777

0.023

3468

5.473

4.41E-08*

+++

0.146

rs73111344

4

a

g

0.872

0.103

0.855

3.17E-06

0.925

0.059

0.628

0.000

0.909

0.083

0.777

0.023

3468

5.474

4.41E-08*

+++

0.146

rs10489015

4

t

c

0.887

0.100

0.849

3.68E-06

0.952

0.057

0.623

0.000

rs73111362

4

a

t

0.884

0.100

0.851

4.01E-06

0.950

0.057

0.623

0.000

0.920

0.082

0.670

0.025

3468

5.379

7.48E-08

+++

0.186

0.917

0.082

0.667

0.032

3468

-5.290

1.22E-07

---

0.243

CHR = chromosome; A1 = allele 1; A2 = allele 2; INFO = imputation quality; MAF – minor allele frequency; HWE = Hardy Weinberg Equilibrium; P = p-value; Q_1k = q-value

Supplementary Table 9.7b: Genomic Bins for SNPs Contributing to Current Use, Following FDR Correction
CHR

START BP

END BP

NSNP

P-VALUE

Q-VALUE

N

WITHIN GENES

16

542536

542536

1

5.48E-09

0.054365312

2172

RAB11FIP3

4

27350593

27350679

2

4.41E-08

0.146066436

3468

None

NEARBY GENES (75KB)
C16orf11,
LINC00235,MIR3176,MIR5587,NHLRC4,PIGQ,RAB11FIP3,SOLH
None

27368605

27373502

2

7.48E-08

0.185710913

3468

None

None

4

CHR = chromosome; Start BP = starting base pair; End BP = ending base pair; NSNP = number of SNPs within genomic bin

Supplementary Table 9.8a: SNPs Contributing to Cigarettes Per Day, Following FDR Correction
AFRICAN ANCESTRY
SNP

CHR

BP

INFO

MAF

HWE

EUROPEAN ANCESTRY
P

INFO

MAF

HWE

P

A1

A2

Weight

Zscore

P

Direction

q_1k

rs9653371

2

230003866

0.840

0.142

0.838

7.58E-01

0.506

0.016

1.000

2.00E-22

a

c

1709

-8.669

4.36E-18

--

3.0E-11

rs34731037

13

98575958

0.537

0.056

1.000

1.85E-27

0.668

0.070

0.516

1.68E-02

t

c

1709

7.357

1.89E-13

++

6.4E-07

rs71427733

2

205109090

0.957

0.058

1.000

4.64E-05

0.962

0.061

0.620

1.39E-05

t

c

1709

5.776

7.67E-09

++

1.1E-02

rs75714873

2

205109081

0.957

0.058

1.000

4.64E-05

0.962

0.061

0.620

1.39E-05

a

g

1709

-5.775

7.68E-09

--

1.1E-02

rs41319146

2

205108675

0.953

0.058

1.000

4.69E-05

0.964

0.060

0.620

1.43E-05

t

c

1709

-5.768

8.01E-09

--

1.1E-02

rs371955890

9

68695692

0.502

0.050

0.613

6.37E-37

0.601

0.113

0.266

5.18E-01

c

g

1709

-5.592

2.25E-08

-+

2.5E-02

178

rs12264038

10

23293025

0.865

0.185

0.505

4.80E-05

0.963

0.064

0.008

8.08E-05

t

c

1709

-5.419

5.99E-08

--

5.0E-02

rs71427734

2

205114662

1.000

0.057

1.000

1.46E-03

1.000

0.059

1.000

1.03E-05

a

g

1709

-5.401

6.61E-08

--

5.0E-02

rs16840927

2

205113668

0.992

0.057

1.000

1.48E-03

0.994

0.059

0.618

1.02E-05

a

g

1709

-5.400

6.66E-08

--

5.0E-02

rs2479719

6

41913081

0.930

0.106

0.786

3.62E-02

0.949

0.016

1.000

7.90E-07

c

g

1709

-5.334

9.60E-08

--

6.2E-02

rs185526451

2

7039120

0.907

0.081

1.000

1.76E-02

0.887

0.023

0.489

1.99E-06

t

g

1709

-5.309

1.10E-07

--

6.2E-02

15:28703003

15

28703003

0.525

0.055

1.000

2.18E-29

0.580

0.029

1.000

8.52E-01

a

g

1709

-5.295

1.19E-07

-+

6.2E-02

rs143847239

15

28703004

0.525

0.055

1.000

2.18E-29

0.580

0.029

1.000

8.52E-01

a

c

1709

-5.295

1.19E-07

-+

6.2E-02

rs7562403

2

213947476

0.891

0.210

0.880

4.59E-01

0.836

0.028

1.000

2.40E-08

t

c

1709

-5.239

1.62E-07

--

7.6E-02

rs16944923

15

91383766

0.542

0.055

1.000

1.76E-24

0.595

0.116

0.684

7.59E-01

c

g

1709

-5.221

1.78E-07

--

7.6E-02

rs10886927

10

123132045

0.985

0.186

0.506

4.83E-02

0.988

0.383

0.725

1.32E-06

t

c

1709

-5.187

2.14E-07

--

7.6E-02

rs10430703

10

123132206

0.981

0.186

0.506

4.88E-02

0.982

0.383

0.682

1.43E-06

t

c

1709

-5.172

2.32E-07

--

7.6E-02

rs11199933

10

123130356

0.999

0.189

0.623

4.51E-02

0.999

0.387

0.726

1.80E-06

c

g

1709

5.147

2.64E-07

++

7.6E-02

rs1896402

10

123130715

0.999

0.189

0.623

4.51E-02

0.999

0.387

0.726

1.80E-06

t

c

1709

-5.147

2.65E-07

--

7.6E-02

rs12220114

10

123130495

1.000

0.189

0.517

4.50E-02

1.000

0.387

0.727

1.81E-06

a

g

1709

-5.147

2.65E-07

--

7.6E-02

rs55823562

10

123130834

0.999

0.189

0.623

4.51E-02

0.998

0.387

0.726

1.81E-06

caata

c

1709

5.146

2.66E-07

++

7.6E-02

rs35059288

10

123131428

0.998

0.189

0.517

4.52E-02

0.998

0.387

0.726

1.81E-06

t

ta

1709

-5.146

2.67E-07

--

7.6E-02

rs10886926

10

123131594

0.996

0.189

0.623

4.52E-02

0.998

0.387

0.683

1.83E-06

t

c

1709

-5.144

2.69E-07

--

7.6E-02

rs10886925

10

123131571

0.996

0.189

0.623

4.52E-02

0.998

0.387

0.683

1.83E-06

a

g

1709

5.144

2.70E-07

++

7.6E-02

rs13128868

4

31329383

0.827

0.188

0.411

1.59E-04

0.937

0.392

0.072

1.72E-04

t

g

1709

5.117

3.10E-07

++

8.4E-02

rs10186370

2

1716434

0.935

0.256

0.357

3.47E-02

0.985

0.027

0.062

3.25E-06

a

g

1709

5.094

3.50E-07

++

9.1E-02

rs10713378

3

141829796

0.830

0.051

1.000

2.20E-03

0.954

0.151

0.161

4.70E-05

g

ga

1709

5.044

4.56E-07

++

1.1E-01

rs10430704

10

123132309

0.958

0.173

0.479

8.55E-02

0.972

0.378

0.480

2.48E-06

a

g

1709

4.952

7.33E-07

++

1.8E-01

rs113116955

6

41914195

0.949

0.060

0.145

6.62E-02

0.948

0.016

1.000

3.70E-06

t

c

1709

-4.938

7.90E-07

--

1.8E-01

rs5809760

14

76944781

0.820

0.304

0.639

3.52E-03

0.935

0.397

0.386

6.50E-05

ctt

c

1709

4.908

9.20E-07

++

2.1E-01

rs867188

19

51631165

1.000

0.114

0.456

2.06E-02

1.000

0.303

0.294

1.59E-05

a

c

1709

-4.898

9.69E-07

--

2.1E-01

rs12259839

10

23290952

0.835

0.113

0.134

1.58E-02

0.961

0.061

0.012

2.19E-05

t

c

1709

-4.882

1.05E-06

--

2.2E-01
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Supplementary Table 9.8b: Genomic Bins SNPs Contributing to Cigarettes Per Day, Following FDR Correction
CHR

STARTBP

ENDBP

NSNP

P-VALUE

Q-VALUE

N

2

WITHIN GENES

NEARBY GENES (75KB)

230003866

230003866

1

4.36E-18

2.96E-11

13

98575958

98575958

1

1.89E-13

6.40E-07

1709

PID1

None

1709

None

IPO5

2

205108675

205114662

5

7.67E-09

9

68695692

68695692

1

2.25E-08

0.010864774

1709

None

None

0.025414477

1709

None

AK096159,LOC100132352

10

23290952

23293025

2

5.99E-08

0.050233272

1709

ARMC3

None

6

41913081

41914195

2

9.60E-08

0.062015813

1709

CCND3

BYSL, CCND3, MED20, USP49

2

7039120

7039120

1

1.10E-07

0.062015813

1709

None

CMPK2, RNF144A, RNF144A-AS1, RSAD2

15

28703003

28703004

2

1.19E-07

0.062015813

1709

None

DQ578199, DQ578700, DQ588687, DQ599733, GOLGA8F, GOLGA8G,
JB175342, MIR4509-1

2

213947476

213947476

1

1.62E-07

0.076203844

1709

IKZF2

None

15

91383766

91383766

1

1.78E-07

0.076203844

1709

None

BLM, FES, FURIN, MAN2A2

10

123130356

123132309

10

2.14E-07

0.076203844

1709

None

None

4

31329383

31329383

1

3.10E-07

0.084203692

1709

None

None

2

1716434

1716434

1

3.50E-07

0.091274956

1709

PXDN

None

3

141829796

141829796

1

4.56E-07

0.114536686

1709

TFDP2

GK5, TFDP2

14

76944781

76944781

1

9.20E-07

0.208066183

1709

ESRRB

None

19

51631165

51631165

1

9.69E-07

0.212190467

1709

SIGLEC9

BC045766, CTU1, KLK13, KLK14, SIGLEC17P, SIGLEC7, SIGLEC9
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CHAPTER 10:
POLYGENIC RISK SCORES FOR TOBACCO USE BEHAVIORS: ARE THEY
PREDICTIVE WITHIN A UNIVERSITY SAMPLE?

Elizabeth K. Do, Jeanne E. Savage, Roseann E. Peterson, Bradley T. Webb, Danielle
M. Dick, Kenneth S. Kendler, Hermine H. Maes

BACKGROUND
Previously conducted genome wide association studies identified several regions and
candidate genes related to smoking behavior1–3. Recently, three large consortia (OxfordGlaxoSmithKline, Tobacco and Genetics Consortium, and ENGAGE consortium)
combined their summary statistics into a single meta-analysis for: smoking initiation,
quantity, and cessation. This

effort yielded a genome-wide significant association

between the number of cigarettes per day and a cluster of nicotinic acetylcholine receptor
genes on chromosome 154–6. Additional genes contributing to tobacco use behaviors
have been identified, such as the neuronal nicotinic acetylcholine receptor subunit beta3 (CHRNB3) and alpha-6 (CHRNA6)7, cytochrome P450, family 2, subfamily A,
polypeptide 6 (CYP2A6)6,7, and LOC100188945. Each of these genes, which include
genetic variants that contribute individually small effects, account for a very small
proportion of the variance within smoking quantity (<2%).
Polygenic risk scores (PRS) are used8 to summarize the genetic effects among a group
of genetic variants that do not individually achieve genome-wide significance (p-value ≤
5 x 10-8) in large-scale genome wide association studies (GWAS). The effects of single
nucleotide polymorphisms, or SNPs, are pooled together to represent a measured set of
variants underlying a trait from GWAS summary statistics9. Traditionally, this is done by
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abstracting the GWAS results from an initial discovery sample, ranking markers by their
evidence of association (e.g. p-value), and then analyzing an independent target sample
by constructing a PRS from the weighted sum of associated alleles using weights from
the discovery sample within each subject. An association analysis is then conducted
between a given trait and the constructed PRS. Where there is a statistically significant
association (p-value ≤ 0.05) between the PRS and a given trait, the genetic effects found
within the discovery sample are thought to contribute to the trait within the target sample 8.
Since the development of this method in 2009, which was first successfully implemented
in a GWAS of schizophrenia10, many other approaches have been developed to account
for linkage disequilibrium11 and improve resolution and determine the best-fit PRS12.
PRS have the potential to be useful in increasing understanding and drawing inferences
about genetic architectures both within and across many complex traits 11. Though, within
existing studies of complex traits, the variance explained by PRS seldom exceeds 2-3%.
Additionally, while some studies report positive findings, others have been unable to find
evidence for common genetic risk variation contributing to selected traits. Since the
accuracy of the prediction score increases with the size of the discovery sample 9, it is
possible that either: previously conducted studies finding null results did not have an
adequate sample size within the discovery sample, there is a lack of genetic contribution
to the phenotype of interest, or the genetic structure of the discovery and target samples
are different11. This is an important point given the current lack of gene identification
studies in populations of diverse ancestry, genetic architecture of tobacco use behaviors
not being well described within ancestral groups outside of European ancestry, and

182

evidence that genetic determinants have important implications for addiction within many
populations across the globe13.
Despite the large epidemiological literature focused on social determinants of tobacco
use and growing literature on the genetic epidemiology of tobacco use behaviors
demonstrating the role that genes and the environment play in the development of
tobacco-related phenotypes, few studies have examined how genetic variants interact
with aspects of the environment to produce tobacco use behaviors. As described in a
recent narrative review of the literature on genes, the environment, and their interaction
on cigarette use, twin and family studies demonstrate that as individuals move from
initiation to more established patterns of use, the importance of environmental factors
decreases while the influence of genes increase. As this occurs, environmental factors
begin to moderate the influence of genetic susceptibilities, implying gene-environment
interaction. To date, these studies have included gene-environment interaction between
either aggregate or individual genetic variants and their interaction with: religiosity,
parental environment, traumatic events, and neighborhood factors 14.
To build upon this existing literature, we investigate two other aspects of parenting –
autonomy granting and involvement – and the experience of stressful life events prior to
university enrollment. In addition to being available for analyses in the current study, the
parental environment and experience of stressful life events seem to be salient factors
contributing to the progression and trajectory of tobacco use behaviors in young
adulthood. Additionally, these analyses expand upon those conducted in previous
chapters of this dissertation; namely, chapter 5 which describes a twin study of the
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association between the experience of stressful life events and smoking initiation, and
chapter 6 which investigates the prevalence and correlates of tobacco use behaviors.
To summarize, the current study seeks to: (1) generate polygenic risk scores from
summary statistics from the TAG Consortium, (2) determine whether these polygenic risk
scores are predictive of tobacco use behaviors within a college-aged sample, and (3)
assess gene-by-environment interactions between polygenic risk scores, parental
environment, and stressful life events prior to university enrollment, across individuals of
European and African ancestry. We hypothesize that the polygenic risk scores will be
predictive of tobacco use behaviors, and that associations will be higher among those in
the European ancestry group, relative to the African ancestry group.
METHODS
Discovery Sample. Data from the Tobacco and Genetics (TAG) Consortium GWAS
meta-analyses for smoking behavior, using genotype and smoking data from existing
GWAS of other traits, was used as the discovery sample. This sample is comprised of
74,035 individuals from sixteen different studies conducted in the United States and
Europe. Associations between approximately 2.5 million imputed markers and four
smoking phenotypes were tested: ever versus never regular smokers, age at onset of
smoking, cigarettes per day, and smoking cessation. For the purposes for the current
analyses, one dimension of smoking behavior was included: ever versus never regular
smokers. For ever versus never regular smokers, regular smokers were defined as those
who reported having smoked ≥100 cigarettes during their lifetime and never regular
smokers were defined as those who reported having smoked between 0 and 99 cigarettes
during their lifetime (n=69,409). Each study conducted uniform cross-sectional analyses
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using an additive genetic model for each tobacco use phenotype. Linear regression was
used for quantitative traits, while logistic regression was used for dichotomous traits.
Although original analyses were run separately for males and females, the TAG
Consortium did not detect significant interactions by sex and data was analyzed together.
Age was not included as a covariate in analyses conducted by the TAG Consortium,
though case-control studies included case/control status as a covariate.
Target Sample. The target sample consisted of participants from Spit for Science, a
longitudinal study of college students enrolled in a large, public, urban university in the
Mid-Atlantic region, as described in previous studies 15. This study collects populationbased longitudinal data across five waves of survey data that were collected from 2011
to 2016. The phenotypes of interest within the target sample are as follows:
1. Ever Tobacco Use: lifetime measure of using any tobacco product
2. Age of Initiation: time at which tobacco product use started
3. Current Use: recent use measure of tobacco use within the past 30 days
4. Regular Use: endorses smoking at least 100 cigarettes in a lifetime
5. Cigarettes Per Day: maximum number of cigarettes smoked per day
6. Time to First Tobacco Use after Waking: amount of time taken between waking
and using tobacco
7. Fagerström Test for Nicotine Dependence: standard measure of physical
dependence on nicotine
Details regarding genotyping, pre-imputation quality control, imputation, population
stratification, within ancestry group principal components analyses, and the inclusion of
covariates can be found in the previous chapter (Chapter 9).
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Polygenic risk scores. For the present study, polygenic risk scores for tobacco use
behaviors were identified based on the large meta-analysis of the Tobacco and Genetics
(TAG) Consortium. The risk alleles from the TAG Consortium measure of “ever vs. never
regular use” were used as the discovery sample, to calculate polygenic risk scores in the
Spit for Science sample. PRS were calculated using the methodology described by
Purcell et al. (2009)10.
This approach generates scores for individuals based on an allelic scoring system
involving single nucleotide polymorphisms. The steps involved include performing quality
control on both samples, filtering on call rate of ≥ 0.9, MAF > 0.01, and the removal of
strand ambiguous SNPs (which occurs when you are unable to differentiate forward vs.
backward strands, without information on allele frequency) and mismatched alleles. Prior
to conducting quality control steps, 17,461,305 SNPs were contained within Spit for
Science and 2,455,593 SNPs within the TAG Consortium data. Following quality control
filtering and the removal of ambiguous SNPs, there were 7,653,789 and 2,455,593 SNPs
retained in S4S and TAG, respectively. Across both samples, there were 1,802,970
common SNPs, after removing 1,924 mismatched SNPs. Then, LD clumping was
performed on the remaining list of common SNPs, within the European and African
ancestry groups. The --clump command considers LD when there are multiple significant
association p-values within the same region. When performed, clumps are formed around
central ‘index variants’ which must have p-values no larger than 0.0001 by default. For
these analyses, the r2 threshold was set to 0.1, the clump kb radius was set to 1000.
Within the European ancestry group, 9,248 clumps were formed from 81,525 index
variants and within the African ancestry group, 11,165 clumps were formed from 81,525
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index variants. After pruning, 9,142 and 11,107 common variants were retained for the
European and African ancestry groups. Scores were then created using the --score
procedure with multiple p-value thresholds, and standardized to have a mean of zero and
a standard deviation of one.
Statistical Analyses. Data analysis processes included: calculation of LD statistics,
matching independent SNPs from the discovery and target samples, and calculation of
ever regular use-based polygenic risks cores to conduct association analyses and predict
tobacco use behaviors. Associations between each threshold were tested using
regression analyses in R, adjusted by sex, age, and significant within ancestry group
principal components from GWAS analyses conducted in the previous chapter. Where
polygenic risk scores were predictive of tobacco use behaviors, regression analyses
including the main effects of the PRS and the environment (e.g. parental involvement,
parental autonomy granting, experience of stressful life events) and an interaction (e.g.
PRS x environment), were tested to determine potential gene-by-environment
interactions, using a significance threshold of p-value ≤ 0.05.
RESULTS
Table 9.1 (previous chapter) depicts the distribution of tobacco use variables for the S4S
target sample, which only included individuals who provided genetic data passing quality
control (n = 5,950). Information regarding the summary of environmental measures in
S4S is shown in Table 10.1 on the next page. The information provided in this table is
limited to post-quality control samples with genotypes, within individuals of European and
African ancestries.
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Table 10.1: Summary of Environmental Measures in S4S
EUR
Environmental Measures

AFR

N / Total

%

N / Total

%

Any Stressful Life Event

372 / 500

74.4

86 / 303

28.3

Accident

223 / 499

46.7

120 / 302

39.7

Physical Assault

125 / 500

25.0

65 / 301

21.6

Sexual Assault

36 / 498

7.2

18 / 299

6.0

Other Sexual Assault

89 / 496

17.9

41 / 298

13.8

Natural Disaster

281 / 500

56.2

170 / 302

56.3

Mean

Range

Mean

Range

Parental Autonomy Granting (unstandardized)

6.49

1-12

6.62

1-12

Parental Involvement (unstandardized)

9.83

1-12

9.47

1-12

Polygenic risk scores (PRS) reflect a combined effect of selected SNPs, based upon five
different p-value thresholds (p-values = 5x10 -8, 5x10-6, 5x10-4, 5x10-2, and 5x102). These
selected SNPs were used to define large sets of risk alleles in the discovery sample,
which were then used to generate a PRS for individuals in the independent target sample,
as shown in Table 10.2. Within this table, we have indicated the total number of SNPs
from the discovery (TAG Consortium) and target (S4S) samples, as well as the total
number of common SNPs found across TAG and S4S, for the African (AFR) and
European (EUR) ancestry groups found in S4S. For each of the p-value thresholds shown
below, we also show the number of SNPs contributing to the estimated PRS. Generally,
as the p-value threshold decreases, so does the number of SNPs contributing to the PRS.
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Table 10.2: P-value Thresholds and Number of SNPs
n SNPs Ever Use
All SNPs TAG

2,457,119

All SNPs S4S

17,461,305
AFR

EUR

Total Common SNPS: TAG and S4S

235,306

130,353

P-value threshold = 5x102

66,282

120,080

P-value threshold = 5x10-2

7,212

13,051

P-value threshold = 5x10

-4

105
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P-value threshold = 5x10-6

37

9

-8

28

6

P-value threshold = 5x10

Prior to running regression analyses, we ran correlations between each polygenic risk
score set and the tobacco use behaviors measured in the target sample. Correlations
between PRS and tobacco use behaviors were wide ranging for both the European
ancestry group and for the African ancestry group, as shown in Table 10.3. Within the
European ancestry group, negative correlations were found between each PRS with: ever
tobacco use (range: -0.0224 to -0.0451) and age of initiation (range: -0.0255 to -0.0016).
Alternatively, positive correlations were found between each PRS with: ever tobacco use
(range: 0.0350 to 0.1014), age of initiation (range: 0.0397 to 0.0881), regular use (range:
0.0238 to 0.0685), and cigarettes per day (range: 0.1235 to 0.1494) within the African
ancestry group. Where correlations are negative, it is suggested that polygenic risk scores
are associated with lower levels of a given tobacco use behavior phenotype (e.g.
polygenic risk scores were associated with never using tobacco products in a lifetime and
older age of initiation within those of European ancestry). Meanwhile, positive correlations
indicate that polygenic risk scores are associated with higher levels of tobacco use
behavior phenotypes (e.g. polygenic risk scores were associated with having used
tobacco products in a lifetime, younger age of initiation, having smoked 100 cigarettes in
a lifetime, and the use of more cigarettes per day within those of African ancestry).
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Table 10.3: Correlations between PLINK-based Polygenic Risk Scores and Tobacco Use
EUROPEAN ANCESTRY GROUP: TAG EVER VS. NEVER REGULAR USE PRS
P-value
Threshold
5x102
5x10-2

EU

AO

CU

RU

RUS

CPD

TFT

FTND

-0.0451
-0.0224

-0.0016
-0.0023

0.0343
0.0331

0.0111
-0.0095

0.0241
0.0042

-0.0698
-0.0159

0.0167
0.0289

0.0072
0.0188

5x10-4

-0.0528

-0.0255

-0.0112

-0.0265

-0.0037

0.0219

0.0444

0.0192

-6

5x10

-0.0374

-0.0102

-0.0133

-0.0224

-0.0154

0.0241

0.0607

0.0308

5x10-8

-0.0388

-0.0141

-0.0227

-0.0247

-0.0188

0.0299

0.0677

0.0395

AFRICAN ANCESTRY GROUP: TAG EVER VS. NEVER REGULAR USE PRS
P-value
Threshold
5x102
5x10-2

EU

AO

CU

RU

RUS

CPD

TFT

FTND

0.1014
0.0350

0.0881
0.0397

0.0211
-0.0145

0.0685
0.0238

0.1235
0.1327

-0.0142
-0.0316

-0.0727
-0.0453

5x10-4

0.0464

0.0576

0.0131

0.0422

-0.0111
-0.0157
0.0229

0.1427

-0.0131

0.0031

0.0287

0.0215

0.1487

0.0035

-0.0001

5x10

-6

0.0408

0.0437

0.0330

0.0270

-8

5x10
0.0420
0.0452
0.0427
0.0303
0.1494
0.0093
0.0031
Note: EU = ever use; AO = age of onset; CU = current use; RU = regular use; RUS = regular use among smokers;
CPD = cigarettes per day; TFT = time to first tobacco use; FTND = Fagerström Test for Nicotine Dependence

We used five sets of risk scores with p-value thresholds ranging from 5x10 -8 to 5x102 to
predict ever tobacco use (EU), age of initiation (AO), current use (CU), regular use (RU),
regular use among smokers (RUS), cigarettes per day (CPD), time to first tobacco use
after waking (TFT), and the Fagerström Test for Nicotine Dependence (FTND) using
either logistic regression, where the outcome was binary, or linear regression, where the
outcome of interest was continuous.
Polygenic risks scores only significantly predicted: ever tobacco use (using the threshold
p-value ≤ 5 x 10-4) and time to first tobacco use after waking (using the threshold p-value
≤ 5 x 10-8) within the European ancestry group (estimates of the effects, z-value, and
model fit statistics are shown in Supplemental Tables 10.4a-b; information also provided
in Figure 10.1a-b). Within these models, PRS using the threshold of p-value ≤ 5 x 10 -4
accounted for 8.0% of the variance of ever tobacco use and the PRS using the threshold
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of p-value ≤ 5 x 10-8 accounted for 8.5% of the variance of time to first tobacco use within
the European ancestry group.
Figure 10.1a. PRS using Ever vs. Never Regular Tobacco Use in the Tobacco and Genetics Consortium
Predicting Tobacco Use Phenotypes in Spit for Science (AFR)

0.18
0.16
0.14
0.12
0.10
0.08
0.06
0.04
0.02
0.00
EU
No PRS

AO
p=0.50

CU
p=0.05

RU
p=0.0005

RUS

CPD
p=0.000005

TFT

FTND

p=0.00000005

Note: EU = ever use; AO = age of onset; CU = current use; RU = regular use; RUS = regular use among smokers; CPD = cigarettes
per day; TFT = time to first tobacco use; FTND = Fagerström Test for Nicotine Dependence

Figure 10.1b. PRS using Ever vs. Never Regular Tobacco Use in the Tobacco and Genetics Consortium
Predicting Tobacco Use Phenotypes in Spit for Science (EUR)

0.18
0.16
0.14
0.12
0.10
0.08
0.06
0.04
0.02
0.00
EU
No PRS

AO
p=0.50

CU
p=0.05

RU
p=0.0005

RUS

CPD

p=0.000005

TFT

FTND

p=0.00000005

Note: EU = ever use; AO = age of onset; CU = current use; RU = regular use; RUS = regular use among smokers; CPD = cigarettes
per day; TFT = time to first tobacco use; FTND = Fagerström Test for Nicotine Dependence

Main Effects of Environment. Since PRS were only significant for ever tobacco use and
time to first tobacco use after waking within those of European ancestry, we went on to
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test whether measures of the parental environment and the experience of stressful life
events prior to university enrollment were significant in predicting those two variables
within those of European ancestry (see Supplementary Tables 10.5a-b). Parental
autonomy granting, parental involvement, as well as experiencing an accident, physical
assault, or other sexual assault prior to university enrollment were predictive of ever
tobacco use. Meanwhile, parental involvement and the experience of physical assault,
sexual assault, or other sexual assault prior to enrollment at university predicted time to
first tobacco use after waking. These variables were used for subsequent analyses to test
PRS by environment interactions, using p-value thresholds that explain the most variance
in ever tobacco use (p-value ≤ 5 x 10 -4) and time to first tobacco use after waking (p-value
≤ 5 x 10-8). Data for the main effects of the environment (and subsequent PRS x
environment interactions) on tobacco use among the African ancestry group are not
shown, since PRS did not significantly predict tobacco use behaviors within this sample,
and because we were interested in testing PRS x environment interactions where main
effects of both PRS and the environmental measures are significant.
Interaction Effects of the Environment. Main and interaction effects of PRS and
measures of the parental environment on ever tobacco use and time to first tobacco use
are shown in Supplementary Tables 10.5a-b, while the main and interaction effects of
stressful life events experienced prior to university enrollment and ever tobacco use and
time to first tobacco use are shown in Supplemental Tables 10.6a-10.3b. Only the
interaction between effect of polygenic risk score (p-value = 5x10 -4) and environment was
significant for the experience of physical assault, predicting ever tobacco use within the
European ancestry group (Supplementary Table 10.6a).
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DISCUSSION
Tobacco use behaviors are complex traits that are highly polygenic in nature. Many
genetic variants, each of small effect (e.g. R2 < 0.005) contributing to the development of
each specific phenotype. Unfortunately, what this means is that it is unlikely that genome
wide association studies will lead to straightforward results to be replicated in independent
samples16 at current sample sizes. Results from the TAG Consortium meta-analysis
demonstrates these difficulties, as even with large sample sizes (greater than 70,000
individuals) no genome wide significant results were obtained for either smoking initiation
or age at smoking initiation. Modeling the additive or cumulative effects of associated
variants works to get around this problem and has the potential to explain a higher
proportion of variation relative to any single genetic variant 17. Thus, in efforts to
investigate the cumulative effects of associated variants contributing to tobacco use
behaviors within our sample, we calculated polygenic risk scores derived from the TAG
Consortium meta-analyses of GWAS results for ever vs. never regular use and conducted
association analyses to determine whether we could predict: ever tobacco use, age of
initiation, current use, regular use among smokers, time to first tobacco use, cigarettes
per day, and the Fagerström Test for Nicotine Dependence.
The standard PRS approach requires testing over a range of p-value thresholds 10, which
are often chosen arbitrarily. Potential limitations of this approach include the possibility of
including variants that could be false positives and raw estimates of effect sizes being
subject to selection bias. One alternative to this approach is to consider linkage
disequilibrium (LD) among markers, using a reference LD panel. However, potential
limitations of the approach using LDpred includes the method’s reliance on LD information
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from a reference panel and potential heterogeneity hindering prediction accuracy 11. This
approach might not be appropriate for the sample described here, since LDpred performs
best with an LD reference panel of at least 1,000 individuals. Additionally, its flagship
paper applied LDpred to GWAS summary statistics for large sample sizes ranging from
27,000 to 86,000 individuals. Our LD reference panel, available from the TAG Consortium
data, includes a sample of 69,409 and meets these requirements. However, it is possible
that our power to detect effects is still limited, since our target sample included less than
10,000 individuals – or more specifically, 3,018 of European ancestry and 1,339 of African
ancestry for these genetic analyses. Given that our target sample size was small, the
relatively small number of individuals may have limited power to detect effects across all
p-value thresholds.
LDpred might also not perform well with our sample, because of the requirement that the
target sample needs to have LD patterns like the discovery set. The discovery sample
from the TAG Consortium is primarily made up of older adults of European ancestry.
Although one of the subsets of our target sample was comprised of individuals of
European ancestry, it is possible that our sample has higher levels of admixture which
could also result in differences in allele frequencies across the discovery and target
samples. Additionally, our sample is younger relative to the discovery set, which is
important if some genetic variants do not play a large role until later in life, as
demonstrated in previously published twin studies18.
Other potential limitations exist in the interpretation of findings from the current study and
those employing polygenic risk score methodologies more broadly. Firstly, adequate
sample size is necessary for score estimates within discovery populations to be precise
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and optimal p-value thresholds used for selecting score variants, depends on the size of
the discovery sample. Generally, the variance explained is dependent upon the sample
size of the discovery set, such that when the sample size is large, the effects detected
within the GWAS contains less noise, which can lead to more accurate predictions in the
target sample19. Disparate patterns of LD and differences in marker allele frequencies
between discovery and target samples are also thought to attenuate effects of PRS
analyses17. Additionally, population stratification and differential patterns of LD across
racial and ethnic groups, like those found in the current sample, may bias results within
genetic association studies20. Since GWAS have traditionally been conducted on
individuals of European descent, and methods for computing polygenic risk scores are
dependent upon GWAS, risk alleles identified from these studies may be specific to the
ancestral group or include tag SNPs not found in other populations 21.
Along those same lines, reported values of R2 might not directly reflect the degree of
missing heritability, but could perhaps reflect the effect of sampling variation on the
variance, as explained by estimated scores. Since the effects of individual SNPs are very
small, they are estimated with a great deal of error. Thus, the prediction of a phenotype
using estimated SNP effects may suffer from sampling variance with which the effect is
estimated. Added to this, the measures of tobacco use are crude within the discovery
sample, and the worse the estimate of the effect size of the variant in the discovery
sample, the worse the variance will be explained by the predictor in the target/validation
sample. Nevertheless, the TAG meta-analysis is the largest GWAS meta-analysis for
tobacco use behavior that exists. The chances of success of polygenic risk score
analyses are dependent upon the size of the discovery set, so if the sample size is too
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small (which is still potentially the case with the TAG Consortium data), the risk profiles
could be based upon random noise and are not expected to explain variance in the target
set.
However, what was encouraging about these analyses, was that they provided further
evidence that different measures of tobacco use behaviors were influenced by
overlapping genetic factors. Ever tobacco use (EUR: h 2 = 0.28, p-value = 0.0133), age of
initiation (EUR: h2 = 0.30, p-value = 0.0288), and regular use among smokers (EUR: h2 =
0.18, p-value = 0.0041) yielded significant SNP-based heritability estimates (at least, prior
to correction for multiple testing) using GCTA within individuals of European ancestry, as
demonstrated in Chapter 9. PRS derived from TAG Consortium data on ever vs. never
regular use significantly predicted both ever tobacco use and time to first tobacco use
within individuals of European ancestry, suggesting that at least some of the SNPs
influencing ever tobacco use were the same as those influencing the time to first tobacco
use after waking. And as expected, the amount of variance explained by PRS were lower
than previously reported heritability estimates from twin studies.
Adding parental environmental variables (parental autonomy granting and parental
involvement) and their interactions with polygenic risk scores explained more of the
variance within the tobacco use behaviors of ever tobacco use and time to first tobacco
use after waking within those of European ancestry, relative to including polygenic risk
scores and covariates alone (see Supplementary Tables 10.5a and 10.5b). This suggests
that the environments provided by parents, as well as the interaction between the parental
environment and PRS, were significant contributors to the variance in ever tobacco use
and time to first tobacco use within this population. Although we also could detect
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significant main effects of stressful life events experienced prior to university enrollment
on these two measures of tobacco use, none of the interactions between stressful life
events and PRS were significant.
PRS did not significantly predict any of the measures of tobacco use behaviors within
individuals of African ancestry within this study. The lack of predictive power for the PRS
among individuals of African ancestry might be the result of differences in patterns of LD
between African and European-ancestry individuals, which has important implications for
future studies that intend to use cumulative measures of risk to predict a given phenotype,
especially when many large-scale GWAS derive their discovery datasets from individuals
of European ancestry. Future studies may require newer methodologies that are able to
incorporate more accurate measures of LD from the target population, particularly within
ancestry groups that are ad-mixed16.
These results must be interpreted in the context of certain limitations. This study does
provide evidence for a genetic architecture of multiple common variants with small
individual effect sizes (as evident from 6 SNPs contributing to PRS for time to first tobacco
use after waking and 194 SNPs contributing to PRS for ever tobacco use, among
individuals of the European ancestry group) influencing tobacco use behaviors.
Additionally, this study explored the contribution of genetic risk across a range of tobacco
use behaviors across both European and African ancestral groups. Using an aggregate
measure of genetic risk by way of polygenic risk scores, we did not need to require the
rigorous statistical test corrections that are required for genome wide association studies.
We were also able to examine specific environmental risk factors, focused on risk prior to
enrollment in university, and how genetic influences might change as a function of
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environmental risk. This information is potentially useful for public health interventions,
since it allows for the identification for potentially modifiable risk factors 13. Also, polygenic
risk scores were based on a large discovery sample – the largest meta-analyses to date
on tobacco use behaviors – which should add to the accuracy of the polygenic risk scores.
However, to be sure that these polygenic risk scores are accurate, more studies need to
be conducted across a variety of different ancestral groups with larger sample sizes especially since it is important to validate the predictive ability of polygenic risk scores for
tobacco use phenotypes, while also gaining a better understanding of the genetic
contributions to these behaviors.
CONCLUSION
In conclusion, we investigated the genetic architecture of tobacco use behaviors within a
sample of young adults attending university. We constructed polygenic risk scores that
predicted ever tobacco use and time to first tobacco use after waking, within individuals
of European ancestry. As hypothesized, PRS did significantly predict tobacco use
behaviors, and PRS explained more of the variance in tobacco use behaviors within
individuals of European ancestry relative to African ancestry. However, PRS only
predicted ever tobacco use and time to first tobacco use after waking within individuals of
European ancestry. Limited predictive power of the PRS may be attributed to three key
issues: differences in phenotype definitions, potential differences in marker allele
frequencies between the discovery and target samples, and issues related to sample size
(potentially in both the discovery and target samples) and power.
Despite these potential limitations, significant additive interactions were observed
between polygenic risk scores and aspects of individual environments prior to university
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enrollment – particularly, parental autonomy granting, parental involvement, and the
experience of an accident, physical, sexual, or other sexual assault prior to university
enrollment. Thus, this study provides support for further study of polygenic risk scores
and gene-environment interactions. This study also suggests that the time prior to
university enrollment may be useful for prevention and intervention strategies.
Specifically, the findings of this study suggest that interventions should look towards
parental environment and the experience of stressful life events prior to university
enrollment to diminishing genetic vulnerability to tobacco use behaviors, such as ever use
and time to first tobacco use after waking.
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Supplementary Table 10.4a: PLINK-based PRS Predicting Measures of Tobacco Use Behaviors in S4S AFR Ancestry Group
Ever Tobacco
Use (AFR)

Base Model
Estimate (z-value)

PGRS
Sex
Age
PC1
PC3
PC8
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

Age of Initiation
(AFR)
PGRS
Sex
Age
PC1
PC2
PC3
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

-0.41 (-3.24)
0.12 (2.55)
7.71 (3.62)
-3.54 (-1.67)
3.06(1.48)
-1.44 (-1.51)
0.034

**
*
***
.

p-value =
5 x 102
Estimate (z-value)
0.11 (1.71)
-0.42 (-3.26)
0.12 (2.53)
5.94 (2.52)
-3.52 (-1.66)
3.16 (1.52)
-1.41 (-1.48)
0.038
0.004

p-value =
5 x 10-2
Estimate (z-value)
.
*
*
.

0.02 (0.34)
-0.41 (-3.24)
0.12 (2.54)
7.50 (3.39)
-3.54 (-1.67)
3.08 (1.49)
-1.42 (-1.49)
0.035
0.001

**
*
**
.

p-value =
5 x 10-4
Estimate (z-value)

p-value =
5 x 10-6
Estimate (z-value)

p-value =
5 x 10-8
Estimate (z-value)

0.05 (0.84)
-0.41 (-3.23)
0.12 (2.53)
7.37 (3.40)
-3.59 (-1.69)
3.16 (1.52)
-1.42 (-1.49)
0.035
0.001

0.04 (0.75)
-0.41 (-3.24)
0.12 (2.53)
7.42 (3.43)
-3.58 (-1.69)
3.16 (1.53)
-1.42 (-1.49)
0.035
0.001

0.04 (0.75)
-0.41 (-3.24)
0.12 (2.53)
7.40 (3.41)
. -3.58 (-1.69)
3.16 (1.52)
-1.42 (-1.49)
0.035
0.001

**
*
**
.

**
*
**
.

**
*
**

.
1329

Base Model
Estimate (z-value)
-0.31 (-4.00)
0.08 (2.59)
4.61 (3.62)
1.83 (1.44)
-1.91 (-1.47)
-0.12 (-0.21)
0.065

***
**
***
.

2.9304 (0.08)

0.1132 (0.73)

0.7017 (0.40)

0.5572 (0.45)

0.5614 (0.45)

1329

1329

1329

1329

1329

p-value =
5 x 102
Estimate (z-value)
0.03 (0.63)
-0.31 (-4.00)
0.08 (2.53)
4.18 (2.88)
1.60 (1.21)
-1.91 (-1.47)
-0.09 (-0.15)
0.066
0.001

***
*
**

p-value =
5 x 10-2
Estimate (z-value)

p-value =
5 x 10-4
Estimate (z-value)

p-value =
5 x 10-6
Estimate (z-value)

0.00 (0.03)
-0.31 (-4.00)
0.08 (2.59)
4.60 (3.43)
1.83 (1.41)
-1.91 (-1.47)
-0.12 (-0.20)
0.065
0.000

0.02 (0.66)
-0.31 (-3.99)
0.08 (2.55)
4.43 (3.39)
1.81 (1.42)
-1.91 (-1.48)
-0.10 (-0.17)
0.066
0.001

0.01 (0.42)
-0.31 (-4.00)
0.08 (2.57)
4.51 (3.46)
1.83 (1.44)
-1.92 (-1.48)
-0.10 (-0.18)
0.066
0.001

.
1039

0.5127 (0.53)
1039

***
**
***

.
0.0012 (0.97)
1039
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***
*
***

.
0.5597 (0.51)
1039

p-value =
5 x 10-8
Estimate (z-value)

***
*
***

0.02 (0.44)
-0.31 (-4.00)
0.08 (2.56)
4.49 (3.44)
1.82 (1.43)
-1.92 (-1.48)
-0.11 (-0.18)
0.066
0.001

.
0.2206 (0.68)
1039

***
*
***

.
0.2566 (0.65)
1039

Current Use
(AFR)
PGRS
Sex
Age
PC1
PC2
PC7
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

Regular Use
(AFR)
PGRS
Sex
Age
PC1
PC2
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

Base Model
Estimate (z-value)
-0.49 (-2.79)
-0.30 (-4.61)
4.57 (2.93)
-5.26 (-1.77)
-5.74 (-2.87)
7.38 (5.54)
0.076

**
***
.
*
***

Base Model
Estimate (z-value)

1329

p-value =
5 x 10-2
Estimate (z-value)

p-value =
5 x 10-4
Estimate (z-value)

p-value =
5 x 10-6
Estimate (z-value)

p-value =
5 x 10-8
Estimate (z-value)

0.003 (0.04)
-0.49 (-2.79)
-0.30 (-4.61)
4.51 (1.36)
-5.29 (-1.72)
-5.74 (-2.00)
7.38 (5.54)
0.076
0.000

-0.01 (-0.17)
-0.49 (-2.79)
-0.30 (-4.61)
4.72 (1.53)
-5.19 (-1.72)
-5.72 (-2.00)
7.38 (5.53)
0.076
0.000

0.03 (0.39)
-0.49 (-2.77)
-0.30 (-4.62)
4.31 (1.43)
-5.25 (-1.77)
-5.76 (-2.00)
7.38 (5.54)
0.076
0.000

0.06 (0.70)
-0.49 (-2.77)
-0.30 (-4.63)
4.13 (1.38)
-5.19 (-1.75)
-5.76 (2.01)
7.41 (5.55)
0.077
0.001

0.07 (0.84)
-0.49 (-2.76)
-0.30 (-4.63)
4.00 (1.33)
-5.17 (-1.74)
-5.76 (-2.01)
7.42 (5.55)
0.077
0.001

**
***
.
*
***

0.0016 (0.97)
742

742

-0.20 (-5.50)
0.04 (3.22)
2.27 (3.82)
-0.38 (-0.65)
-0.09 (-0.32)
0.048

p-value =
5 x 102
Estimate (z-value)

***
**
***
.

0.2228 (0.42)
1329

.
*
***

0.0275 (0.86)
742

p-value =
5 x 102
Estimate (z-value)
0.02 (0.81)
-0.20 (-5.51)
0.04 (3.18)
2.02 (3.03)
-0.51 (-0.84)
-0.08 (0.29)
0.049
0.001

**
***

***
**
**
.

0.0000 (0.99)
1329
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.
*
***

0.1517 (0.70)
742

p-value =
5 x 10-2
Estimate (z-value)
0.00 (0.00)
-0.20 (-5.50)
0.04 (3.20)
2.27 (3.66)
-0.38 (-0.64)
0.10 (0.18)
0.048
0.000

**
***

***
**
***

p-value =
5 x 10-4
Estimate (z-value)
0.01 (0.60)
-0.20 (-5.50)
0.04 (3.20)
2.20 (3.63)
-0.39 (-0.66)
-0.08 (-0.30)
0.049
0.001
0.1226 (0.55)
1329

***
**
***

**
***
.
*
***

**
***
.
*
***

0.4865 (0.49)
742

0.7121 (0.40)
742

p-value =
5 x 10-6
Estimate (z-value)

p-value =
5 x 10-8
Estimate (z-value)

0.01 (0.34)
-0.20 (-5.50)
0.04 (3.21)
2.23 (3.69)
-0.38 (-0.65)
-0.08 (-0.31)
0.048
0.00
0.0405 (0.73)
1329

***
**
***

0.01 (0.38)
-0.20 (-5.50)
0.04 (3.21)
2.22 (3.67)
-0.38 (-0.65)
-0.08 (-0.31)
0.048
0.00
0.0483 (0.71)
1329

***
**
***

Regular Use
Among Smokers
(AFR)
PGRS
Sex
Age
PC1
PC2
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

p-value =
5 x 102
Estimate (z-value)

Base Model
Estimate (z-value)
-0.81 (-3.27)
0.12 (1.34)
6.06 (1.50)
-3.71 (-1.04)
0.83 (1.37)
0.046

**

.

744

CPD (AFR)
Base Model
Estimate (z-value)
PGRS
Sex
Age
PC1
PC2
PC7
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

-0.14 (-2.70)
0.00 (0.01)
1.64 (2.05)
-1.87 (-2.29)
-2.20 (-2.48)
1.38 (3.58)
0.065

369

**
*
.*
*
***

-0.11 (-0.82)
-0.81 (-3.26)
0.12 (1.36)
7.84 (1.71)
-2.76 (-0.74)
-3.38 (-1.82)
0.047
0.001

p-value =
5 x 10-2
Estimate (z-value)

**

.

-0.06 (-0.50)
-0.81 (-3.26)
0.12 (1.37)
6.63 (1.58)
-3.36 (-0.92)
-3.39 (-1.82)
0.047
0.001

p-value =
5 x 10-4
Estimate (z-value)

**

.

0.01 (0.05)
-0.81 (-3.27)
0.12 (1.33)
6.01 (1.45)
-3.71 (-1.04)
-3.33 (-1.79)
0.046
0.001

**

.

0.6775 (0.41)
744

0.2502 (0.62)
744

0.0029 (0.96)
744

p-value =
5 x 102
Estimate (z-value)

p-value =
5 x 10-2
Estimate (z-value)

p-value =
5 x 10-4
Estimate (z-value)

0.02 (0.81)
-0.14 (-2.73)
-0.00 (-0.02)
1.27 (1.37)
-1.87 (-2.29)
-2.03 (-2.41)
-2.24 (-2.52)
0.067
0.001
0.1440 (0.42)
369

**

.*
*
***

0.04 (1.55)
-0.15 (-2.78)
-0.001 (-0.09)
1.26 (1.51)
-2.06 (-2.49)
-2.30 (-2.59)
1.42 (3.68)
0.071
0.005
0.5242 (0.12)
369
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**

.*
*
***

0.03 (1.37)
-0.14 (-2.71)
-0.00 (-0.03)
1.35 (1.64)
-1.87 (-2.29)
-2.28 (-2.57)
1.38 (3.61)
0.070
0.004
0.4102 (0.17)
369

p-value =
5 x 10-6
Estimate (z-value)
0.004 (0.04)
-0.81 (-3.27)
0.12 (1.33)
6.03 (1.45)
-3.71 (-1.04)
-3.33 (-1.79)
0.046
0.001

**

.

0.0014 (0.97)
744

**

.*
*
***

0.3539 (0.20)
369

0.02 (0.13)
-0.81 (-3.27)
0.12 (1.32)
5.94 (1.42)
-3.70 (-1.04)
-3.32 (-1.79)
0.046
0.001

**

.

0.0163 (0.89)
744

p-value =
5 x 10-6
Estimate (z-value)
0.03 (1.27)
-0.14 (-2.73)
-0.00 (-0.04)
1.39 (1.69)
-1.84 (-2.25)
-2.26 (-2.55)
1.39 (3.63)
0.070
0.004

p-value =
5 x 10-8
Estimate (z-value)

**
.
.*
*
***

p-value =
5 x 10-8
Estimate (z-value)
0.03 (1.23)
-0.14 (-2.73)
-0.00 (0.03)
1.38 (1.66)
-1.84 (-2.25)
-2.26 (-2.54)
1.39 (3.62)
0.069
0.003
0.3340 (0.22)
369

**
*
.*
*
***

TFT (AFR)

p-value =
5 x 102
Estimate (z-value)

Base Model
Estimate (z-value)
PGRS
Sex
Age
PC1
PC2
PC3
PC5
PC7
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

-0.29 (-3.72)
-0.00 (-0.01)
0.68 (0.56)
-2.53 (-2.18)
2.24 (1.69)
-2.07 (-1.47)
-2.54 (-1.93)
0.83 (1.37)
0.083

***
*
.
.

427

FTND (AFR)
Base Model
Estimate (z-value)
PGRS
Sex
Age
PC1
PC2
PC3
PC7
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

0.004 (0.02)
0.19 (2.71)
0.40 (0.13)
-6.78 (-2.24)
5.17 (1.63)
-4.80 (-1.51)
-2.67 (-1.81)
0.149

527

**
.*
.

-0.01 (-0.24)
-0.29 (-3.69)
-0.00 (-0.00)
0.85 (0.61)
-2.46 (-2.03)
2.26 (1.70)
-2.05 (-1.46)
-2.52 (-1.91)
0.82 (1.35)
0.083
0.000

***
*
.
.

p-value =
5 x 10-2
Estimate (z-value)

p-value =
5 x 10-4
Estimate (z-value)

p-value =
5 x 10-6
Estimate (z-value)

p-value =
5 x 10-8
Estimate (z-value)

-0.004 (-0.12)
-0.29 (-3.70)
-0.00 (-0.01)
0.73 (0.57)
-2.51 (-2.12)
2.25 (1.70)
-2.05 (-1.45)
-2.53 (-1.92)
0.82 (1.35)
0.083
0.000

-0.004 (-0.13)
-0.29 (-3.71)
-0.00 (-0.01)
0.72 (0.58)
-2.54 (-2.18)
2.24 (1.70)
-2.05 (-1.45)
-2.53 (-1.92)
0.83 (1.36)
0.083
0.000

-0.002 (-0.07)
-0.29 (-3.71)
-0.00 (-0.01)
0.70 (0.56)
-2.54 (-2.18)
2.25 (1.69)
-2.06 (-1.46)
-2.54 (-1.93)
0.83 (1.37)
0.083
0.000

-0.0002 (-0.01)
-0.29 (-3.71)
-0.00 (-0.01)
0.68 (0.54)
-2.54 (-2.17)
2.24 (1.69)
-2.07 (-1.46)
-2.54 (-1.93)
0.83 (1.36)
0.083
0.000

***
*
.
.

***
*
.
.

0.0332 (0.81)
427

0.0086 (0.90)
427

0.010 (0.89)
427

p-value =
5 x 102
Estimate (z-value)

p-value =
5 x 10-2
Estimate (z-value)

p-value =
5 x 10-4
Estimate (z-value)

-0.10 (-1.02)
0.01 (0.07)
0.19 (2.70)
2.02 (0.58)
-5.93 (-1.89)
5.29 (1.67)
-4.64 (-1.45)
-2.66 (-1.81)
0.156
0.007
4.6852 (0.31)
527

**
.
.

-0.03 (-0.33)
0.01 (0.04)
0.19 (2.71)
0.70 (0.22)
-6.59 (-2.15)
5.23 (1.65)
-4.76 (-1.49)
-2.68 (-1.82)
0.150
0.001
0.4919 (0.74)
527

203

**
.*
.

0.0008 (0.01)
0.004 (0.02)
0.19 (2.70)
0.39 (0.12)
-6.78 (-2.24)
5.17 (1.63)
-4.81 (-1.50)
-2.67 (-1.81)
0.149
0.000
0.0004 (0.99)
527

***
*
.
.

0.0024 (0.95)
427

**
.*
.

0.0458 (0.92)
527

.
*

0.0001 (0.99)
742

p-value =
5 x 10-6
Estimate (z-value)
-0.01 (-0.10)
0.005 (0.03)
0.19 (2.71)
0.47 (0.15)
-6.78 (-2.24)
5.19 (1.63)
-4.79 (-1.50)
-2.67 (-1.81)
0.149
0.000

**
***

p-value =
5 x 10-8
Estimate (z-value)

**
.*
.

-0.005 (-0.06)
0.005 (0.02)
0.19 (2.71)
0.44 (0.14)
-6.78 (-2.24)
5.19 (1.63)
-4.80 (-1.50)
-2.67 (-1.81)
0.149
0.000
0.0140 (0.96)
527

**
.*
.

Supplementary Table 10.4b: PLINK-based PRS Predicting Measures of Tobacco Use Behaviors in S4S EUR Ancestry Group
Ever Tobacco
Use (EUR)
PGRS
Sex
Age
PC1
PC2
PC5
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

Age of Initiation
(EUR)
PGRS
Sex
Age
PC1
PC2
PC5
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

Base Model
Estimate (z-value)
-0.47 (-5.71)
0.12 (3.50)
-0.94 (-0.42)
-2.17 (-0.97)
-4.57 (-2.01)
-0.77 (-1.14)
0.023

***
***
*

Base Model
Estimate (z-value)

2632

0.0002 (0.01)
-0.47 (-5.71)
0.12 (3.50)
-0.94 (-0.41)
-2.17 (-0.97)
-4.58 (-2.01)
-0.77 (-1.14)
0.023
0.000

p-value =
5 x 10-2
Estimate (z-value)

***
***
*

0.00002 (0.99)
2980

2980

-0.24 (-5.14)
0.06 (3.47)
0.78 (0.60)
-2.13 (-1.68)
-2.07 (-1.63)
0.47 (1.26)
0.029

p-value =
5 x 102
Estimate (z-value)

***
***
.

0.0082 (0.94)
2632

***
***
*

0.8213 (0.36)
2980

p-value =
5 x 102
Estimate (z-value)
0.002 (0.08)
-0.24 (-5.14)
0.06 (3.47)
0.75 (0.56)
-2.13 (-1.69)
-2.07 (-1.63)
0.47 (1.26)
0.029
0.000

-0.04 (-0.91)
-0.47 (-5.71)
0.12 (3.49)
-0.64 (-0.28)
-2.14 (-0.95)
-4.58 (-2.01)
-0.77 (-1.13)
0.024
0.001

p-value =
5 x 10-4
Estimate (z-value)

5.3679 (0.02)
2980

p-value =
5 x 10-2
Estimate (z-value)

***
***
.

-0.002 (-0.08)
-0.24 (-5.14)
0.06 (3.47)
0.79 (0.61)
-2.13 (-1.68)
-2.07 (-1.63)
0.47 (1.26)
0.029
0.000
0.0086 (0.94)
2632
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-0.09 (-2.31)
-0.47 (-5.70)
0.12 (3.59)
-0.71 (-0.32)
-2.00 (-0.89)
-4.45 (-1.94)
-0.84 (-1.23)
0.025
0.002

*
***
***
*

*

.

-0.02 (-1.22)
-0.24 (-5.12)
0.07 (3.51)
0.84 (0.65)
-2.07 (-1.64)
-2.01 (-1.58)
0.45 (1.20)
0.030
0.001
2.0460 (0.22)
2632

-0.07 (-1.70)
-0.47 (-5.71)
0.12 (3.54)
-0.90 (-0.40)
-2.06 (-0.92)
-4.48 (-1.96)
-0.80 (-1.18)
0.025
0.002
2.8822 (0.09)
2980

p-value =
5 x 10-4
Estimate (z-value)

***
***

p-value =
5 x 10-6
Estimate (z-value)
.
***
***
*

.

.

-0.01 (-0.51)
-0.24 (-5.13)
0.06 (3.48)
0.78 (0.61)
-2.11 (-1.67)
-2.05 (-1.60)
0.47 (1.24)
0.029
0.000
0.3632 (0.61)
2632

-0.06 (-1.60)
-0.47 (-5.70)
0.12 (3.54)
-0.86 (-0.39)
-2.06 (-0.92)
-4.48 (-1.96)
-0.80 (-1.18)
0.025
0.002

***
***
*

2.5536 (0.11)
2980

p-value =
5 x 10-6
Estimate (z-value)

***
***

p-value =
5 x 10-8
Estimate (z-value)

p-value =
5 x 10-8
Estimate (z-value)

***
***
.

-0.01 (-0.61)
-0.24 (-5.13)
0.06 (3.48)
0.79 (0.61)
-2.10 (-1.66)
-2.04 (-1.61)
0.46 (1.24)
0.029
0.000
0.5100 (0.54)
2632

***
***
.

Current Use
(EUR)
PGRS
Sex
Age
PC1
PC2
PC6
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

Regular Use
(EUR)
PGRS
Sex
Age
PC1
PC2
PC6
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

Base Model
Estimate (z-value)
-0.54 (-5.46)
-0.30 (-7.51)
-6.17 (-2.18)
-1.21(-0.45)
5.18 (1.88)
7.45 (9.31)
0.070

***
***
*
.
***

Base Model
Estimate (z-value)

2980

0.06 (1.24)
-0.54 (-5.44)
-0.29 (-7.45)
-7.08 (-2.42)
-1.32 (-0.48)
4.99 (1.80)
7.41 (9.24)
0.071
0.001

p-value =
5 x 10-2
Estimate (z-value)
0.04 (0.81)
-0.54 (-5.43)
-0.29 (-7.47)
-6.52 (-2.28)
-1.29 (-0.47)
5.06 (1.82)
7.43 (9.26)
0.070
0.000

***
***
*
.
***

1.5399 (0.21)
2063

2063

-0.17 (-6.05)
0.08 (6.76)
0.99 (1.29)
-0.71 (-0.92)
1.40 (1.82)
-0.40 (-1.77)
0.037

p-value =
5 x 102
Estimate (z-value)

***
***
.
.

0.0255 (0.83)
2980

-0.02 (-0.35)
-0.54 (-5.46)
-0.29 (-7.50)
-6.12 (-2.16)
-1.19 (-0.44)
5.21 (1.89)
7.45 (9.30)
0.070
0.000

***
***
*
.
***

0.6606 (0.42)
2063

p-value =
5 x 102
Estimate (z-value)
0.003 (0.21)
-0.17 (-6.05)
0.08 (6.76)
0.94 (1.19)
-0.71 (-0.92)
1.39 (1.81)
-0.41 (-1.78)
0.037
0.000

p-value =
5 x 10-4
Estimate (z-value)

.
.

-0.01 (-0.75)
-0.17 (-6.05)
0.08 (6.76)
1.07 (1.38)
-0.70 (-0.91)
1.41 (1.84)
-0.40 (-1.77)
0.037
0.000
0.3324 (0.45)
2980
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-0.03 (-0.60)
-0.54 (-5.46)
-0.29 (-7.50)
-6.15 (-2.17)
-1.17 (-0.43)
5.21 (1.88)
7.45 (9.30)
0.070
0.000

***
***
*
.
***

0.1226 (0.73)
2063

p-value =
5 x 10-2
Estimate (z-value)

***
***

p-value =
5 x 10-6
Estimate (z-value)

.
.

-0.02 (-1.72)
-0.17 (-6.04)
0.08 (6.82)
1.04 (1.36)
-0.67 (-0.86)
1.42 (1.85)
-0.42 (-1.83)
0.038
0.001
1.7218 (0.09)
2980

***
***
*
.
***

0.3594 (0.55)
2063

p-value =
5 x 10-4
Estimate (z-value)

***
***

p-value =
5 x 10-8
Estimate (z-value)

.
.

.

-0.02 (-1.43)
-0.17 (-6.04)
0.08 (6.80)
1.00 (1.30)
-0.68 (-0.88)
1.42 (1.84)
-0.41 (-1.81)
0.038
0.001
1.1992 (0.15)
2980

***
***
*
.
***

0.6815 (0.41)
2063

p-value =
5 x 10-6
Estimate (z-value)

***
***

-0.04 (-0.83)
-0.54 (-5.46)
-0.29 (-7.50)
-6.10 (-2.16)
-1.14 (-0.42)
5.23 (1.89)
7.45 (9.30)
0.070
0.000

p-value =
5 x 10-8
Estimate (z-value)

***
***
.
.

-0.02 (-1.46)
-0.17 (-6.04)
0.08 (6.79)
1.01 (1.32)
-0.68 (-0.88)
1.42 (1.84)
-0.41 (-1.80)
0.038
0.001
1.2415 (0.14)
2980

***
***
.
.

Regular Use
Among
Smokers (EUR)
PGRS
Sex
Age
PC1
PC2
PC6
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

Base Model
Estimate (z-value)
-0.41 (-4.35)
0.18 (4.85)
3.09 (1.17)
-2.66 (-1.04)
6.97 (2.65)
-3.68 (-4.84)
0.033

***
***
**
***

Base Model
Estimate (z-value)
-0.14 (-4.38)
0.04 (3.33)
-1.78 (-1.76)
-0.08 (-0.08)
0.64 (2.48)
0.031

1277

0.02 (0.45)
-0.41 (-4.34)
0.18 (4.86)
2.77 (1.02)
-2.69 (-1.05)
6.90 (2.62)
-3.71 (-4.87)
0.034
0.001

p-value =
5 x 10-2
Estimate (z-value)
-0.01 (-0.22)
-0.41 (-4.36)
0.18 (4.84)
3.17 (1.18)
-2.65 (-1.04)
6.99 (2.65)
-3.68 (-4.83)
0.034
0.001

***
***
**
***

0.2053 (0.65)
2066

2066

CPD (EUR)

PGRS
Sex
Age
PC1
PC2
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

p-value =
5 x 102
Estimate (z-value)

***
***
.
*

0.8216 (0.13)
1277

-0.02 (-0.51)
-0.41 (-4.35)
0.18 (4.86)
3.14 (1.19)
-2.63 (-1.03)
7.00 (2.66)
-3.69 (-4.86)
0.034
0.001

***
***
**
***

0.0488 (0.83)
2066

p-value =
5 x 102
Estimate (z-value)
-0.03 (-1.51)
-0.15 (-4.37)
0.04 (3.24)
-1.40 (-1.35)
-0.03 (-0.03)
0.66 (2.56)
0.033
0.000

p-value =
5 x 10-4
Estimate (z-value)

*

-0.01 (-0.46)
-0.15 (-4.39)
0.04 (3.30)
-1.07 (-1.66)
-0.06 (-0.07)
0.64 (2.50)
0.031
0.000
0.0781 (0.64)
1277
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-0.04 (-0.87)
-0.41 (-4.36)
0.18 (4.86)
3.10 (1.17)
-2.60 (-1.01)
7.00 (2.66)
-3.69 (-4.85)
0.034
0.001

***
***
**
***

0.2612 (0.61)
2066

p-value =
5 x 10-2
Estimate (z-value)

***
***
.

p-value =
5 x 10-6
Estimate (z-value)

*

0.01 (0.39)
-0.15 (-4.38)
0.04 (3.33)
-1.81 (-1.79)
-0.09 (-0.10)
0.64 (2.48)
0.031
0.000
0.0553 (0.70)
1277

-0.02 (-0.95)
-0.41 (-4.36)
0.18 (4.86)
3.13 (1.19)
-2.59 (-1.04)
7.00 (2.67)
-3.69 (-4.85)
0.034
0.001

***
***
**
***

0.7486 (0.39)
2066

p-value =
5 x 10-4
Estimate (z-value)

***
***
.

p-value =
5 x 10-8
Estimate (z-value)

*

0.01 (0.31)
-0.14 (-4.38)
0.04 (3.33)
-1.79 (-1.77)
-0.09 (-0.10)
0.64 (2.48)
0.031
0.000
0.0345 (0.76)
1277

**
***

0.8922 (0.34)
2066

p-value =
5 x 10-6
Estimate (z-value)

***
***
.

***
***

p-value =
5 x 10-8
Estimate (z-value)

***
***
.
*

0.01 (0.37)
-0.15 (-4.38)
0.04 (3.33)
-1.80 (-1.78)
-0.09 (-0.11)
0.64 (2.48)
0.031
0.000
0.0489 (0.71)
1277

***
***
.
*

TFT (EUR)
Base Model
Estimate (z-value)
PGRS
Sex
Age
PC1
PC2
PC5
PC7
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

-0.20 (-4.44)
0.05 (3.01)
-0.78 (-0.61)
-0.03 (-0.03)
1.89 (1.60)
1.96 (1.64)
-0.22 (-0.62)
0.032

***
**

1476

FTND (EUR)
Base Model
Estimate (z-value)
PGRS
Sex
Age
PC1
PC2
PC5
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

-0.33 (-2.97)
0.22 (5.26)
-1.68 (-0.54)
4.04 (1.40)
-7.61 (-2.62)
-2.51 (-2.92)
0.134

1690

**
***
**
**

p-value =
5 x 102
Estimate (z-value)
0.03 (1.13)
-0.20 (-4.44)
0.05 (3.08)
-1.20 (-0.90)
-0.10 (-0.81)
1.86 (1.57)
1.97 (1.65)
-0.24 (-0.69)
0.033
0.001

***
**

p-value =
5 x 10-2
Estimate (z-value)
0.03 (1.24)
-0.20 (-4.40)
0.05 (3.09)
-1.10 (-0.83)
-0.09 (-0.07)
1.87 (1.58)
1.93 (1.62)
-0.24 (-0.70)
0.033
0.001

***
**

p-value =
5 x 10-4
Estimate (z-value)
0.03 (1.46)
-0.20 (-4.44)
0.05 (3.00)
-0.88 (-0.69)
-0.11 (-0.10)
1.86 (1.57)
1.97 (1.65)
-0.21 (-0.61)
0.033
0.001

***
**

0.9353 (0.26)
1476

1.1245 (0.22)
1476

1.575 (0.14)
1476

p-value =
5 x 102
Estimate (z-value)

p-value =
5 x 10-2
Estimate (z-value)

p-value =
5 x 10-4
Estimate (z-value)

0.03 (0.61)
-0.32 (-2.96)
0.22 (5.28)
-2.18 (-0.68)
3.99 (1.37)
-7.66 (-2.63)
-2.55 (-2.95)
0.135
0.001
1.8633 (0.54)
1690

**
***
**
**

0.06 (1.15)
-0.32 (-2.91)
0.22 (5.31)
-2.26 (-0.72)
3.93 (1.36)
-7.67 (-2.64)
-2.56 (-2.98)
0.137
0.003
6.6392 (0.25)
1690
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**
**
**
**

0.08 (1.39)
-0.32 (-2.95)
0.22 (5.24)
-1.90 (-0.62)
3.91 (1.35)
-7.70 (-2.65)
-2.50 (-2.91)
0.138
0.004
9.5950 (0.17)
1690

p-value =
5 x 10-6
Estimate (z-value)
0.04 (1.77)
-0.20 (-4.44)
0.05 (3.01)
-0.83 (-0.65)
-0.14 (-0.12)
1.86 (1.57)
2.00 (1.67)
-0.21 (-0.62)
0.034
0.002
2.2932 (0.08)
1476

**
***
**
**

.
***
**

.

14.7980 (0.08)
1690

0.05 (2.02)
-0.20 (-4.44)
0.05 (3.01)
-0.87 (-0.68)
-0.16 (-0.13)
1.86 (1.58)
1.98 (1.66)
-0.22 (-0.62)
0.035
0.003
2.9995 (0.04)
1476

p-value =
5 x 10-6
Estimate (z-value)
0.09 (1.72)
-0.32 (-2.93)
0.22 (5.25)
-1.76 (-0.57)
3.90 (1.34)
-7.70 (-2.65)
-2.51 (-2.92)
0.141
0.007

p-value =
5 x 10-8
Estimate (z-value)

.
**
***
**
**

.

*
***
**

*

p-value =
5 x 10-8
Estimate (z-value)
0.10 (1.92)
-0.32 (-2.93)
0.22 (5.25)
-1.84 (-0.60)
3.88 (1.34)
-7.71 (-2.65)
-2.51 (-2.92)
0.142
0.008
18.2930 (0.05)
1690

.
**
***
**
**

.

Supplementary Table 10.5a: Main and Interaction Effects of PLINK-based PRS and Parental Environment
Variables on Ever Tobacco Use in European Ancestry Group within Spit for Science

Ever Tobacco Use (EUR)
Parental Environment (PE)
Sex
Age
PC1
PC2
PC5
Intercept
Nagelkerke R2
Change in R2
Chi-Square: Deviance, p
N

Base Model
Estimate (z-value)

-0.46 (-5.53)
0.11 (3.31)
-0.85 (-0.37)
-2.10 (-0.93)
-4.63 (-2.01)
-0.67 (-0.99)
0.022

0.18 (4.24)
-0.45 (-5.37)
0.11 (3.27)
-0.48 (-0.21)
-1.53 (-0.68)
-4.65 (-2.00)
-0.69 (-0.98)
0.032
0.010
18.2980 (0.00005)
2940

***
***
*

2940

Base Model
Estimate (z-value)
Ever Tobacco Use (EUR)
PGRS (p-value = 5 x 10-4)
Parental Environment (PE)
PGRS x PE
Sex
Age
PC1
PC2
PC5
Intercept
Nagelkerke R2
Change in R2
Chi-Square: Deviance, p
N

Autonomy Granting
Main Effect Only
Estimate (z-value)

-0.46 (-5.53)
0.11 (3.31)
-0.85 (-0.37)
-2.10 (-0.93)
-4.63 (-2.01)
-0.67 (-0.99)
0.022

***
***
**
.

***

Autonomy Granting Main
and Interaction Effects
with PGRS
Estimate (z-value)
-0.09 (-2.33)
0.17 (4.19)
0.06 (1.42)
-0.45 (-5.35)
0.12 (3.41)
-0.08 (-0.03)
-1.34 (-0.59)
-4.52 (-1.95)
-1.27 (-1.32)
0.035
0.013
26.234 (0.000008)
2940

***
***
*

2940
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*
***
***
*
***
.

***

Involvement
Main Effect Only
Estimate (z-value)
-0.09 (-2.15)
-0.45 (-5.37)
0.11 (3.31)
-0.70 (-0.31)
-2.04 (-0.91)
-4.60 (2.00)
-0.70 (-1.02)
0.024
0.002
4.7177 (0.03)
2940

*
***
***
*

*

Involvement
Main and Interaction
Effects with PGRS
Estimate (z-value)
-0.10 (-2.41)
-0.09 (-2.14)
0.01 (0.33)
-0.45 (-5.37)
0.12 (3.40)
-0.47 (-0.21)
-1.87 (-0.83)
-4.46 (-1.93)
-0.76 (-1.11)
0.027
0.005
10.575 (0.01)
2940

*
*
***
***
.

*

Supplementary Table 10.5b: Main and Interaction Effects of PLINK-based PRS and Parental Environment
Variables on Time to First Tobacco Use After Waking in European Ancestry Group within Spit for Science

Time to First Tobacco Use After
Waking (EUR)

Base Model
Estimate (z-value)

Parental Environment (PE)
Sex
Age
PC1
PC2
PC5
PC7
Intercept
Nagelkerke R2
Change in R2
Chi-Square: Deviance, p
N

Time to First Tobacco Use After
Waking (EUR)
PGRS (p-value = 5 x 10-8)
Parental Environment (PE)
PGRS x PE
Sex
Age
PC1
PC2
PC5
PC7
Intercept
Nagelkerke R2
Change in R2
Chi-Square: Deviance, p
N

-0.19 (-4.28)
0.05 (2.97)
-0.86 (-0.66)
-0.17 (-0.14)
1.86 (1.57)
1.83 (1.57)
-0.21 (-0.62)
0.030

***
**

Base Model
Estimate (z-value)

-0.19 (-4.28)
0.05 (2.97)
-0.86 (-0.66)
-0.17 (-0.14)
1.86 (1.57)
1.83 (1.57)
-0.21 (-0.62)
0.030

0.07 (3.18)
-0.18 (-4.09)
0.05 (2.91)
-0.74 (-0.57)
0.11 (0.09)
1.84 (1.56)
1.85 (1.55)
-1.27 (-1.32)
0.040
0.001
7.3368 (0.001)
1455

1455

***
**

209

**
***
**

-0.11 (-5.06)
-0.19 (-4.23)
0.05 (3.14)
-0.85 (-0.66)
-0.06 (-0.05)
1.93 (1.64)
1.87 (1.58)
-0.28 (-0.80)
0.054
0.024
18.3730
(0.0000004)
1455

**

Autonomy Granting Main
and Interaction Effects with
PGRS
Estimate (z-value)
0.04 (1.95)
0.07 (3.20)
0.01 (0.33)
-0.18 (-4.08)
0.05 (2.92)
-0.83 (-0.64)
-0.02 (-0.01)
1.81 (1.53)
1.88 (1.58)
-0.21 (-0.62)
0.039
0.009
10.2520 (0.003)
1455

1455

Involvement
Main Effect Only
Estimate (z-value)

Autonomy Granting
Main Effect Only
Estimate (z-value)

.
**
***
**

***
***
**
***

***

Involvement
Main and Interaction
Effects with PGRS
Estimate (z-value)

0.05 (2.14)
-0.11 (-5.09)
0.01 (0.46)
-0.19 (-4.23)
0.05 (3.14)
-0.95 (-0.74)
-0.18 (-0.15)
1.93 (1.63)
1.91 (1.61)
-0.28 (-0.80)
0.058
0.028
21.6880 (0.000001)

**

*
***
***
**

***
1455

Supplementary Table 10.6a: Main Effects of Stressful Life Events on Measures of Ever Tobacco Use and Time to First Tobacco Use After Waking within
European Ancestry Group within Spit for Science

Ever Tobacco Use
(EUR)
Environment
Sex
Age
PC1
PC2
PC5
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

Time to First
Tobacco Use
After Waking
(EUR)
Environment
Sex
Age
PC1
PC2
PC5
PC7
Intercept
Nagelkerke R2
Change in R2
Chi-Square:
Deviance, p
N

Base Model
Estimate (z-value)
-0.50 (-2.35)
0.15 (1.64)
-2.72 (-0.53)
3.31 (0.73)
2.23 (0.36)
-1.21 (-0.64)
0.027

*

495

Base Model
Estimate (z-value)

-0.28 (-2.45)
0.08 (2.27)
-5.87 (-1.90)
2.51 (0.96)
-1.37 (-0.42)
-1.48 (-0.47)
-0.65 (-0.86)
0.097

230

Accident
Estimate (z-value)

*
*
.

.

Physical Assault
Estimate (z-value)

0.57 (2.65)
-0.52 (-2.41)
0.17 (1.74)
-3.79 (-0.73)
2.96 (0.65)
3.57 (0.58)
-1.69 (-0.88)
0.048
0.021

**
*
.

7.2471 (0.0007)
495

**

Accident
Estimate (z-value)
0.09 (0.78)
-0.28 (-2.50)
0.08 (2.25)
-6.00 (-1.93)
2.38 (0.90)
-1.22 (-0.37)
-1.64 (-0.52)
-0.67 (-0.89)
0.100
0.003

Sexual Assault
Estimate (z-value)

0.90 (3.17)
-0.46 (-2.11)
0.18 (1.82)
-3.29 (-0.64)
3.17 (0.69)
3.90 (0.61)
-1.93 (-1.00)
0.060
0.033

**
*
.

11.3400 (0.0008)
495

***

Physical Assault
Estimate (z-value)

0.96 (1.89)
-0.57 (-2.67)
0.16 (1.69)
-2.64 (-0.51)
2.99 (0.66)
2.54 (0.41)
-1.31 (-0.69)
0.040
0.013

.
**
.

4.2864 (0.04)
495

*

Sexual Assault
Estimate (z-value)

Other Sexual
Assault
Estimate (z-value)
0.69 (2.24)
*
-0.61 (-2.78)
**
0.15 (1.54)
-3.83 (-0.74)
3.22 (0.71)
2.42 (0.39)
-0.99 (-0.53)
0.043
0.016
5.4930 (0.02)
495

*

Other Sexual
Assault
Estimate (z-value)

Natural Disaster
Estimate (z-value)
0.01 (0.03)
-0.50 (-2.35)
0.15 (1.63)
-2.73 (-0.53)
3.31 (0.73)
2.24 (0.36)
-1.21 (-0.64)
0.027
0.000

Natural Disaster
Estimate (z-value)

***
*
*
*

0.84 (4.49)
-0.40 (-3.56)
0.09 (2.45)
-5.54 (-1.86)
1.79 (0.71)
-1.15 (-0.36)
-1.67 (-0.55)
-0.61 (-0.85)
0.199
0.102

***
***
*
.

0.63 (4.78)
-0.43 (-3.77)
0.09 (2.48)
-7.92 (-2.65)
1.30 (0.52)
-1.02 (-0.33)
-1.72 (-0.58)
-0.66 (-0.92)
0.211
0.114

***
***
*
**

0.08 (0.70)
-0.27 (-2.42)
0.08 (2.31)
-6.08 (-1.95)
2.73 (1.03)
-1.10 (-0.33)
-1.46 (-0.46)
-0.74 (-0.96)
0.099
0.002

0.4461 (0.44)

10.0330 (0.0001)

***

13.6450 (0.000007)

***

***

0.3623 (0.48)

230

230

15.2780
(0.000002)
230

210

230

.

0.0007 (0.98)
495

0.46 (3.81)
-0.26 (-2.30)
0.09 (2.46)
-6.36 (-2.11)
2.34 (0.92)
0.38 (0.12)
-1.51 (-0.50)
-0.92 (-1.25)
0.172
0.075

*
*
.

*

230

*
*
.

Supplementary Table 10.6b: Main and Interaction Effects of PGRS and Stressful Life Events on Ever Tobacco Use and Time to First Tobacco Use After
Waking within European Ancestry Group within Spit for Science

Ever Tobacco Use (EUR)

Base Model
Estimate (z-value)

Accident
Main and Interaction
Effects
Estimate (z-value)

PGRS (p-value = 5 x 10-4)
Environment
PGRS x Environment
Sex
Age
PC1
PC2
PC5
Intercept
Nagelkerke R2
Change in R2
Chi-Square: Deviance, p

-0.50 (-2.35)
0.15 (1.64)
-2.72 (-0.53)
3.31 (0.73)
2.23 (0.36)
-1.21 (-0.64)
0.027

N

495

Time to First Tobacco Use After
Waking (EUR)

*

Base Model
Estimate (z-value)

PGRS (p-value = 5 x 10-8)
Environment
PGRS x Environment
Sex
Age
PC1
PC2
PC5
PC7
Intercept
Nagelkerke R2
Change in R2
Chi-Square: Deviance, p

-0.28 (-2.45)
0.08 (2.27)
-5.87 (-1.90)
2.51 (0.96)
-1.37 (-0.42)
-1.48 (-0.47)
-0.65 (-0.86)
0.097

*
*
.

.

-0.39 (-2.66)
0.53 (2.44)
1.29 (1.27)
-0.51 (-2.35)
0.18 (1.86)
-3.49 (-0.66)
4.69 (1.02)
2.57 (0.41)
-1.92 (-0.99)
0.068
0.021

**
*

14.44 (0.002)
495

**

230

*
.

Physical Assault
Main and Interaction
Effects
Estimate (z-value)
0.04 (0.56)
0.47 (3.85)
***
0.17 (1.48)
-0.24 (-2.13)
*
0.08 (2.23)
*
-6.44 (-2.15)
*
2.06 (0.81)
0.99 (0.31)
-1.19 (-0.39)
-0.77 (-1.06)
0.200
0.103
10.0330 (0.0001)

N

Physical Assault
Main and Interaction Effects
Estimate (z-value)

230
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***

Other Sexual Assault Main
and Interaction Effects
Estimate (z-value)

-0.40 (-3.06)
0.94 (3.22)
0.58 (1.99)
-0.45 (-2.06)
0.20 (2.01)
-2.56 (-0.48)
5.14 (1.11)
4.71 (0.72)
-2.37 (-1.20)
0.089
0.033

**
**
*
*
*

-0.29 (-2.31)
0.78 (2.41)
-0.13 (-0.41)
-0.61 (-2.76)
0.17 (1.73)
-3.71 (-0.71)
5.06 (1.10)
1.92 (0.31)
-1.42 (-0.74)
0.064
0.016

21.8240 (0.00007)
495

***

13.0650 (0.005)
495

Sexual Assault
Main and Interaction Effects
Estimate (z-value)
0.07 (1.14)
0.90 (4.84)
0.30 (1.91)
-0.39 (-3.46)
0.08 (2.37)
-6.01 (-2.04)
1.12 (0.45)
-1.40 (-0.45)
-1.80 (-0.60)
-0.56 (-0.79)
0.237
0.140
13.6450 (0.000007)
230

***
.
***
*
*

***

*
*
**

**

Other Sexual Assault Main
and Interaction Effects
Estimate (z-value)
0.03 (0.48)
0.60 (4.42)
0.10 (0.87)
-0.40 (-3.54)
0.08 (2.34)
-7.98 (-2.66)
1.09 (0.43)
-0.84 (-0.27)
-1.42 (-0.47)
-0.59 (-0.82)
0.220
0.123
15.2780 (0.00002)
230

***
***
*
**

***

CHAPTER 11:
A MOVING TARGET: THE EMERGENCE OF NICOTINE DELIVERY SYSTEMS AND
ITS POTENTIAL PUBLIC HEALTH IMPACTS
Elizabeth K. Do
Tobacco use remains the leading cause of preventable morbidity and mortality within the
United States, accounting for over 400,000 deaths per year1. Despite an overall decrease
in the use of cigarettes, increases in the use of cigars, e-cigarettes, and hookah/waterpipe
among adolescents and young adults have been reported 2,3. It has also been suggested
that the overall increase in use of electronic cigarettes and hookah between 2011 and
2014 has offset the overall decrease in more traditional tobacco products, like cigarettes
and cigars4. Additionally, the use of alternative tobacco products and nicotine delivery
systems are evolving rapidly. Estimates from a national survey conducted in 2014
demonstrate that: one in four current cigarette smokers use alternative tobacco products
and nicotine delivery systems, and almost one-third of current users of alternative tobacco
products are ex-smokers and never smokers5. To some extent, this growth in the
availability and use of products is driven by market forces: the tobacco industry and
financial markets are capitalizing on this period of tobacco product innovation and
transformation6,7.The potential impact of these products on public health is faced with
uncertainty, though a report by the 2014 Surgeon General suggests that additional
“endgame strategies” are needed to reduce the projected and sustained pattern of
tobacco-related morbidity and mortality1. This is especially important, given that other
tobacco products and nicotine delivery also have negative health consequences, despite
most tobacco-related morbidity and mortality being attributed to the use of cigarettes. It
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is plausible that the severity of negative consequences may vary across products; but,
overemphasizing this point may counter public health efforts to reduce harm.
Categories of Alternative Tobacco Products and Nicotine Delivery Systems
Alternative tobacco products include two types of products: smoked and smokeless.
Smoked products include cigars, cigarillos, and hookah/waterpipe, while smokeless
products refer to chewing tobacco, snuff (smokeless tobacco), chaw, and dip. Like these
alternative tobacco products, electronic nicotine delivery systems (ENDS) – such as
electronic cigarettes, or e-cigarettes – are highly available in the US market and are being
promoted as potentially less harmful alternatives to cigarettes. They are also being
marketed as products to be used as substitutes for cigarette smoking. However, these
products occur more often in combination with the use of cigarettes, rather than in
isolation. Multiple studies of tobacco use have reported concurrent use of tobacco
products among college students8 – a population that is prone to experimentation and is
actively developing patterns of tobacco use behaviors that could affect their risk for
tobacco-related morbidity and mortality. Studies demonstrate that concurrent users of
tobacco products and nicotine delivery systems experience higher intermediate levels of
mortality, tend to ingest more nicotine daily, and have more difficulty when trying to stop
the use of tobacco9,10.
Why Alternative Tobacco Products/ Nicotine Delivery Systems are Growing in
Popularity
Despite the harms involved with any tobacco use, alternative tobacco products and
electronic nicotine delivery systems are growing in popularity – especially among
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adolescents and young adults. The growing popularity of these products is attributed to
multiple factors, though the most common explanations are: the widespread availability,
lax regulation, targeted advertising, and perceptions that these products are safer, relative
to cigarettes.
Widespread availability of alternative tobacco products. As new tobacco products
are being developed, the availability of alternative tobacco products and nicotine delivery
systems will grow over time11. By January 2014, there were more than 460 brands and
7760 unique flavors of electronic nicotine delivery systems available for purchase
online12. Reviews of tobacco industry documents demonstrate that tobacco companies
are using flavoring to make tobacco products more palatable and attractive to new users
of tobacco products13. The widespread availability of alternative tobacco products may be
driven by the changing preferences that exist among current and former users of tobacco
products, who are either looking for a product to use instead of or in addition to
cigarettes14.
Targeted advertising. Tobacco product marketing has emphasized the point that
alternative tobacco products may facilitate reduction or cessation of cigarette use 15.
Meanwhile, some advertisements use messages that position alternative tobacco
products as a modern substitute to be used in places where smoking is banned or made
inconvenient by smoking bans15,16. Given the declining cigarette consumption, major US
tobacco companies have tried to maintain their profits through the marketing (and
development) of alternative tobacco products and nicotine delivery systems 17,18. Much of
the current research has focused on how tobacco companies have focused on the
increased use among youth, who are more price sensitive and interested in tobacco214

masking flavors relative to older adults14. Manufacturers of alternative tobacco products
and electronic nicotine delivery systems have utilized lax regulation over the marketing of
alternative tobacco products to their advantage in that they have aggressively marketed
products to youth through product flavoring, promotional materials, and the distribution of
free samples19.
Lax regulation. The FDA currently holds immediate authority over cigarettes, smokeless
tobacco products, and roll-your-own tobacco. As of October 2015, the Food and Drug
Administration lacks the authority to regulate novel tobacco products, such as electronic
vapor products marketed for non-therapeutic purposes 20, even though the FDA can
promulgate regulations extending regulatory authority over all other products meeting the
definition of tobacco product under the Family Smoking Prevention and Tobacco Control
Act (FSPTCA)21. The FSPTCA was originally enacted in 2009, and provided the FDA with
the power to regulate the manufacture, sale, marketing and distribution of tobacco
products. Under the FSPTCA, the FDA has the power to restrict marketing and sales of
tobacco products to youth, mandate reporting of ingredients and additives, ban cigarette
flavorings, and review manufacturers’ claims to lower-risk19. In 2016, the FDA finalized a
rule (also referred to as the “Deeming Rule”) extending the agency’s authority to regulate
electronic cigarettes and related vapor products as tobacco products. This rule, makes it
illegal for any e-cigarettes, e-liquids, and other tobacco products without FDA approval to
remain on the market and takes effect on August 8, 2018. What this means is that
manufacturers must submit a package of research required by the FDA prior to this date,
to be considered for approval to stay on the market 22.
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Perception that products are safer relative to cigarettes. Research has suggested
that marketing focused on potential-harm reduction aspects of alternative tobacco
products may cause tobacco users to reject or ignore health messages regarding the
potential dangers of these products23. There is also a common belief among users of
tobacco products that the government evaluates most tobacco products for safety. This
is problematic in that the belief that the government evaluates certain products for safety
(when many tobacco products are unregulated by the government) may contribute to
continued use24. It becomes even more problematic when we consider that polytobacco
users report the least perceived dangers of various tobacco products 25, despite
heightened risk for escalated use and addiction among individuals who use more than
one tobacco product concurrently. Polytobacco users may view alternative tobacco
products as less dangerous, perhaps because they see alternative tobacco products as
an effective means for cessation, or as an acceptable substitute when smoking is publicly
prohibited26.
Who Uses Alternative Tobacco Products and Nicotine Delivery Systems?
Some research has been done to identify which individuals are at higher risk of using
alternative tobacco products and nicotine delivery systems. Generally, individuals with
peers or family members supporting tobacco use, who hold favorable beliefs about
smoking, are younger in age and male are at higher risk of using alternative tobacco
products. Some recent studies suggest that the uptake of certain alternative tobacco
products may differ by race/ethnicity, but the evidence is mixed. Whereas some studies
have indicated that individuals who self-identify as White endorse using alternative
tobacco products relative to other race/ethnicities 27, others have demonstrated that the
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prevalence is higher among those who self-identify as Black 28. Furthermore, those who
are never smokers are at highest risk of using alternative tobacco products, relative to
former, non-daily smokers and non-smokers. The reason for this might be that young
adults who use alternative tobacco products might not (want to) perceive themselves to
be smokers28. Rather, initial users of alternative tobacco products and electronic nicotine
delivery systems may self-identify as non-users who are experimenting, or only users
within social settings. Data from focus groups conducted to assess themes related to ecigarette experimentation and discontinuation support this viewpoint by showing that the
top reasons for experimenting with or initiating the use of electronic nicotine delivery
systems were curiosity, appealing flavors, and peer influences 29. Since almost a third of
current users report that they are nonsmokers, the use of alternative tobacco products
and electronic nicotine delivery systems are contributing to nicotine addiction and
renormalizing tobacco use30,31. The extent to which alternative tobacco products and
electronic nicotine delivery systems are contributing to nicotine addiction and tobaccorelated morbidity and mortality is not yet clear, though there is evidence demonstrating
that concurrent use of tobacco products may sustain nicotine dependence and potentially
postpone cessation32. More studies need to be conducted to quantify the risks involved
with using alternative tobacco products and electronic nicotine delivery systems.
Future Directions of Research
The main challenge to public health regarding tobacco control is how to address the
growing use of alternative tobacco products and nicotine delivery systems and balance
public health messaging about the use of these products. It remains unclear whether
these alternative tobacco products and nicotine delivery systems will be replacing
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traditional tobacco products without expanding patterns of nicotine use among
adolescents and young adults – the main target of tobacco company advertising and
public health harm reduction and prevention efforts. As information is collected regarding
how much and how these products are being used, the availability and marketing of these
products will continue to grow and change with user preferences 5 – especially since
young adulthood is an ideal period during which tobacco use can be introduced and
solidified33.
One area of research that needs more attention is the relationship between the use of
alternative tobacco products and electronic nicotine delivery systems, and traditional
cigarette use. Alternative tobacco products might serve as gateway products for
adolescents, leading to the use of other tobacco products – including cigarettes. A study
conducted by Soneji et al. (2015), demonstrates this by providing data from a national
survey of young adults aged 15-23 years, showing that baseline water pipe tobacco and
snus use were associated with increased interim cigarette initiation, current cigarette
smoking, and high-intensity cigarette use after a 2-year follow-up period 34. Added to this,
half of adolescent tobacco users within the US are dual or poly-tobacco users 35. Yet, their
tobacco use trajectories remain poorly characterized. We know from other studies, that
several young adults have used multiple tobacco products in their lifetime, and are current
dual and poly-tobacco users36. More work needs to be done to better understand the
increasing complexity of tobacco use among adolescents and young adults to promote
effective public health planning and to ensure that the regulation of alternative tobacco
products (or potential lack thereof) does not undermine current anti-tobacco regulatory
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efforts19 which have predominantly been focused on consumption changes, successful
quitting, as well as attitude and belief changes among current users37.
To reduce and/or prevent the use of alternative tobacco products, more data needs to be
collected on the use of all tobacco products as they are being developed, rather than just
focusing on cigarettes38. It also seems to be the case that a two-pronged approach needs
to be taken in the research field: one focused on how to alter existing social norms
regarding tobacco use that may be undermining current tobacco control efforts, and one
focused on the reduction of harm of products that are currently and/or will be made
available in the future. Much of this research will be driven by changes in consumer-driven
preferences already being studied by tobacco companies, who pay close attention to how
products are being used and adapted39.
Thus, in addition to determining the prevalence of use of different tobacco products, better
characterization of tobacco products in terms of composition and toxicity should be
undertaken to inform regulators to develop guidelines for safety and focus should be
placed on minimizing risks associated with tobacco products and nicotine delivery
systems12. It is also important to determine what the overall morbidity and mortality
contributions of different tobacco products are, relative to cigarettes and in combination
with cigarette use – given that concurrent tobacco use of multiple products is increasingly
common, especially among adolescents and young adults who are the moving targets of
both the tobacco industry and public health messaging.
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CHAPTER 12:
PLANS FOR A PILOT RANDOMIZED CONTROL TRIAL OF AN INTERNET-BASED
EDUCATIONAL INTERVENTION FOR THE REDUCTION OF TOBACCO USE (AND
NICOTINE DEPENDENCE)
Elizabeth K. Do, Juan Lu, and Hermine H. Maes
INTRODUCTION
Tobacco use results in $130 billion annually in direct adult medical care costs. It is
projected that 5.6 million of Americans under the age of 18 years will die prematurely from
tobacco-related illnesses. Thus, developing methods to reduce tobacco use among
individuals is necessary1. However, before this is possible, a better understanding of the
etiology of tobacco use and nicotine dependence is required and examining risk factors
for tobacco use behaviors may be useful for the identification of potential areas of
intervention and prevention.
Tobacco use behaviors involve the interplay of genetic and environmental factors. Adding
to this complexity, the influence of genes and the environment seems to change over the
life course. Twin studies of adult samples show that genetic and shared environmental
influences contribute significantly to the liability of tobacco initiation, regular use, and
nicotine dependence2–4, with significant overlap in the genetic and/or environmental risk
factors at each stage5. Adolescent studies suggest that the impact of the shared
environment is more pronounced during mid-adolescence when many initiate use, but the
influence of genes - though present to some degree early on - comes to play a larger role
by late adolescence, when the etiological structure of tobacco use resembles that of
adults5–7, such that initiation is explained by genetic, shared, and unique environmental
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factors in early adolescence and genetic and unique environmental factors in young
adulthood8.
Despite the growing evidence that genetic factors play an important role in tobacco use,
genome wide association studies (GWAS) have only identified a few genes associated
with smoking quantity and nicotine dependence so far. Identification and exploration of
genetic loci influencing smoking behavior have primarily been conducted in adults and in
populations of European ancestry9. The most robust finding to emerge from GWAS
studies of smoking behavior is the association between genetic variant rs16969968,
located within the α5-α3-β4 nicotinic receptor gene cluster on chromosome 15, and
smoking quantity10–13. A study of African Americans confirmed this region as an important
susceptibility locus for smoking quantity in men and women. There is also a reported
association between rs1051730 and nicotine dependence (and two tobacco-related
diseases, lung cancer and peripheral arterial disease)13. Yet, larger studies are needed
to validate other suggestive loci not reaching genome-wide significance 9.
Consortia-based GWAS meta-analyses of individuals of European ancestry with sample
sizes approaching 10,000 individuals have identified several novel genomic regions
associated with a range of smoking phenotypes. A nonsynonymous SNP (rs6265) located
on the brain-derived neurotrophic factor (BDNF) gene on chromosome 11 has been
associated with smoking initiation, while a gene variant on chromosome 9 near the
dopamine beta hydroxylase (DBH) gene was associated with smoking cessation 12,14. Two
nicotinic receptor sub-unit genes (CHRNB3/CHRNA6) on chromosome 8 and CYP2A6
on chromosome 19 have also been associated with smoking quantity12. However, the
proportion of phenotypic variance explained by rs16969968-rs1051730 SNPs is less than
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1%15. A recent genome-wide meta-analysis of an objective marker of smoking has
observed an association between multiple variants within the 15q24 region, in strong
linkage disequilibrium with rs16969968, associated with cotinine level16 and explaining a
larger proportion of the phenotypic variance.
Despite studies demonstrating that genes contribute to tobacco use behaviors, current
prevention and intervention approaches do not take the contribution of genetic factors to
tobacco use into account. Instead, focus is placed on mean behavior change, either
through advice and behavioral counseling at the individual level 17 or through populationlevel tobacco control measures such as tobacco advertising bans seeking to reduce
smoking initiation and prevalence among minors and young adults or smoke-free policies
aimed to reduce secondhand smoke exposure to nonsmokers and create an environment
that aids smokers to quit18. Using datasets incorporating measured aspects of the
environment into genetically informed studies allows for a greater understanding how
specific environments are related to tobacco use outcomes, interact with genetic liability,
and are helpful in identifying potential points of intervention. For example, studies have
identified parental environment, parental monitoring19,20, maternal smoking during
pregnancy21, peer smoking22, average neighborhood social cohesion23, traumatic
events23, self-rated religiousness24, and marketing and vending machine restrictions 22 as
moderators of genetic and/or environmental factors influencing smoking behaviors, as
summarized in two recently published systematic reviews25,26.
Other studies suggest that notification of susceptibility for tobacco-related illness may
influence individual-level tobacco use. Interestingly, awareness of the health hazards
associated with cigarette consumption appears not to be sufficient in the initiation of
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smoking cessation27. This could be due to tobacco users’ underestimation of personal
risk of tobacco-related illness28. Research suggests that improvements in cessation rates
may be achieved by providing personal feedback on susceptibility for tobacco-related
illness29. Short-term benefits of this approach include: positive change in perceptions of
risk and beliefs about quitting29–31 and increased attempts to quit/enhanced cessation
rates at six months32. However, empirical data have not provided sufficient evidence that
knowledge of genetic variants conferring susceptibility to tobacco-related illness yields
long-term benefit in terms of quit rate33. Additionally, there are concerns that genotypic
notification could demotivate high-risk individuals to change their behavior, due to feelings
of fatalism or reduced sense of personal control over chances of getting smoking-related
diseases, while individuals receiving low-risk results may be falsely reassured and
become complacent34. Further research is needed to delineate the direction of effect of
genetic notification of susceptibility for smoking-related outcomes.
The current study tries to build on this existing research by providing information on the
planning of a feasibility study involving an Internet-based educational intervention
examining how providing college students with information on the influence of genes and
the environment on tobacco use behaviors and nicotine dependence impacts subsequent
patterns of tobacco use behavior. To date, few interventions are specifically aimed at
young adult smokers, even though tobacco use is common among college students.
College is a critical time in the development of tobacco use behaviors 35, especially since
young adults are at risk for experimenting with tobacco use and establishing tobacco use
patterns. Furthermore, their current use may be predictive of tobacco use in years to
come. As such, tobacco use prevention, reduction, and nicotine dependence treatment
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efforts aimed at college students could have the potential to yield considerable benefits
in reducing the overall health burden of nicotine dependence 36.
This study will apply the principles of the Health Belief Model (HBM), which assumes that
health behavior is determined by perceptions of perceived threat, perceived susceptibility
and severity, perceived benefits, and perceived barriers and the strategies available to
decrease its occurrence37. By applying the HBM concept and constructs to our
intervention, which seeks to reduce tobacco use (and risk for nicotine dependence) in
young adult tobacco users, we seek to increase their perceived threat, susceptibility, and
severity of nicotine dependence while decreasing their perceived barriers to reducing
tobacco use among college student participants by providing knowledge of genetic and
environmental risks for nicotine dependence and means to decrease barriers to reducing
tobacco use. We hypothesize that personalizing the information presented (e.g. using the
pronoun “you” in explanations of risk) will improve outcomes, relative to individuals in the
control group and those receiving generalized risk information about tobacco use
behaviors and risks for nicotine dependence. We also predict that this reduction of
tobacco use will be the same or higher for those who also receive information on their
genetic risk for developing nicotine dependence.
METHODS
Design. Participants will be recruited into a four-arm randomized control trial pilot study,
from an ongoing study that investigates the role of genes and the environment on
emotional health and substance use within a university setting. The four-arms of the study
include a control, generalized risk information, personalized risk information, and
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personalized risk information with added genetic component group. Baseline
characteristics and outcomes of interest will be compared across each of the four arms
of the study groups. Recruitment, study consent and enrollment, and data collection will
all be conducted online, with no face-to-face contact. The registry of the parent study will
initially contact eligible participants to determine interest in the study, and report back to
this research study team. The research team will then ask those who indicated their
interest in participation in the study to fill out an electronic consent form and continue with
baseline assessment. The baseline assessment will be found as a survey link that
participants can click on. However, before providing consent, participants will need to
read study information that outlines procedures, inclusion criteria, and will be encouraged
to contact the research team regarding any questions/comments they have regarding the
study protocol. After providing electronic consent, participants will complete the baseline
assessment and then be randomized to receive one of the study conditions. Participants
who indicate that they are not comfortable with receiving any genetic risk information will
not be allocated to the personalized risk with genetic component group. A few weeks after
the completion of the baseline assessment, participants will be automatically followed-up
through e-mail and asked to complete the internet-based educational intervention, which
includes: online self-assessment questionnaires and viewing a set of three-minute videos.
Participants who do not complete the internet-based educational intervention within a
couple of weeks will be re-contacted via reminder e-mail. Thirty days following the
completion of the internet-based educational intervention, participants are re-contacted
to complete an online self-assessment follow-up questionnaire. Again, participants who
do not complete the online follow-up were re-contacted via e-mail. Figure 12.1 depicts
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study design and recruitment strategy. The university Institutional Review Board
approved the study.
Figure 12.1: Study Protocol

Participants and Eligibility Criteria. We aim to recruit 140 participants (35 participants per
arm). This estimate is based upon the available budget and expected recruitment rates,
from previously conducted spin-off studies. To be eligible for the study, participants had
to be: at least 18 years of age, previously enrolled in the parent study, Spit for Science,
provided a DNA sample, and indicated that they had used any tobacco product (e.g.
cigarettes, cigars/cigarillos, hookah/waterpipe, smokeless tobacco, and/or electronic
cigarettes or other nicotine delivery systems) in the past 30 days on their most recent Spit
for Science follow-up survey. Eligible participants must confirm that they either currently
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use or intend to use tobacco products in the next six months (i.e. the duration of the study)
during the consent process.
Compensation. Participants will be compensated for participating in the study, which
requires: one baseline assessment, an internet-based educational intervention (which
includes a set of three-minute videos and surveys), and one follow-up assessment.
Participants will be compensated $10 for each of these assessments and will be eligible
to receive an additional $10 for the completion of all assessments.
Recruitment Duration. Recruitment will end once we reach our desired sample size of
140 participants, which is estimated to take about two months. Recruitment will be
extended by one month, if the sample size is not reached. If, after three months, the
desired sample size is not reached, study procedures will continue with whatever sample
size is obtained and the analysis procedure will be adapted accordingly.
Consent Process. Participants will be asked to answer questions to determine eligibility
for this study and were told that by participating, they will be randomly assigned to one of
four educational intervention groups: control group, generalized risk information,
personalized risk information, and personalized risk information with genetic component.
Participants will not be told what their assignment is, but will be given the opportunity to
obtain information from the alternative condition(s) to which they were assigned, after the
termination of the study. All participants will be told that they will be asked to watch a set
of 2-3 minute videos and complete online survey questions regarding their own tobacco
use behavior and life experiences. Participants will also be notified that by consenting to
participate in this study, they will be granting researchers access to data from Spit for
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Science38 surveys and the DNA sample that they provided previously. However, all
responses will be stripped of identifiers, coded, and linked with survey data and the DNA
sample provided for Spit for Science using only coded numbers. Research analyses will
be done without names attached to the data. Participants will not receive any direct benefit
from completing the study, other than compensation for their participation, and the study
involves no more than minimal risks. Finally, participants will be reminded that as
voluntary participants, they have the option to withdraw from the study at any time.
Data Capture and Management. Participant data will be collected and maintained in
REDCap39, the online survey tool that will send survey invitations and receive the survey
data. All private identifiable information and data collected will be secured in a REDCap
database that is accessible only to the research coordinator and staff. After the study is
complete, REDCap data will be de-identified by the research coordinator and extracted
for analysis. Only de-identified data will be shared with investigators.
Outcome Measures of Interest. This study aims to explore the feasibility and efficacy of
the proposed intervention. Feasibility outcomes included: recruitment and retention rates,
acceptability of the intervention, and follow-up and adherence/compliance rates. Although
many measures will be collected as a part of this project, primary efficacy outcomes
included: tobacco use behaviors of participants (e.g. current use, frequency of use, and
FTND following the intervention). Secondary outcome measures include measures that
may influence the primary efficacy outcomes, such as: self-efficacy to quit using tobacco,
perceived benefits to reducing tobacco use, perceived susceptibility to tobacco use, and
perceived barriers to tobacco use. An overview of the collected measures is shown below,
in Figure 12.2.
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Figure 12.2: Overview of Survey Measures

Baseline Assessment. Eligible participants will be asked to fill out a questionnaire
immediately after consent is provided via a survey linked to REDCap that includes
measures of: demographic characteristics (i.e. race/ethnicity, sex, year in college, health
insurance status), family history of tobacco use, current tobacco use (i.e. tobacco
products used, quantity, frequency, and quit attempts), FTND, self-efficacy to quit using
tobacco, perceived benefits to reducing tobacco use, perceived susceptibility to tobacco
use, perceived barriers to tobacco use, perceived severity of risks due to tobacco use,
motivations to obtain genetic testing, and knowledge of nicotine dependence risk factors.
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Randomization. Randomization will be conducted using the Randomization Module in
REDCap using a 1:1:1:1 ratio, in blocks of 4 following the collection of consents and
baseline assessments.
Intervention Descriptions. Two weeks following randomization, participants will be
contacted via e-mail to let them know that the internet-based educational intervention is
ready to be completed. Again, the participants will not know to which intervention arm
they are assigned. All groups will receive a set of surveys to complete, along with a set
of four 2-3 minute videos. All groups, but the control group, will watch educational video
modules describing risk factors for nicotine dependence. The control group will be shown
a set of videos not related to risk factors for nicotine dependence.
The main difference between the generalized risk group and the personalized risk groups
(one with genetic component and the other without) will be the way the information is
presented. For the personalized risk groups, information will be framed using the word
“you” (e.g. You are at slight/mild/moderate/severe increased risk for nicotine dependence)
and for the generalized risk group, information will be framed in terms of “an individual”
(e.g. “Individuals who ____ are at slight/mild/moderate/severe increased risk of nicotine
dependence”). In addition to receiving personalized feedback on risks for nicotine
dependence, participants receiving the personalized risk with genetic component
condition will also receive information regarding genetic variant(s) associated with
nicotine dependence. Participants will be advised that having this genetic variant does
not guarantee that they will develop nicotine dependence, but rather, having certain
genetic variants increases their likelihood of developing nicotine dependence and this
information should be regarded as preliminary research that is ongoing in the field of
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behavior genetics. Participants will have one week to complete the educational
intervention and brief questionnaires that go along with the educational intervention. Both
groups will also be given the contact information of a genetic counselor, in case they have
questions regarding the interpretation of genetic and environmental risks related to
nicotine dependence.
Video Modules and Questionnaires. Video modules will cover the following topics: (1)
genetics and nicotine dependence, which explains how genetic factors contribute to
tobacco use behavior, (2) family history and parental environment in adolescence, which
explains how individual tobacco use is shaped by family history and environment, (3) early
experiences with tobacco use, which explains how early experiences shape tobacco use
patterns, and (4) environmental stressors, which provides information on the influence
that stress may have on tobacco use. The short questionnaires following each module
will be used to gauge comprehension and knowledge of genetic and environmental risk
information provided in the online video modules. They will also be used to determine if
a participant completed the educational modules and will be like quizzes commonly used
in college-level courses. Participants will also be asked to answer a few questions on:
how they define their tobacco use, potential exposure to nicotine in-utero, family tobacco
use, symptoms they had when they first started using tobacco, parental monitoring, and
stressful life events. Questionnaires will also contain measures on self-efficacy to quit
using tobacco, perceived benefits to reducing tobacco use, perceived susceptibility to
tobacco use, perceived barriers to tobacco use, perceived severity of risks due to tobacco
use, and motivations to obtain genetic testing for comparison to baseline. It is estimated
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that this one-time intervention will take 35-45 minutes (including educational videos and
questionnaires).
30-Day Follow-Up Assessment. Approximately 30 days following the completion of the
educational intervention, participants will be invited to take a 30-minute follow-up survey
via email with a link to the questionnaire which includes questions on: knowledge of
nicotine dependence risk factors, current tobacco use, self-efficacy to quit using tobacco,
perceived benefits to reducing tobacco use, perceived susceptibility to tobacco use,
perceived barriers to tobacco use, perceived severity of risks due to tobacco use, and
motivations to obtain genetic testing. This will serve as the second point of assessment,
since the questions will be the same as those asked at baseline, and immediately
following the educational intervention. Participants will also be asked to answer several
questions regarding their perceptions of the proposed intervention and its acceptability,
to serve as process evaluation measures. The follow-up survey will be available for two
weeks.
6-Month Follow-Up Assessment. As a third point of assessment, information will be
gathered from the Spit for Science Spring follow-up survey regarding current tobacco use
and the Fagerström Test for Nicotine Dependence.
Data Analysis. Analyses regarding acceptability and feasibility outcomes will be mainly
descriptive. Recruitment rate (i.e. ratio of individuals who complete the eligibility screener
to those that are randomized) and retention rate (i.e. ratio of number of retained
participants to number of participants enrolled in the study) will be reported. To assess
whether outcomes are affected by attrition bias, we will examine the baseline
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characteristics (obtained from parent survey registry data; e.g. sex, race/ethnicity, year in
school, average frequency/quantity of tobacco use) of participants who were lost to followup and those remaining and compare rates of loss to follow-up between the arms of the
intervention. Baseline characteristics of participants’ tobacco use will be reported as
means/standard deviations for continuous variables and frequencies/percentages for
categorical variables. Chi-square tests, Mann-Whitney tests, or t-tests will be used to
examine baseline differences between intervention arms in terms of demographic
characteristics, tobacco use measures, and other assessment measures between the
different intervention conditions. Regression models will be used to determine if there are
differences between the outcomes of the intervention arms. Potential covariates included
in these analyses include: sex, race/ethnicity, and type/ number of tobacco products used.
The data will be analyzed on an intention-to-treat (ITT) basis, as if participants who do
not complete the trial had not reduced tobacco use. Under ITT, data for all subjects
randomized to a treatment is analyzed according to the treatment to which subjects were
allocated, regardless of whether they received the treatment or not. Its purpose is to
preserve the theoretical basis for the validity of statistical results, particularly by
eliminating subjects with prognostic factors, which could systematically influence a
participant’s selection to a given treatment40. This approach was selected because a
previous study demonstrates that ITT gives unbiased estimates of treatment effects (e.g.
effectiveness)41, while also preserving the sample size. However, the estimate of
treatment effects is generally more conservative, relative to alternative approaches such
as-treated (or per-protocol) analysis42.
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As-treated analysis involves analyzing study data from only subjects who complete the
study and adhere to protocol requirements. The main advantage of this approach is that
only participants with complete data are examined, and the resulting information can be
used to determine what the effect of treatment is, when taken in an optimal manner (e.g.
efficacy). However, as-treated analysis could lead to a significant reduction in sample
size, especially if many participants do not follow protocol, and is prone to potential bias,
since participants might deviate from the protocol for non-random reasons, such as
experiencing unpleasant side effects from treatment, or failure to see improvement in
health43.
The main outcome measure calculated would be the reduction in tobacco use incidence
ratio, using two-tailed Fisher’s exact tests to compare the proportion of participants who
reduced tobacco use between the intervention groups. Two-tailed paired t-tests will also
be used to compare the change in the average use of tobacco overall (and if applicable,
across each tobacco product). Tobacco reduction incidences will be computed at 30-day
and 6-month follow-up. All analyses will be conducted using SAS 9.4.
DISCUSSION
Potential Limitations. Participant recruitment is essential to the success of this project.
However, we are confident that we will be able to recruit the desired number of
participants since procedures to recruit these participants have already been established
and utilized successfully in the past. For example, of those invited to the most recent spinoff study, 56.5% expressed interest and 40.4% were enrolled. Thus, a potential strategy
to overcome this obstacle of participant recruitment is to contact many participants during
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the recruitment period. There might also be concerns over whether there will be adequate
power to conduct the planned analyses. Fortunately, the sample size of the brief
intervention proposed is within the range of sample sizes found in related studies (range:
61-697)35. However, since the suggested sample size for this study is towards the lower
end of the range, results from this study should be regarded as preliminary and replication
is needed for any effects that we identify. Related to sample size, are the concerns
regarding participant drop-out. Short-term follow-up duration does protect the study
against possible participant dropout; however, it may also mask the possibility of longerterm effects. To get around this issue, it would be possible to look at long-term effects
from responses provided in follow-up surveys conducted by the parent study, collected
every spring semester. One last potential limitation can be found in our reliance on selfreported data. Some individuals may feel uncomfortable sharing information about their
substance use and/or answering questions about their previous tobacco use. However,
since this study is being conducted over the Internet and there is minimal to no personal
contact, there is unlikely to be any differential biases by intervention group 44.
Study Strengths and Potential Contributions. The contributions of this proposed project
are potentially significant due to its focus on young adulthood, a critical period of change
in the lifespan and the period when the use and abuse of substances peaks. Furthermore,
this proposed project will be one of only a few tobacco reduction interventions aimed at
non-treatment-seeking college students, a population with the highest prevalence of
substance use and the greatest likelihood to quit following intervention. This is an
especially important task to undertake, given that few studies examine how presenting
genetic and environmental risk information to tobacco users will influence patterns of
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tobacco use through increased knowledge of risk factors for nicotine dependence, as well
as motivations and barriers to the reduction of tobacco use. Given that tobacco use
among young adults is both common and associated with several adverse consequences
(i.e. tobacco-related illness and addiction, cancer, and death), the potential impact of
intervention on the overall disease burden of this group is large. This emphasizes the
need to understand factors contributing to substance use in young adulthood, to which
this study contributes by including longitudinal, repeated measures of tobacco use
prevalence and behavior across multiple tobacco products. Furthermore, Spit for Science
is one of just a few samples asking survey questions about more recent forms of tobacco
use, such as electronic cigarettes and hookah use. Finally, studying college students
allows for a unique opportunity to intervene, since all major life activities are concentrated
in a single setting.
Future Implications
The present study will provide information on whether providing college students
information about the risk factors for tobacco use behaviors and nicotine dependence
impacts tobacco use behaviors, such as frequency and quantity of use, current use, and
symptoms of nicotine dependence as measured by the Fagerström Test for Nicotine
Dependence, through self-efficacy, perceived benefits to quitting, perceived susceptibility
to risks, and perceived barriers to reducing tobacco use. Even if we find the effects of the
intervention to be small, the information gained from the survey measures collected can
be used to characterize motivations for tobacco use within young adults.

Process

evaluation measures, such as program acceptability, can be used to inform follow-up
studies and future interventions.
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CHAPTER 13:
GLOBAL DISCUSSION - THEMES, RESEARCH FINDINGS, AND FUTURE DIRECTIONS

This dissertation thesis presents a comprehensive set of studies investigating genetic and
environmental risk for tobacco use behaviors and nicotine dependence, using samples of
adolescents and young adults, covering a broad range of methodologies. Altogether, this
set of studies contributes to the existing literature by providing information on how genes,
the environment, and their potential interactions may influence tobacco use behaviors.
THEMES
In conducting these studies, several overall themes emerge regarding the complexity of
tobacco use behavior phenotypes specifically, and how we investigate risk factors for
complex traits, such as tobacco use, more broadly. The themes resulting from this
research, which integrates literature reviews, twin/family studies, population-based
studies, epidemiology, and genomic analyses include:
1. Behaviors are complex, and we need to develop better strategies for the
harmonization and standardization of phenotypes.
2. Although twin methods have been found to obtain higher heritability estimates than
genomic approaches for complex traits, such as tobacco use behaviors, they are
still very useful in determining genetic and environmental architecture, and
identifying

potential

covariation

and

environmental influences.
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3. Polygenic risk scores might account for more variance in traits than single genetic
variants do individually, but the clinical utility of these genomic approaches are still
to be determined.
4. Public health planning needs to consider, and where possible, incorporate,
knowledge regarding social and genetic influences on complex behaviors, such as
tobacco use.
RESEARCH FINDINGS
The themes listed above were derived from examining each of the chapters presented in
this thesis. Under each thematic heading are more specific details about how research
findings from singular studies in this dissertation are related to the listed themes.
Developing better strategies for harmonization and standardization of phenotypes
Phenotype heterogeneity across studies represents a continuing obstacle that limits
successful identification of (replicable) associations 1. The narrative and systematic
literature reviews conducted in chapters 2 and 3 of this dissertation which assess the
existing literature on contributions of genes, the environment, and their interactions on
tobacco use phenotypes, support this claim. By reviewing the choice of measurement for
environmental variables, how main and interaction effects are tested and reported across
existing studies, how covariates are treated in analyses, and how gene-by-environment
correlations are reported, chapter 3 demonstrates that differences in the approach taken
by studies seeking to answer similar research questions make it difficult to interpret and
summarize findings.
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Harmonization and standardization of phenotypes is especially important in the realm of
genome wide association studies, like those described in chapters 9 and 10. As explained
elsewhere, phenotype harmonization requires identifying common phenotypes,
determining the feasibility of cross-study analysis for each, and preparing common
definitions1. These concerns are not limited to epidemiological studies, but extend to
genetic studies as well. Although considerable time and effort has gone into reducing
genotype measurement error and ensuring accuracy and consistency of results 2,
phenotype heterogeneity still represents a huge challenge to successful GWAS analyses
of complex traits and replication studies. Despite continual efforts, some differences are
inevitable3 due to differences in study design, what data is collected, and how data was
collected. The implications of developing better strategies for harmonization and
standardization of phenotypes are many; increasing sample size (and consequently,
greater power to detect effects), allows for the optimization of power for discovering new
associations3.
Utility of twin analyses in determining the genetic architecture of traits
Twin studies use correlations between pairs of relatives to parses the individual
differences in a trait to latent (unmeasured) genetic and environmental influences,
allowing for the estimation of heritability or the percentage of variance due to genetic
influences. In the context of tobacco use behaviors, twin studies have been useful in
determining the heritability of a range of phenotypes, including those examined in
chapters 4 and 5: namely, smoking initiation and current quantity smoked. Results from
the study conducted in chapter 4 demonstrate that various factors contribute to smoking
initiation and current quantity smoked across mid-adolescence into early adulthood, such
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that smoking initiation and current quantity smoked have independent liabilities until
adulthood when liabilities are shared. This change might be attributed to access and
availability to cigarettes, such that as access and availability of cigarettes increase, the
expression of genetic predispositions towards increased smoking frequency and potential
addiction may also increase, after initiation.
Results from chapter 5 provide evidence for shared genetic and environmental liability for
the association between stressful life events and smoking initiation and that this structure
differs in early adolescence and young adulthood, but not by sex. This suggests that the
same genes and environments are influencing both stressful life events and smoking
initiation in males and females, such that the underlying factors influencing stressful life
events and smoking initiation are influenced by partly shared environmental factors in
young adolescents and by partly shared genetic risk factors in young adulthood. This
might suggest that once an individual is exposed to the effects of stressful life events,
genetic factors come into play, and that only individuals with a certain set of genes will
choose to initiate tobacco use.
The utility of studies is found in the fact that twin models allow for the testing of various
hypotheses regarding the genetic architecture of traits, while also considering the
potential influence of the environment. Twin studies such as the one conducted in chapter
5, demonstrate that both genetic and environmental factors can have different effects on
tobacco-related phenotypes, such as smoking initiation, across time. For example, there
exists little evidence currently of common genetic effects that influence both initiation and
persistence, implying that there are genetic processes contributing to experimentation
and the initiation of tobacco use that are distinct from those influencing the development
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and maintenance of tobacco use patterns. Although these studies do not provide
information about what specific genes or environments are involved with these processes,
they are useful in generating hypotheses for future studies.
Clinical utility of (aggregated) measures of genetic risk
The genetic analyses presented in chapters 9 and 10 demonstrate that genetic factors
are involved with the liability of tobacco use behaviors among university students, at both
the level of individual variants and at the aggregate level. Estimates of SNP-based
heritability using genome wide complex trait analyses (GCTA)4 indicate that tobacco use
behaviors are moderately heritable, and lower than those estimated from twin studies.
Yet, estimates of heritability were non-zero and significant amongst those of European
ancestry, suggesting that sample sizes for other ancestry groups found in Spit for Science
were too small to detect significant heritability. At the level of individual variants, no
findings from larger meta-analyses could be replicated. It was suggested in chapter 9,
and described previously, that the failure to replicate might be attributed to variability of
phenotype, inadequate sample size, false positive results, and population specific effects.
Given that novel loci were identified in the Spit for Science sample, and no loci was
replicated from the TAG Consortium data, we would deduce that either: the genetic
architecture of tobacco use behaviors within these two studies are different, or that the
current study is underpowered, making it less likely to find significant hits while also
making it more likely that the significant hits found are false positives. In either case, these
findings contribute to the existing literature by demonstrating the polygenic nature of the
phenotypes investigated.
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Chapter 10 expands upon the aims of chapter 9 in efforts to find evidence for common
genetic risk variation through the aggregation of genetic effects that do not individually
achieve significance in large-scale GWAS. In conducting the analyses for chapter 10,
polygenic risk scores were constructed and then put into predictive models of tobacco
use behavior. Regression analyses indicated that polygenic risk scores were predictive
of some tobacco use behavior phenotypes. The analyses from this chapter also indicate
that environmental variables, as well as interactions between polygenic risk and
environmental variables (e.g. parental autonomy granting, parental involvement, physical
abuse prior to university enrollment) also contribute to the variability in tobacco use
behavior phenotypes.
Although polygenic risk scores can be useful for examining the cumulative predictive
ability of genetic variation of a trait, there is limited clinical utility for these scores beyond
risk prediction due to concerns regarding predictive accuracy, as well as the cost and
ability of clinicians and patients to effectively use this information 5. In addition to varied
predictive power based upon methodological approach, we do not yet have enough
information regarding specific variants contributing to tobacco use behaviors for clinical
risk prediction. Expanding the number of replicated variants associated with tobacco use
behaviors, such as nicotine dependence, would improve risk prediction models. However,
a prediction tool based upon genetic information alone would probably not be sufficient
for clinical use, especially since environmental factors have been found to account for a
considerable portion of variability in tobacco use behaviors. Additionally, many of the
previous studies have only been conducted within those of European ancestry and still
need to be tested within other ancestry groups – especially since the genetic architecture
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of tobacco-related phenotypes may differ across populations (and ages). Thus, more
research needs to be done to identify genetic factors associated with subclinical
phenotypes, especially among non-European ancestry groups 6.
Public health planning and future directions
As explained in chapter 6, despite public health successes in reducing the consumption
of cigarettes, the increasing popularity of alternative tobacco products and nicotine
delivery systems poses new challenges for researchers and policymakers alike. This is
especially true, given that these products contribute to negative outcomes similar to
cigarette use and may make it more difficult to quit if used concurrently with cigarettes.
As described in chapter 11, national survey data collected in 2014 demonstrate that one
in four current cigarette smokers use other tobacco products and nicotine delivery
systems7. Thus, one of the main challenges for public health research and planning is
how to address the growing availability and use of alternative tobacco products and
nicotine delivery systems. To reduce and/or prevent the use of these products, more data
needs to be collected on the use of all tobacco products as they are being developed,
rather than solely focusing on cigarette use8. Furthermore, a two-pronged approach may
be necessary: one focused on how to alter existing social norms and perceptions
regarding alternative tobacco products and nicotine delivery systems and one focused on
the reduction of harm caused by products currently and/or will be brought to market. One
such direction to take is to educate young adults – a population with the highest
prevalence of substance use and the greatest likelihood to quit following intervention –
on genetic and environmental risk factors contributing to certain tobacco use behaviors
and nicotine dependence, as outlined in chapter 12.
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Another approach would be to consider what we know about the correlates and predictors
of tobacco use behaviors, including nicotine dependence, and identify potential areas of
prevention and intervention. For example, from chapter 7, we know that initial reactions
to tobacco differ by tobacco type, and by sex and that age of onset, sex, and positive
initial experiences predict both recent use and meeting criteria for nicotine dependence.
Thus, it would be beneficial to conduct further research to identify genetic and biological
pathways influencing initial experiences with nicotine and the social contexts that
influence initial experiences with tobacco use in efforts to delay the overall age of onset
for tobacco use and reduce individual risk for nicotine dependence. The information
gained from such studies can be used to characterize motivating factors for (alternative)
tobacco product use and use reduction within young adults and inform the planning and
implementation of future studies.
LIMITATIONS OF THE CURRENT SET OF STUDIES
Like all other studies, this dissertation is not free from limitations. To some extent, these
limitations are attributed to study design, which are described in greater detail below.
Concerns regarding power to detect effects of genetic factors influencing tobacco
Power to detect effects is influenced by the size of the effect and the size of the sample
used to detect it. In the case where prevalence is low, like in chapter 4 where the
prevalence of smoking behavior among early adolescents is low, the power to detect
effects is also low. The issue of power is also of importance in the genomic studies
conducted in chapters 9 and 10. Previous studies investigating the genetic architecture
of tobacco use behaviors that have reported significant SNP associations with tobacco
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use phenotypes report much larger sample sizes than those found in the current study.
This is a concern since low-powered studies tend to produce more false negatives relative
to higher-powered studies and have reduced probabilities of observing effects that pass
the required threshold of significance. And, when true effects are found within low
powered studies, it is likely that the estimate of the magnitude of the effect is exaggerated.
However, after conducting power analyses, it was determined that we did have sufficient
power (e.g. >80%) to detect aggregate effects of all SNPs, using GCTA – but only for
sample sizes of >1500 individuals.
Interpretation of heritability
GCTA yielded significant, non-zero estimates for SNP-based heritability (at p-value
≤0.05), but only amongst those of European ancestry for ever tobacco use and age of
initiation. However, once we corrected for multiple testing, these effects were no longer
significant. This suggests that the total variance explained by all SNPs is zero; however,
this does not necessarily mean that genes are unimportant for the specific traits studied.
Rather, it might suggest that the genetic markers used in these studies might not be able
to explain the existing phenotypic differences in the population that we are examining or
that factors, other than the genetic variants being investigated contribute more to the
variation in phenotypic differences.
Inability to infer causality
Due to cross-sectional nature, none of the current studies can infer causality. To get
around this issue, the exposure time for the experience of stressful life events, parental
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autonomy granting, and parental involvement were limited to prior to university enrollment
(chapter 6).
Self-reported data and the potential for recall bias
Across each of the studies, participants were asked to answer questions about their
experiences in the past. For example, students were asked to retrospectively report their
parental environment and stressful life events prior to university enrollment (chapter 6).
Since recall of information is solely dependent on memory, self-reports may be imperfect
and potentially unreliable. It is possible that using self-reported data underestimates the
prevalence of smoking behaviors across each of the studies included in this dissertation,
because of social desirability bias, which has downstream effects on genetic analyses.
Variability in phenotype definitions. Since measurement protocols differ across
studies, it is inevitable that there will be variability in phenotype definitions. In efforts to
address this problem, we attempted harmonize phenotypes in related analyses, and
make measures as comparable as possible.
Generalizability of findings. Many of the studies included in this dissertation have
focused on samples of White/Caucasian Americans and Black/African Americans due to
concerns regarding sample size and power to detect effects in other race/ethnicity and
ancestral groups. Thus, more research needs to be done to assess whether the findings
of these studies are generalizable to other groups of young adults who do not fall within
these race/ethnicities or ancestral groups. These concerns are also shared across
genetic studies, since disparate patterns of linkage disequilibrium and differences in
marker allele frequencies between discovery and target samples could attenuate genetic
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effects. This is a critical point, since our genomic analyses are conducted on an ethnicallydiverse population that is very different from a majority of genomic studies conducted on
individuals of European descent.
CLOSING REMARKS
Despite these limitations, the findings from this dissertation contribute to the literature by
providing a better comprehensive understanding of how genes, the environment, and
their potential interactions influence many tobacco use behavior phenotypes. A key
strength of this dissertation project is the variety in the methodologies explored in
untangling the influences of genes and the environment on tobacco use behaviors in
young adulthood – an understudied population – and the amount of training opportunities
afforded from the conducting analyses for and writing up this dissertation.
The studies included in this project focused primarily on the transition from adolescence
to young adulthood, to capture the critical period of change during the lifespan and a time
at which the use and abuse of substances peak. Given that tobacco use among young
adults is both prevalent and associated with several adverse consequences, it is
important to understand factors contributing to tobacco use behaviors. This dissertation
accomplishes this through multiple methodologies, including: reviews of existing literature
on genes, environment, and tobacco use; twin studies of genetic and environmental
influences on tobacco use behavior phenotypes; epidemiological studies of prevalence,
correlates, and predictors of tobacco use behaviors; genomic analyses of tobacco use
behaviors; a commentary on the emergence of alternative nicotine delivery systems and
its public health impacts; and, plans for an internet-based educational intervention
seeking to reduce tobacco use (and nicotine dependence) by providing students
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attending university with information on genetic and environmental risk factors for nicotine
dependence.
Of course, although the work accomplished in this set of studies is extensive, it is far from
exhaustive. With the changing climate of tobacco use behaviors and available products,
further research is needed to not only uncover new environmental risk factors contributing
to tobacco use in a broader sense, but also to investigate more deeply the genetic and
environmental influences on tobacco use that are already known – which I hope comes
across clearly from reading this dissertation thesis.
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